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ABSTRACT 
This report describes two methodology studies dedicated towards development of metal catalysed cross-
coupling reactions in the synthesis of novel heterocyclic compounds. 
 
Firstly, a Heck-Mizoroki arylation reaction is reported for the direct functionalisation of tetrahydropyridines, 
towards the synthesis of kainoid analogues.  Kainoids are a group of non-proteinogenic pyrrolidine 
dicarboxylic acids, which have attracted considerable interest because of their potent biological activity, 
including insecticidal, anthelmintic and neuroexcitatory properties.  The ideal synthesis of kainoids would 
allow the ability to introduce various side chains at the C-4 position to access diverse pharmacologically 
active kainoid analogues.  Tandem asymmetric Heck-Mizoroki arylation reaction and [2,3]-sigmatropic 
rearrangement provides a quick and efficient way to access these molecules. The Heck-Mizoroki arylation 
of 1-methyl-1,2,5,6-tetrahydropyridine and its hydrochloride salt is reported, with the arylation in the 3-
position of the  tetrahydropyridine as the major product.  The reaction has been applied to a variety of 
substituted aryliodides, with promising results, demonstrating functional group tolerance of the method, 
however isolation and purification of the resulting compounds has remained challengeing.  Diarylation of 
tetrahydropyridines has also been achieved.    
 
Secondly, a new catalytic method for arylative spirocyclisation is reported, using stoichiometric Grignard 
reagents and iron(III) catalysts, to induce cyclisation of (2-iodo)benzyl ethers of furan in a highly 
stereoselective manner to produce novel functionalised spirocyclic compounds.  Method optimisation and 
application of a variety of Grignard reagents is reported with aryl cross-coupling achieved in high yields.  
Alkyl- cross coupling has also been achieved with ethylmagnesium bromide Grignard reagent. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Cross-Coupling Reactions – General Overview 
During the second half of the 20th century, transition metals have come to play an important role in 
organic chemistry, leading to the development of a large number of transition metal-catalysed reactions 
for creating organic molecules. Transition metals have a unique ability to activate various organic 
compounds and through this activation they can catalyse the formation of new bonds. The development 
of metal-catalysed cross-coupling over the last four decades has revolutionised carbon-carbon bond 
construction, allowing chemists to assemble complex molecular frameworks with a wide range of 
applications, including total synthesis of natural products,
[1]
 medicinal chemistry,
[2]
 and industrial process 
development
[3]
 as well as chemical biology,
[4]
 materials,
[5]
 and nanotechnology.
[6]
 
 
Table 1. Common cross-coupling reactions 
 
 
Cross-Coupling 
Reactions 
Catalyst M R R' X 
Kumada-Corriu 
(1972)
[7]
 
Ni or Pd Mg Aryl, alkyl, vinyl Aryl, alkyl, vinyl Cl, Br, I, 
OTs 
Sonogashira 
(1975)
[8]
 
Pd/CuI Cu Alkyne Aryl, alkyl, vinyl Br, I 
Negishi (1977)
[9]
 Ni or Pd Zn Aryl, allyl, benzyl, 
propargyl 
Aryl, alkyl, vinyl, 
alkynyl, benzyl, 
allyl 
Cl, Br, I, 
OTs 
Stille (1978)
[10]
 Pd Sn Aryl, vinyl,benzyl, 
alkynyl 
Aryl, alkyl, vinyl, 
benzyl, allyl, acyl 
Cl, Br, I, 
OTs 
Suzuki (1979)
[11]
 Pd B Aryl, alkyl Aryl, alkyl, alkynyl Cl, Br, I, 
OTs 
Hiyama (1988)
[12]
 Ni or Pd Si Aryl Aryl, alkyl, vinyl Br, I, OTs 
 
With the exception of the Sonogashira cross-coupling which involves an alkyne, in general, cross-
coupling reactions involve combining a substrate (organic electrophile) with a coupling partner 
(organometallic nucleophile) reacting in the presence of a substoichiometric transition metal catalyst, 
R'-X + R-MX' R-R' + MXX'
catalyst
substrate
(organic 
electrophile)
coupling partner
(organometallic
nucleophile)
coupling 
product
metal halide
or salt
R = alkyl, aryl, vinyl, allyl, alkynyl, benzyl
R' = alkyl, aryl, vinyl, allyl, alkynyl, benzyl, acyl
X = I, Br, Cl, OTf, OTs
M = Mg, Zn, Cu, Sn, Si, B
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most commonly palladium or nickel (typically 1-10 mol%), to form the desired coupling product and a 
metal halide/salt (Table 1).  
 
1.2 Palladium Catalysed Cross-Coupling Reactions  
Palladium-catalysed reactions have become a crucial part of organic synthesis, and have greatly 
improved the possibilities for chemists in the creation of sophisticated compounds.
[13]
  Among palladium-
catalysed transformations, the Heck reaction and related chemistry has become a vital and highly utilised 
tool for synthetic chemists, being recognised with the award of the Nobel prize in Chemistry in 2010, 
awarded jointly to Richard Heck, Ei-ichi Negishi and Akira Suzuki for the develoment of palladium-
catalysed cross-couplings.   
 
1.2.1 The Heck-Mizoroki Reaction 
In the late 1960s,
[14]
 Heck reported that olefins may be arylated in the presence of a stoichiometric 
amount of arylpalladium complex, generated in situ by reacting phenylmercury chloride with palladium(II) 
chloride or phenylmercury acetate with palladium acetate (Scheme 1).
[15]
 In 1971, Mizoroki reported 
preliminary results on the palladium(II) chloride catalysed arylation of alkenes by iodobenzene 1 in the 
presence of potassium acetate as base (Scheme 2).
[16]
   
 
Scheme 1. Heckʼs arylation of olefins by group VII metal aryls 
 
 
Scheme 2. Mizorokiʼs arylation of olefins with aryl iodides catalysed by palladium 
 
The Heck-Mizoroki reaction is a cross-coupling reaction between aryl halides and olefinic compounds.  In 
the presence of a base and substoichiometric amount of palladium(0) catalyst or palladium(II) pre-
catalyst, olefinic compounds are formed, in which the aryl, benzyl or styryl group has replaced an alkenyl 
proton of the original olefin.
[17] 
 Since its discovery, this methodology has been found to be very versatile 
and applicable to a wide range of aryl species and a diverse range of olefins.  
 
Heck-Mizoroki reactions may proceed through one of two mechanistic pathways: neutral mechanism and 
ionic mechanism (Scheme 4).   Both mechanisms involve the same fundamental processes, initiated by 
pre-activation of the palladium species to generate a palladium(0) catalyst (A, Scheme 3), which 
PdCl2 or 
Pd(OAc)2 (1 eq)
30oC
MeCN, 15-24 hrs
88% yield
O
O
O
O
HgCl
+
PdCl2 (10  mol%)
CH3COOK
MeOH
120 oC, 2 hrs
90% yield
I
+
1
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undergoes oxidative addition with an organohalide (B, Scheme 3).  Association with the olefin (C, Scheme 
3) and migratory insertion follows, producing an intermediate species (D, Scheme 3), which can then 
undergo β-hydride elimination to release the cross-coupled product (E, Scheme 3).  In the presence of a 
base, the activated palladium(0) catalyst is regenerated (A, Scheme 3). 
 
Scheme 3. General Heck-Mizoroki Catalytic cycle 
 
By altering reaction conditions, one pathway may be accessed in preference to the other, for example the 
reaction of alkenyl and aryl halides may be directed into the cationic pathway by the addition of a silver or 
thallium salt, which acts as a halide scavenger (Scheme 4).  Alkenyl and aryl triflates may progress 
through the neutral manifold by addition of tetrabutylammonium salts.
[18]
 
Pd(0) or Pd(II)
precatalyst preactivation
PdL2
Pd LL
X
R'
R'X
oxidative addition
PdL
X
R'
R
R
L
Pd LL
X
R
R'
L
migratory insertion
!-hydride
elimination
R
R'
base
base.HX
regeneration
Pd LL
X
H
A
B
C
D
E
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Scheme 4. Neutral (blue) and Ionic (red) Heck reaction pathways
[19] 
 
Heck-Mizoroki reactions have traditionally been carried out in polar aprotic solvents at high reaction 
temperatures (often >100 
o
C), in the presence of a stabilising ligand, which is often phosphine based, and 
a base to facilitate reductive elimination.  Recent advances have however allowed for milder conditions to 
be developed resulting in many procedures utilising room temperature reactions.
[20]
   
 
Jeffrey conditions, first reported in the 1980s
[21]
 enabled reaction temperatures to be greatly reduced 
without the requirement for high catalyst loading, through the combination of a phase-transfer catalyst (a 
tetraalkylammonium salt) and insoluble base, resulting in an acceleration of the reaction rate.  For 
example, iodobenzene (1) was successfully cross-coupled with methyl acrylate (2) in the presence of 
tetrabutylammonium chloride (3) in quantitative yield.  In the absence of 3 only 2% of the cross-coupled 
product was obtained (Scheme 5).
[22]  
The acceleration of reaction rate in the presence of 
tetraalkylammonium salts is reported as due to assistance of the salt in the regeneration of the zerovalent 
palladium catalyst by decomposition of the hydride-palladium species.  
 
Scheme 5. Jeffery Conditions 
 
In the presence of an organic base, Jeffery proposes a nucleophilic mechanism involving hydrogen 
bonding between the hydridopalladium halide and the ammonium salt (Scheme 6).
[23]
   
R
Ph
R
R
Ph
PhX
Pd
Ph
R
Ph
Ph
PhX
X
R
R
Base
Base.XH
neutral pathwayionic pathway
PdL2
R R
XL
L
Pd
Ph
L
L
Pd
X
L
L
Pd
Ph
XL
L
Pd
Ph
X
L
Pd
L
X
L
Pd
L
L
H
X
I
+ CO2Me
Pd(OAc)2 [5 mol%]
NaHCO3, 3A MS
DMF, 50 oC, 2 hrs
CO2Me
0 eq nBu4NCl (3) 2% yield
1 eq nBu4NCl (3) 99% yield
1 2
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Scheme 6. Jeffery Conditions, where RX = tetraalkylammonium salt 
 
The Heck-Mizoroki cross-coupling of heterocycles has been widely explored and applied to a large array 
of compounds of varying complexity.  For example, Kaufmann utilized reductive Heck conditions in the 
synthesis of the alkaloid epibatidine (4, Scheme 7) utilising triphenylarsine ligand (5) in place of the more 
commonly applied phosphines.
[24]   
Under reductive Heck conditions, the saturated
 
compound 4 was 
obtained in place of the standard Heck product, which would lead to a highly strained bridgehead olefinic 
system. 
 
Scheme 7. Synthesis of epibatidine (4) 
 
Triphenylarsine ligands are often utilized due to the observed increase in reaction rate.   Farina and 
Krishnan demonstrated that in the Suzuki reaction, rate accelerations as large as 10
3
 may be observed 
when arsine ligands are applied in place of the corresponding phosphines.
[25]
  This has been attributed to 
the soft AsPh3 ligand being thermodynamically and kinetically more labile than PPh3, which resulted in 
more rapid ligand dissociation in the rate determining transmetalation step.
[26]
  
 
Cross-coupling reactions with heterocycles may also be achieved intramolecularly, and in the presence of 
water as demonstrated by Sinou, resulting in the formation of bicyclic compounds with migration of the 
double bond (Scheme 8).
[27] 
 
Scheme 8. Intramolecular Heck reaction 
 
For the utilisation of aqueous solvent systems, hydrophilic ligands have been prepared such as 
triphenylphosphine trisulfonate (TPPTS, 6) and monoguanidino phosphine (7) (Figue 1).
[28]
 These have 
been applied to a range of cross-coupling reactions including intramolecular reactions of heterocyclic 
compounds resulting in a widening of reaction scope (Scheme 9). 
RX   +   [H-Pd-X'] Pd
H
X'
X
R
[Pd(0)]   +   HX.RX'
NR3
R3N.HX   +   RX'
N
O
MeO
+
N Cl
I
N
O
MeO
N Cl
Pd(OAc)
Ph3As (5)
NEt3, HCOOH
DMSO
92% yield
4
O
HO
O
Br
OEt
Pd(OAc) [5 mol%]
PPh3 (2 eq)
NEt3, Bu4NHSO4
MeCN-H2O, 80 
oC
O
HO
O
O
HO
O
[PdBr]
via
OEt
O
HO
O
[PdBr]
OR
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Figure 1. Water soluble phosphine ligands 
 
 
Scheme 9. Aqueous Intramolecular Heck reaction of nitrogen hetoercycles with Ligand 6
[29] 
 
Only limited Heck cross-couplings on N-alkyl heterocycles have been reported.
[30]
  N-Acyl heterocycles 
have been more widely investigated, such as N-substituted 2,5-dihydropyrroles, which have been 
successfully cross-coupled with aryl halides (and triflates) in moderate to high yields (47-70%, Scheme 
10).
[31]
 
 
Scheme 10. Heck reaction of pyrrolines 
 
1.2.2 The Heck-Matsuda Reaction 
Heck reactions performed with arenediazonium salts are frequently referred to as the Heck–Matsuda 
(HM) reaction to acknowledge the extensive investigations carried out by the group of Matsuda in 
developing this methodology.  The HM reaction, first reported by Tsutomu Matsuda in 1977,
[32]
 is a 
palladium-catalysed arylation of olefins with arenediazonium salts in place of the traditionally used halides 
or triflates. The arylation of ethylene (9) may be achieved in good yields with a variety of substituted 
aryldiazonium tetrafluoroborate salts (10) at room temperature in only one hour (Scheme 11).
[33]
  
 
P SO3
SO3
O3S
P N
H
NH
NH
6 7
N
O
I
Pd(OAc)2
Ligand (6)
 
NEt3, Na2CO3
MeCN-H2O (1:1)
 95 oC, 50% yield
N
O
N
H
I
Pd(OAc)2
Ligand (6)
NEt3, Na2CO3
MeCN-H2O (1:1)
 25-40 oC, 97% yield
N
H
X
R +
N
CO2Me
Pd(OAc)2 [5 mol%]
P(o-tol)3 [11 mol%]
iPr2NEt (4 eq)
Ag2CO3
DMF, 100 oC, Ar
N
CO2Me
R R = H, X = I,                68% yield
R = o-OMe, X = I,        47% yield
R = p-OMe, X = I,        56% yield
R = m-CF3, X = I,         63% yield
R = m-SO2Me, X = Br, 70% yield
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Scheme 11. Heck-Matsuda reaction of ethylene (9) with functionalised diazonium tetrafluoroborates (10) 
 
Later, Matsuda evaluated different olefins and catalytic systems with arenediazonium salts, with highest 
yields obtained using Pd2(dba)3 as catalyst, NaOAc as base, and acetonitrile as solvent.
[34]
 
 
Amongst the various arylating agents currently available for the Heck reaction, arenediazonium salts are 
among the least explored, despite offering some economic and environmental advantages when 
compared to traditional electrophiles (halides and triflates).  
 
Reactions involving the diazonium salts are often more efficient than the Heck-Mizoroki reaction, requiring 
a reduced reaction time, providing the arylated products faster.
[35]  
The efficiency and high reactivity of 
arenediazonium salts are related to the ease with which they undergo oxidative addition with zerovalent 
palladium at the C–N2
+
 bond,
[36]
 generating highly reactive cationic palladium species during the catalytic 
cycle (Scheme 12). Consequently, the reactions can be carried out at milder temperatures. 
 
Aryl halides may pass through a neutral or ionic Heck-Mizoroki mechanism (Scheme 4)
[37]
 however, Heck 
reactions involving arenediazonium salts operate under a polar cationic mechanism, due to the Pd–N2 
bond being labile and easily ionizes after oxidative addition to liberate molecular nitrogen, leading to the 
cationic palladium species (Scheme 12).  
 
 
Scheme 12. Mechanism of the Heck-Matsuda reaction 
 
In general terms, the catalytic cycle for the HM arylation reaction involves four steps; oxidative addition of 
Pd
0
 with the arenediazonium salt resulting in a cationic palladium intermediate by elimination of N2, 
R
N2BF4
+
Pd(dba)2 [2 mol%]
NaOAc (3 eq)
acetone/DCM (1:1)
rt, 1 hr
61-78% yield
R
10 9 8
R = Me, CH2O, CO2Et, Cl, Br, NO2
Pd(0)L2
R
Ar-N2
Base
Base.HI
oxidative addition
migratory insertion
syn !"elimination
reductive elimination
ArPdN2L2
ArPd+L2
N2
R
Pd+L2
Ar
H H
R
Pd+L2
H
H Ar
HPd+L2
Ar
R
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migratory insertion leading to the formation of a new C-C bond, syn β-hydride elimination to form the 
Heck adduct and palladium hydride, and reductive elimination to restore the active catalyst (Scheme 
12).
[38]
  
 
Although arenediazonium salts undergo oxidative addition with Pd with relative ease, the subsequent 
cationic intermediate is only weakly stabilised by the coordinating solvent (or acetate) and is therefore 
prone to aggregation, forming inactive palladium-black (Figure 2).  Phosphanes are able to transfer an 
electron to arenediazonium salts, resulting in an arene radical, destabilising the cationic palladium 
intermediate.  The HM reaction is therefore incompatible with phosphanes. 
 
Figure 2. Palladium black aggregation
[39] 
Reproduced from ref. 39 with permission from The Royal Society of Chemistry. 
 
Carbenes derived from imidazole, pyrazole and triazole derivatives have been reported to be good, 
stabilising ligands for palladium due to the ability for σ-donation, forming stable metal adducts.
[40]
 These 
carbene complexes have high thermal stability, and are able to be used in place of phosphine ligands due 
to their nucleophilic behaviour.  Carbene ligands are also inexpensive, and can be easily prepared from 
azolium salt precursors which are are stable in the presence of air and moisture.
[41]
  
 
Song reported the cross-coupling of a range of olefins including methyl acrylate (2) (Scheme 13) with aryl 
diazonium tetrafluoroborates at room temperature in the presence of an imidazolium carbene; N,N-
bis(2,6-diisopropylphenyl)dihydroimidazolium chloride and palladium(II) acetate (11, 2 mol %), giving 
products within 2 to 4 hours in 80−90% yields.
[42]
 
 
Scheme 13. Heck-Matsuda reaction of methylacrylate (2) with functionalised diazonium tetrafluoroborates 
 
Heck-Matsuda reactions have also been applied to cross-coupling of heterocycles, such as in the 
synthesis of the alkaloid codonopsine (12), resulting in high yields of the target product under phosphine-
N N
iPr
iPr iPr
iPr
Cl
+ Pd(OAc)2
Pd cat
+
Pd cat
THF, rt
3 hrs
N2BF4
R
OMe
O
R
OMe
O
R = H,       68% yield
R = o-Me,  66% yield
R = m-Me, 64% yield
R = p-Me,  65% yield
R = o-OMe,   70% yield
R = p-OMe,   71% yield
R = p-Br,       81% yield
2
11
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free conditions, eliminating the need for expensive ligands (Scheme 14).
[43]
   
 
Scheme 14. Heck-Matsuda Reaction in synthesis of codonopsine 
 
Correia reported the ligand-free Heck-Matsuda arylation of substituted acrylates using several 
arenediazonium tetrafluoroborates, without requiring anhydrous, inert conditions.  This resulted in the 
synthesis of the corresponding substituted acrylates in moderate to high isolated yields (43-92%) 
irrespective of the electronic nature of the substituents on the arenediazonium tetrafluoroborates 
employed (Scheme 15).
[44]
  
 
Scheme 15. Heck-Matsuda Reaction 
 
Correia also reported asymmetric Heck-Matsuda arylations using chiral bisoxazoline ligands, with good to 
excellent yields (63–91%) in enantiomeric excesses from 60% to 84% ee (Scheme 16).
[45]
    
 
Scheme 16. Asymmetric Heck-Matsuda Reaction 
 
1.3 Alternative Metal Catalysts for Cross-Coupling Reactions 
As described, metal complexes have become essential for organic synthesis, allowing access to a wide 
variety of fast, efficient, clean and selective processes.
[46]
  The demand for metal-based reagents, 
especially those which can be used catalytically in processes such as cross-coupling, or which can be 
recovered and recycled is continuing to increase.  Many catalysts have a high toxicity and are often 
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expensive, as they are derived from heavy or rare metals.  Both the expense and toxicity of these 
reagents are drawbacks for large scale application, increasing the cost of production and requiring 
thorough purification to remove any trace metals from product streams.  Replacing materials with metals 
of higher natural abundance, particularly in applications that use large amounts of catalysts is highly 
beneficial.  Due to the increased abundance, these materials are often less susceptible to supply 
fluctuations and therefore cheaper.
[47]
   
 
Although palladium loadings in catalytic processes can be very low and so the financial cost of the 
catalyst is not a significant facter in the overall process, palladium is not an abundant metal, and therefore 
has limited supply.  One of the most abundant metals on Earth is iron (second to aluminium, iron 
abundance in Earthʼs crust is 5.0% by weight, palladium 0.015% by weight).  Although iron is inexpensive 
and environmentally benign, it is only recently that iron-catalysed processes have begun to be 
investigated.  This includes cross-coupling reactions, with some very efficient processes recently being 
reported,
[48]
 which have been shown to be able to compete with other more commonly used metals.     
 
The interest in iron catalysis may be attributed to the fact that iron salts are inexpensive, readily 
accessible, generally nontoxic and environmentally benign.  Despite the advances in iron-catalysed cross-
coupling, mechanistic understanding remains largely unknown due to the actual active catalytic species 
usually being generated in situ as ill-defined but highly sensitive and short-lived entities.   
 
Various oxidation states for the catalytic species have been reported including Fe(-II)/Fe(0), Fe(0)/Fe(II) 
and Fe(I)/Fe(III).  Other mechanisms not based on redox processes have also been reported, applying 
nucleophilic organoferrate complexes of a different composition as the intermediates, based on principles 
governing organocopper chemistry.
[49]
  Overall, the chemistry of iron represents an under-investigated 
area of organometallic research. 
 
Since the discovery of the reaction of compounds with the general formula RMgX with carbonyl 
compounds by Grignard in 1900,
[50]
 efforts have been devoted to investigating the reactivity of such 
species and to develop new applications in the synthesis of natural and synthetic compounds. Grignard 
reagents continue to be synthetic tools of high importance for organic chemists and are frequently used in 
the laboratory.
[51]
  In addition, numerous industrial applications have also been reported, such as in the 
synthesis of the nonsteroidal anti-inflamatory drug Naproxen (Scheme 17).
[52]
  The introduction of 
transition metal catalysts has greatly expanded the reactivity of Grignard reagents and therefore their 
utility in organic synthesis. 
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Scheme 17. Grignards in the synthesis of Naproxen 
 
As early as 1972 Corriu and Kumada independently developed nickel-catalysed coupling reactions of 
Grignard reagents with alkenyl halides (Scheme 18 and Scheme 19 respectively).
[53]
 However, the year 
before, Kochi had shown that iron salts could be used as catalysts for the same purpose (Scheme 20).
[54]
 
These early iron-catalysed cross-couplings were performed with vinyl bromide derivatives and 
alkylmagnesium reagents, with catalytic iron(II) or iron(III) salts. 
 
Scheme 18. Corriuʼs nickel-cataysed coupling with Grignards 
 
 
Scheme 19. Kumadaʼs nickel-cataysed coupling with Grignards 
 
 
Scheme 20. Kochiʼs iron catalysed cross-coupling with Grignards 
 
Important contributions in the cross-coupling of alkenyl halides with organometallic species were made by 
Cahiez, who greatly increased the scope of the reaction by demonstrating the possibility, in the presence 
of iron acetylacetonate (13), of the cross-coupling of alkenyl iodides, bromides and chlorides with 
Grignard reagents.  Cahiez first recognised the advantages associated with the use of N-methyl-
pyrrolidinone (NMP, 14) in the iron-catalysed vinylation process leading to high yields, with ca. 80% yields 
of the cross-coupling products compared to the same reaction in THF, where less than 5% yield was 
obtained (Scheme 21).
[55]
  The discovery of this solvent effect had significant consequences in the 
development of the process. 
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Scheme 21. Effect on reaction yield by incorporation of NMP co-solvent 
 
NMP as a co-solvent suppresses the formation of side products formed through halogen-hydrogen 
reduction.  It also allows alkenyl halides to react readily with a variety of aryl and alkyl Grignard reagents 
to afford highly substituted olefins with retention of configuration and drastically improved yields.
[56]
 The 
polar nature of 14 is believed to help stabilise the iron organometallic species in the catalytically active 
species.
[57]
 
 
Cahiez also investigated the nature of the iron salt used as catalyst, and observed no difference by 
replacing Fe(acac)3 (13) with Fe(dpm)3, Fe(dbm)3 or FeCl3.  However, in the absence of 14 the catalyst 
deeply influences the course of the reaction.  In the absence of NMP, Fe(dpm)3 and Fe(dbm)3 were found 
to be more efficient catalysis than Fe(acac)3, and lowest yields obtained with FeCl3,
[58]
 again suggesting 
that 14 has a stabilising effect on the iron-organometallic species.   
 
Mechanistic studies of the metal-catalysed (iron and cobalt) cross-coupling reaction of Grignard reagents 
with vinyl bromides have been carried out by Hoffmann,
[59]
 in which an enantiomerically enriched chiral 
organomagnesium species was used (Scheme 22).  With Fe(acac)3 as catalyst, the transmetallation step 
was suggested to be a a single electron transfer (SET) process.  This was based on observed partial 
racemisation of the final product. 
 
Scheme 22. Hoffmanʼs mechanistic study of the metal-catalysed cross-coupling 
 
Both Kochi
[60]
 and Fürstner
[61]
 have proposed catalytic cycles for the iron catalysed cross-coupling, from 
Fe(III) pre-catalyst where Fe(I) is the reported active species (Scheme 23, cycle A), and from Fe(II) pre-
catalyst where Fe(-II) is the reported active species (Scheme 23, cycle B).  
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Scheme 23. Kochi
 
(A) and Fürstner
 
(B) proposed iron catalysed cross-coupling catalytic cycles 
 
Fürstner conducted extensive investigations with a series of organoiron complexes and showed that 
Ph/MeMgBr and EtMgBr (and higher chains) exhibit significantly different behavior.  They reported that in 
attempted cross-coupling reactions of aryl chlorides with EtMgBr (or higher alkyl Grignard reagents) in the 
presence of Fe(acac)3 (13) or FeCln (n = 2, 3) as precatalyst, the desired product was obtained in virtually 
quantitative yield within minutes, whereas MeMgBr failed to react (Scheme 24). 
 
Scheme 24. Behaviour of different Grignard reagents towards cross-coupling 
 
Fürstner characterised a number of iron complexes, and concluded that nucleophiles unable to undergo 
β-hydride elimination, such as MeLi, PhLi, or PhMgBr, rapidly reduce Fe(III) to Fe(II) and then 
exhaustively alkylate the metal centre, whereas higher chains form a different iron complex intermediate 
which undergoes cross-coupling.
[62]
  
 
Iron-catalysed cross-coupling has been shown to be sensitive to steric hindrance exerted by α-
substituents at the cross-coupling site.    Fürstner examined the cross-coupling of a variety of cyclic 
alkenyl triflates and found a significant reduction in the reaction yield in the presence of a methyl 
substituent α- to the triflate  (Table 2).
[63]
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Table 2. Effect of an α-substituent on cross-coupling 
 
Entry R
1
X RMgX R-R
1
 Yield (%) 
1 
 
C4H9MgCl 
 
80% 
2 
 
C4H9MgCl 
 
53% 
3 
 
C14H29MgCl 
 
67% 
4 
 
C14H29MgCl 
 
17% 
 
1.3.1 Synthesis of Grignard Reagents 
Grignard reagents are classically prepared by combining activated magnesium with an organic halide, in 
a suitable anhydrous ethereal solvent (such as THF or diethyl ether).
[64] 
 Magnesium metal is usually 
unreactive due to the formation of an oxide layer on its surface, and therefore is often activated by the 
addition of small amounts of iodine, 1,2-diiodoethane or 1,2-dibromoethane.   The ethereal solvent also 
acts to dissolve and stabilise the Grignard reagents, by forming Lewis acid base complexes (Scheme 25).  
 
Scheme 25. Synthesis of Grignard reagents, with stablilisation from co-ordinating solvent 
 
The use of activated magnesium for the preparation of Grignard reagents is not always possible, since 
highly electrophilic functional groups inhibit the insertion of magnesium into the carbon-halogen bond.
[65]
 
Knochelʼs chemoselective magnesium-iodine exchange reaction provides an alternative route to these 
highly functionalised Grignard reagents.
[66]
  The method has been extensively utilised in the synthesis of 
alkenyl-, aryl- and heteroarylmagnesium reagents which are not commercially available.  The process 
involves exchange of a halide with isopropyl magnesium bromide (15) or chloride, to give the desired 
Grignard, which may then be utilised in subsequent cross-coupling reactions (Scheme 26).  In this way, 
functional groups such as iodides, esters, imines, nitriles and nitro groups can be incorporated in a wide 
range of aromatic and heterocyclic organomagnesium reagents. 
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Scheme 26. Knochelʼs magnesium!iodine exchange reaction 
 
The magnesium-halogen exchange process occurs due to the position of the equilibrium lying in favour of 
the formation of the aryl Grignard over the alkyl Grignard as a result of the stability of the intermediate 
carbanion species.  sp-Hybridised carbanions are of higher stability than sp
2
-hydridised carbanions, 
which are of higher stability than sp
3
-hybridised carbanions (Scheme 27).   
 
 
Scheme 27. Stability of metal carbanions in the magnesium iodine exchange reaction 
 
Hence, the formation of aryl Grignards is the favoured process.  The rate of magnesium-halogen 
exchange is also accelerated by electron-withdrawing groups on the aromatic ring, and is slowed by 
electron-donating groups.
[67]
 
 
1.3.2 Metal-Catalysed Cyclisations in the Generation of Spirocycles  
In 1900, Baeyer first introduced the term ʻspirocyclaneʼ to represent two rings which are connected 
through one atom to form a rigid tetrahedral center fused at a common quaternary carbon center (spiro 
carbon atom).
[68]
  Spirocyclic structures have been found in a wide range of natural and clinically valuable 
compounds,
[69] 
access to which may be achieved through synthetic construction of these spirocentres.   
 
Spirocyclic compounds are named based on the number of carbon atoms in the ring structure, with the 
given prefix spiro[x.y], where x and y are the number of atoms in the links that make each ring, excluding 
the spirocentre itself, listed in increasing magnitude.   For substituted spiroalkanes, the rings are 
numbered starting on the smallest ring attached to the spirocentre (for examples see Figure 3). 
 
Figure 3. Spiroalkane nomenclature 
 
The construction of spirocyclic centres can be categorised into four main synthetic approaches: alkylation, 
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rearrangement, cycloaddition and cleavage of bridged systems. Intramolecular alkylation of a tertiary 
carbon center is one of the most common methods of constructing spirocentres. Iwata
[70]
 reported the 
stereoselective synthesis of spiro[5.5]undecane systems using Lewis acid promoted spiroannulation of 
acetals (Scheme 28).  A tandem reaction involving ynamines was used by Ficini
[71]
 during the synthesis of 
acoradiene (Scheme 29).  Spiroannulation was employed by Brands and DiMichele to synthesise the 
functionalised pyrrolo[2,3-i]isoquinoline subunit of manzamine A (Scheme 30).
[72] 
 
Scheme 28. Iwataʼs stereoselective synthesis of spiro[5.5]undecane systems 
 
 
Scheme 29. Ficiniʼs spiroannelation reaction towards acoradiene synthesis 
 
 
Scheme 30. Brands and DiMicheleʼs synthesis of functionalised pyrrolo[2,3-i]isoquinoline 
 
Heck reactions have also been employed in the generation of spirocenters.  Overman reported a 
intramolecular palladium-catalysed Heck reaction of trienyl triflate in a bis-cyclisation, with excellent yield 
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and modest enantioselectivity (Scheme 31).
[73]
   
 
Scheme 31. Overmanʼs intramolecular Heck reaction 
 
Overman improved the enantioselectivity in the reported asymmetric synthesis of spiro-oxindoles from the 
corresponding aryl iodide, by palladium catalyzed cyclisations using the chiral ligand BINAP (Scheme 
32).
[74]
 Overman found that cyclisations also occurred with good enantioselectivity without incorporation of 
the silver salt (an HI scavenger). 
 
Scheme 32. Overmanʼs asymmetric intramolecular Heck cyclisation 
 
 
1.4 Project Goals 
This project had two main aims, firstly to employ metal-catalysed processes in the development of a 
simplified method to functionalise nitrogen containing heterocycles, which may allow access to 
compounds of pharmaceutical interest.  These functionalised compounds are intended for further 
application to rearrangement chemistry which has previously been developed in our group to access 
kainoids.  In order to access these kainoids with the desired stereochemistry, exploitation of quaternary 
cyclic nitrogen centres were investigated in an attempt to access single enantiomers of quaternary 
ammonium salts.  When these salts are applied to the developed rearrangement chemistry, access to 
kainoid analogues with controled facial selectivity can be achieved, implimenting desired stereochemistry.    
 
Through investigations into metal catalysed cross-coupling reactions, more economically viable and lower 
toxicity metals were investigated, predominantly iron.  Althought the cross-coupling reaction of primary 
interest was not successful in the presence of iron, a second arylative-spirocyclisation reaction was 
developed which is also reported herein. 
 
1.5 Kainic Acid and Analogues as Target Molecules 
In the mammalian central nervous system (CNS), glutamic acid (16) is the primary excitatory 
neurotransmitter.
[75] 
 Abnormalities in glutamatergic transmission at synapses in the brain have been 
linked to a wide range of CNS disorders which includes Huntingtonʼs, Alzheimerʼs and Parkinsonʼs 
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diseases.
[76]
 The development of glutamate mimics which may regulatate these abnomalities has become 
a challenging synthetic target for chemists in the potential treatment of symptoms associated with these 
disorders.  
 
Amino acids bind to cellular trans-membrane proteins, leading to a conformational change of the receptor 
protein, which stimulates a signal within the cell via secondary messengers.  The mode of action of the 
secondary messenger determines receptor type as ionotropic or metabotropic.  Ionotropic receptors 
rapidly activate cation specific ion channels (Na
+
, K
+
 and Ca
2+
), whereas metabotropic receptors are 
large, single-membrane proteins coupled via G proteins to intracellular signaling enzymes or ion channels 
in comparatively slower processes.
[77]
 
 
The ionotropic receptors can be divided into three subgroups, named according to their agonists: kainic 
acid (17), N-methyl-D-aspartate (NMDA, 18) and 2-amino-3-(3-hydroxy-5-methyl-4-isoazoyl)-propionic 
acid (AMPA, 19) receptors (Figure 4). 
 
 
Figure 4. Glutamic acid and ionotropic receptors 
 
Kainic acid (17) is the parent member of the kainoid amino acid family;
[78] 
a group of non-proteinogenic 
pyrrolidine dicarboxylic acids, with three asymmetric centres at positions 2, 3 and 4 of the pyrrolidine ring.  
Kainic acid (17, originally known as digenic acid) was first isolated in 1953 from the Japanese marine 
algae Digenea simplex.
[79]
  Kainoids have attracted considerable interest largely because of their potent 
biological activity, in particular their insecticidal, anthelmintic and neuroexcitatory properties.
[80]
 Kainate 
analogues are therefore compounds of pharmacological interest. 
 
Trans-2-carboxy-3-pyrrolidine-acetic acid (CPAA 20) is an important conformationally restricted glutamate 
analogue bearing a pyrrolidine dicarboxylic acid structure,
[81]
 which represents the common amino acid 
moiety in many naturally occurring members of the kainoid family, including kainic acid 17,
[82]
 the 
acromelic acids 21 and domoic acid 22
[83]
 (Figure 5). 
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Figure 5. CPAA (20), acromelic acid A (21) and domoic acid (22) 
 
Acromelic acid A (21) is a potent neuroexcitatory amino acid member of the kainoid family, which was first 
isolated from the poisonous fungi Clitocybe acromelalga Ichimura (Japanese name, Dokusasako) by 
Shirahama, who isolated 110 mg from 16.2 kg of fungus.
[84]
  
 
Synthesis of the kainoid amino acids represents a considerable challenge, as the synthesis is required to 
address the formation of a pyrrolidine-2-carboxylic acid with defined stereochemistry at three adjacent 
chiral centres of the ring, bearing cis-stereochemistry at the 3 and 4 positions.   In addition an ideal 
synthesis would allow the ability to introduce various side chains at the C-4 position to afford various 
functionalised kainoid analogues. 
 
Since first being isolated, numerous groups have investigated the synthesis of acromelic acid A (21) and 
analogues, including Takano, who reported the synthesis of 21 in 1987 via 12 steps, starting from (S)-O-
benzylglycidol employing intramolecular [1,3]-dipolar addition as the key reaction (Scheme 28),
[85]
 Benetti 
utilised tandem Michael reaction methodology to synthesise 21 in 1993 (Scheme 29),
[86]
 and Baldwin 
reported the total synthesis via 13 steps in 9% yield in 1998 from commercially available trans-4-hydroxy-
L-proline (Scheme 30).
[87]
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(a) THF-HMPA, -70 
o
C to rt, 8 hrs; (b) H2/Lindlar catalyst, benzene, quinoline, rt, 24 hrs; (c) BrCH2CHBrCOCl, NEt3, 
DCM, 0 
o
C, 2 hrs, then C6H5CH2NH2, 0 
o
C, 2 hrs; (d) 200 
o
C, 1.7% in o-C6H4Cl2, 1.5 hrs; (e) H2/10%Pd-C, MeOH-
HCl, rt, 3 days; (f) (Boc)2O, 3N NaOH-dioxane (1:1), rt, 1 hrs, NaIO4(aq), 0 
o
C, 15 min, then KMnO4(aq), 0 
o
C, 2 hrs; (g) 
conc H2SO4, MeOH, reflux, 24 hrs; (h) (Boc)2O, NEt3, DCM, rt, 15 mins; (i) NaH, DBU, benzene, rt, 5 hrs; (j) mCPBA, 
DCM, rt, 24 hrs; (k) (CF3CO)2O, DMF, rt, 45 hrs; (l) KOH, TFA
[88] 
 
Scheme 33. Takanoʼs synthesis of acromelic acid A from (S)-O-benzylglycidol 
 
 
 
(a) O3, DCM/pyridine; (b) MeNO2, C5H11N (72% yield); (c) MeSO2Cl, NEt3 (82% yield); (d) CH2O, NEt3; (e) Ac2O, H
+
 
(90% yield); (f) Pd(PPh2)4, PPh3, HCO2NH4; (g) TBDMSCl, NEt3 (63% yield); (h) ACE-Cl then (Boc)2O (77% yield); (i) 
NaOMe, MeOH; (j) Jones reagent then CH2N2 (72% yield); (k) CAN, MeCN/H2O (50% yield); (l) KOH then TFAA 
(71% yield) 
 
Scheme 34. Benettiʼs synthesis of acromelic acid A 
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(a) NBS, AcOH, rt, then BnBr, K2CO3, DMF, rt; (b) 
n
BuLi, THF, -78 
o
C, then B(OMe)3, -78
o
C to 0
o
C, then NH4(aq); (c) 
Pd(Ph3)4, DME, 2M Na2CO3(aq), LiCl, Δ (67% yield); (d) NaBH4, MeOH, 0 
o
C (78% yield); (e) H2, catalyst, solvent; (f) 
Pd(OAc)4, MeOH, 0 
o
C (95% yield); (g) CrO3, conc. H2SO4, acetone, H2O then  CH2N2, Et2O, rt (54% yield); (h) 6M 
HCl(aq), 100 
o
C; (i) NH3(aq), rt, ion-exchange chromatography (quant. yield), actovated charcole, cellulose 
chromatography (60% yield); 
 
Scheme 35. Baldwinʼs total synthesis of acromelic acid A in 13 steps (9% yield) from 
trans-4-hydroxy-L-proline.
[89] 
 
Each of these routes involves multiple complex processes, resulting in extended linear syntheses.  Within 
this group, a method has been reported for the [2,3]-rearrangement of tetrahydropyridneyilds.  
Development of methodology to allow direct functionalisation of tetrahydropyridines by cross-coupling 
combined with [2,3]-rearrangement would enable a convergent synthesis to access a wide variety of 
analogues, with potential for a reduction in the length of the synthetic process.   
 
1.5.1 Tetrahydropyridines - Overview 
There are three isomeric tetrahydropyridines; 1,2,5,6-tetrahydropyridine (23), 1,4,5,6-tetrahydropyridine 
(24) and 3,4,5,6-tetrahydropyridine (25) (Figure 6). 
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Figure 6. Isomeric tetrahydropyridines 
 
The ground state conformation of all tetrahydropyridines confirmed by x-ray analysis is the half chair form.  
1,2,5,6-tetrahydropyridines (23) can exist in two half chair conformations, with the nitrogen substituent in 
the axial or equatorial positions (Figure 7).
[90] 
 
Figure 7. Half-chair conformation of 23 with axial and equatorial NH 
 
Since the discovery of the neurotoxic properties of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP, 
26), extensive research has been, and continues to be conducted on the synthesis and pharmacological 
properties of the compound and its analogues. The aim is to develop an extensive database for structure-
activity relationship (SAR) studies, leading towards a potential Parkinsonʼs disease treatment.  
Parkinsonʼs disease is a progressive neurodegeneration of the nigrostriatal dopaminergic neuron and is 
characterised by symptoms such as tremor, rigidity and poor balance.
[91]
  Studies have shown that MPTP 
is a potent neurotoxin in the dopaminergic system, producing Parkinsonʼs-like symptoms.
[92]
  The effects 
of 25 have been attributed to the oxidation of the molecule by monoamine oxidase (MAO) A and B.  
Through an oxidative biological cascade 26 is converted to MPP
+
, which accumulates in the central 
nervous system.  MPP
+
 is taken into the dopaminergic neurons and inhibits the production of cellular ATP 
in the mitochondria resulting in cell death (Scheme 36).
[93]
  
 
Scheme 36. Catalytic oxidation of MPTP by MAO-B 
 
Some synthetic analogues of MPTP have been shown to have affinity for MAO-B enzyme active site, and 
a number have been shown to display high potency for the enzyme.  These compounds have displayed 
significant pharmacological effects and demonstrated medicinal value that include dopaminergic, nicotinic 
and muscarinic receptor agonist/antagonist action.
[94]
  Molecules containing tetrahydropyridines have also 
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been examined for their uses as analgesics, anti-inflammatory agents, antipsychotic and nerve gas 
antidotes.  
 
Figure 8. MPTP (26) and Arecoline (27) 
 
Alzheimerʼs Disease (AD) and senile dementia of the Alzheimerʼs type (SDAT) are associated with a loss 
of neurone receptor activity in the brain.
[95]
  The effects of the disease are irreversible and believed to be 
a result of impaired cholinergic transmission and a depletion of acetylcholine in the forebrain.  In an 
attempt to replace the acetylcholine function of AD patients, muscarinic receptor agonists have been 
employed as therapeutic agents.  Arecoline (methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate, 
27, Figure 8) is an alkaloid natural product found in the areca nut, the fruit of the areca palm (Areca 
catechu).  Arecoline is known to be a partial agonist of muscarinic acetylcholine receptors.  Owing to its 
muscarinic agonist properties, arecoline has been examined for its clinical application to AD treatment.  
Administered intravenously, arecoline shows modest verbal and spatial memory improvement in AD 
patients,
[96]
 however due to its possible carcinogenic properties, and the low affinity of the ligand at 
muscarinic receptors, development of a more potent candidate for AD treatment is necessary. 
 
Our group has demonstrated that analogues of acromelic acid (21) may be accessed via the Sommelet-
Hauser [2,3] sigmatropic rearrangement of tetrahydropyridines.  A sigmatropic rearrangement is defined 
as migration in an uncatalysed intramolecular process, of a σ-bond adjacent to one or more π-systems, to 
a new position in a molecule, with the π-system becoming reorganised in the process.
[97]  
The order of a 
rearrangement is expressed in the form [a,b], where a and b refer to the number of atoms on either side 
of the bond broken.  Thus, in Scheme 37, a [3,3]-sigmatropic rearrangement is shown.
[98]
 
 
Scheme 37. Example of a sigmatropic rearrangement 
 
The Sommelet-Hauser rearrangement consists of the rearrangement of benzyl quaternary ammonium 
salts.   The [2,3]-rearrangement is a concerted process proceeding through a five membered, 6π 
electrocyclic transition state.  Sigmatropic rearrangements are not confined to entirely carbon systems,
[99]
 
with [2,3]-rearrangements often involving a heteroatom.
[100]
 [2,3]-Sigmatropic rearrangements proceed via 
a highly reactive ylid (a species bearing a positively charged heteroatom connected to a carbon atom 
possessing an unshared pair of electrons).
[101] 
  These ylid intermediates may be generated via treatment 
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of a salt with a base, or by use of a metal catalyst, to trigger decomposition of a diazo species to the 
corresponding electrophilic metal carbenoid.  Tautomeric proton transfer to rearomatise the ring results in 
the Sommelet-Hauser [2,3]-rearranged product (Scheme 38).
[102]
 
 
Scheme 38. Mechanism of Sommelet-Hauser [2,3] rearrangement 
 
[2,3]-Sigmatropic rearrangement of tetrahydropyridinium ylids was first reported in 1973 by Ollis, who 
carried out rearrangements of benzoyl stabilised ylids in boiling benzene to give cis-2-benzoyl-3-vinyl 
pyrrolines 28 (Scheme 39).
[103]
 
 
Scheme 39. Ollisʼs [2,3] rearrangement of benzoyl-stabilised cyclic ylids 
 
Our group has investigated [2,3] rearrangements of 1-methyl-1,2,5,6-tetrahydropyridines (NMTP 29) and 
the effect of substituents, to provide an alternative pathway for the synthesis of constrained amino 
acids.
[104]
  Under the reaction conditions, pyrrolidine carboxylic esters (30) may be accessed with trace 
amounts of the acyclic diene (methyl 3-aza-3-methyl-octa-5,7-dienoate, 31) also obtained. 
 
It was reported 
that  [2,3]-rearrangement of NMTP esters (32) could be achieved in moderate to good yields with a variety 
of substituted methyl esters, with both those containing electron withdrawing and electron donating 
characteristics (Table 3), with low yields of the acyclic dienes 31a-j produced due to the stability of the 
ammonium ylids formed.
[105]
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Table 3. Pyrrolidine carboxylic acids via NMTP ester rearrangement 
 
 
Entry R Product Yield 30 (%) Yield 31 (%) 
1 H a 58 0 
2 CO2Me b 79 0 
3 Ph c 71 3 
4 1-Naphthyl d 89 0 
5 4-MeO-C6H4 e 28 25 
6 4-NO2-C6H4 f 48 0 
7 4-Cl-C6H4 g 32 11 
8 3-Cl-C6H4 h 43 9 
9 4-F-C6H4 i 58 0 
10 3-F-C6H4 j 36 0 
 
Rearrangement could proceed either by an endo or exo process.  However, as shown in Scheme 40, the 
endo route results in secondary orbital interaction between the olefin and the carbonyl, which stabilises 
the transition state.  As a result, the reaction is highly selective, giving one diastereoisomer; the more 
favoured endo product 30.
[106] 
 
 
Scheme 40. Optimised salt formation and rearrangement of NMTP 29, where R=H. 
 
Prior to the application of the developed [2,3]-rearrangement to synthesise pyrrolidine carboxylic acids, 
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access to tetrahydropyridines are required. 
 
1.5.2 Tetrahydropyridine Synthesis 
Tetrahydropyridines have been synthesised from their N-alkylpyridinium salt precursors via sodium 
borohydride reduction in a protic solvent.
[107]
  This method has been utilised for the synthesis of 
pharmacologically interesting tetrahydropyridines (Scheme 41).  
 
Scheme 41. Borohydride reduction of pyridinium salts 
 
The reduction of pyridines and pyridinium salts with reducing agents of the complex hydride type is 
essentially a nucleophilic addition.  It is therefore much easier to reduce pyridines than benzenes.  
However, in simple pyridines it is difficult to achieve selective reduction.
[108]
  Pyridinium is reduced by 
LiAlH4 to a mixture of 1,2- and 1,4-dihydropyridines.  With lithium triethylborohydride, pyridine is fully 
reduced to piperidine,
[109]
 however if sodium borohydride is utilised as the reducing agent, 
tetrahydropyridines are synthesised.
[110]
 
 
Lyle
[111]
 carried out mechanistic studies on the sodium borohydride reduction of pyridinium ions in 
deuterium oxide.  Initial attack of the hydride ion on a carbon adjacent to the positive charge was shown 
to occur to give the 1,2,5,6-tetrahydropyridine.  Where bulky substituents were present (R, Scheme 42), 
steric hindrance resulted in initial attack occurring at the 4-position of the pyridinium ion, which resulted in 
isolation of the saturated piperidine. 
 
Scheme 42. Borohydride reduction of pyridinium salts 
 
Control over the reduction process was demonstrated by changing the alkyl substituent.  It was shown 
that as the alkyl group increased in size, the relative amount of piperidine isolated increased, with Me < 
Bu < Bn < 
i
Pr, consistent with the hypothesis that the larger substituents sterically interfere with the 
approach of the hydride ion to the 2-position (Table 4).   
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Table 4. Effect of substituent on pyridinium reduction 
 
 
R 
Yield (%) 
tetrahydropyridine 
Yield (%) piperidine 
-CH3 100 0 
-(CH2)3CH3 95 5 
-CH2Ph 88 12 
-CH(CH3)2 72 28 
 
Synthesis of a range of pyridinium salts enables access to a versatile library of tetrahydropyridines via 
borohydride reduction.  Pyridinium salts are commonly synthesised via electrophilic reactions at the 
nitrogen center of pyridine (Scheme 43).
[112]
 
 
Scheme 43. Electrophilic reactions of nitrogen 
 
Pyridine (33) is a good nucleophile and can be readily alkylated with alkyl halides, alkyl tosylates or dialkyl 
sulfates to give N-alkyl pyridinium salts (34), while activated haloarenes form N-aryl pyridinium salts (35).  
Pyridine (33) reacts readily but reversibly with acid chlorides and acid anhydrides yielding N-acyl 
pyridinium salts (36), which are highly reactive and sensitive to hydrolysis.  Peroxy acids react with 
pyridine to give pyridine N-oxide (37) by an electrophilic oxygen transfer.   N-Alkyl pyridinium halides of 
varying alkyl chain length (C8 to C20) have been successfully synthesised by Marek, who demonstrated 
the versatility of the method in the preparation of cationic surfactants from pyridine.
[113]
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For more complex substituents where steric hinderance or electronic factors may inhibit reactions of 
pyridine, the Zinke reaction may be applied.  The Zinke reaction, first reported in 1903,
[114]
 is an amine 
exchange process which provides an efficient approach to the preparation of N-aryl or N-alkyl pyridinium 
salts, where the alkyl groups can be primary, secondary or tertiary.   The Zinke reaction converts N-(2,4-
dinitrophenyl)pyridinium chloride salts (Zinke salts) to N-aryl or N-alkyl pyridinium salts by reaction with an 
appropriate aniline or alkyl amine
[115]
  via a ring opening, cis-trans interconversion and ring closure.
[116]
 
 
Where synthesis via the pyridinium salts is not suitable, tetrahydropyridines may also be accessed via 
ring closing metathesis.  Grubbsʼ catalyst is a member of a family of well-defined ruthenium complexes 
capable of ring-closing both strained and unstrained olefins.  This catalyst is commonly applied due to its 
diminished sensitivity to atmospheric oxygen and moisture, and increased tolerance of most functional 
groups including acids, alcohols, and aldehydes (Scheme 44).
[117]
 
 
Scheme 44. Grubbs ring closing methathesis 
 
Ring closing metathesis via Grubbs catalyst can efficiently generate five-,
[118]
 six-,
[119]
 and seven-
membered
[120]
 heterocycles and carbocycles at room temperature in good yields.  However, Grubbs 1 is 
not effective for the cyclisation of amino dienes due to coordination of the nitrogen lone pair to the 
catalyst, in which case the corresponding hydrochloride salts are required (Scheme 45).
[121]
 
 
Scheme 45. Cyclisation of amino diene salts 
 
Ring closing metathesis utilising Grubbs 1
st
 generation catalyst has been used within our group for the 
synthesis of several tetrahydropyridines (Scheme 46). 
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Scheme 46. Synthesis of tetrahydropyridines via Grubbs ring closing metathesis 
  
1.5.3 Functionalisation of Tetrahydropyridines 
Early structure-activity relationship studies of acromelic acid (21, Figure 9) analogues have shown that 
the nature of the C-4 substituent of the pyrrolidine is key to the resulting biological activity observed. 
When Shinozaki synthesised dihydrokainic acid 38 with an isopropyl C-4 substituent and therefore no π-
electron density, no excitatory activity was observed.
[122]
 Lehmann demonstrated that CPPA 20 with no C-
4 substituent also does not show kainate selectivity.
[123]
 Hashimoto prepared numerous acromelate 
analogues, some of which proved to be as potent as kainic acid (39
[124]
 and 40-41
[125]
, Figure 9).  
However they obtained their best results with the methoxyphenyl analogue 42, which proved to be 3 to 5 
times more potent than acromelic acid A (21) in new born rat spinal motor neurons and 10 times more 
potent than kainic acid (17).
[126]
   
 
Figure 9. Acromelate analogues 
 
The configuration of the C-4 substituent of the pyrrolidine ring has also been shown to influence the 
intensity of the excitatory response. Hashimoto demonstrated that in order to achieve maximum 
neuroexcitatory activity, the same absolute (4S) configuration as the natural products is required in the 
synthetic analogues.
[127] 
 
Aryl functionalisation at the C-4 position therefore represents a key synthetic target for acromelic acid (21) 
analogue synthesis.  Direct functionalisation of N-methyl-1,2,5,6-tetrahydropyridine (29) through methods 
such as cross-coupling and subsequent [2,3]-sigmatropic rearrangement as previously described, could 
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allow access to these pharmacologically interesting compounds (Scheme 47). 
 
Scheme 47. Direct functionalisation of N-methyl-1,2,5,6-tetrahydropyridine (29) and subsequent  
[2,3]-sigmatropic rearrangement 
 
Preparation of functionalised NMTPs is a laborious process, as is the corresponding synthesis of 
enantiomerically-pure NMTPs.
[128]
  Therefore, direct functionalisation of tetrahydropyridines before 
rearrangement would be beneficial.  One method to do this is via the Heck-Mizoroki reaction.  Currently 
there is only one example reported of the Heck-Mizoroki reaction of tetrahydropyridines, which utilises N-
propyl tetrahydropyridine (43).  In a multi-vessel process, Hallberg
[129]
 synthesised racemic 1-propyl-3-(-3-
hydroxyphenyl)piperidine (44) from 1-propyl-1,2,5,6-tetrahydropyridine (43, Scheme 48), in 12% yield 
over the 2 steps through the tetrahydropyridine 45, with a high preference for 3-arylation, over the  4-
position. 
 
Scheme 48. Hallbergʼs synthesis of 1-propyl-3-(-3-hydroxyphenyl)piperidine 45 
 
Previous work within our group has confirmed that this reaction can be utilised to arylate 1-methyl-1,2,5,6-
tetrahydropyridine (NMTP 29) with arylation occurring selectively at the 3 position (Scheme 49).
[130]
 
 
Scheme 49. Heck-Mizoroki arylation of NMTP (29) 
 
The high regioselectivity found with these Heck arylations is due to the preference for addition to the 3-
position rather than the 4-position, due to the N-chelation which presents both the olefin and amine 
functionality towards the palladium catalytic centre.  The formation of stabilised 5-membered σ-palladium 
adducts by arylation of the 3-position occurs, in preference to the more strained 4-membered adduct 
which would be formed by arylation of the 4-position (Scheme 50). 
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Scheme 50. Formation of stabilised 5-membered σ-palladium adducts 
 
High regioselectivity is also obtained due to the insertion and elimination steps of the catalytic cycle being 
syn-processes.  For β-hydride elimination to occur, rotation about the Cα-Cβ bond is required, which is 
not feasible.  Therefore there is no competition between the β-hydride and βʼ-hydride elimination 
processes (Scheme 51).
 [131]
 
 
Scheme 51. Four step catalytic cycle of Heck arylations leading to high regioselectivity 
 
Once the tetrahydropyridine has been arylated, further transformations and rearrangements may be 
carried out such as [2,3]-sigmatropic rearangements towards the synthesis of pharmacologically 
interesting analogues of kainic acid (17). 
 
1.5.4 Nitrogen Chirality in Quaternary Ammonium Salts 
The formation of enantiomerically enriched compounds is an essential requirement for the synthesis of 
complex molecules. The use of an existing stereocentre to control the stereochemistry of subsequent 
transformations is an efficient route to introduce complexity into substrates.   The literature has focused 
almost exclusively on the formation of optically enriched carbon centres. The use of enantiomerically pure 
heteroatom centres to control stereochemistry remains an underdeveloped area.  
 
Preparation of N-chiral ylids would be an effective method to synthesise chiral pyrrolidines such as 
enantiomerically enriched kainic acid (17) derivatives via [2,3]-rearrangements.  
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When quaternary ammonium tetrahydropyridine salts are formed, the nitrogen atom forms an asymmetric 
centre resulting in a racemic mixture of the R and S enantiomers, which cannot be separated 
chromatographically.  This asymmetry controls the facial selectivity in the [2,3]-rearrangement (Scheme 
52).  
 
Scheme 52. [2,3]-Rearrangement products from each ammonium salt enantiomer 
 
 
To control the selectivity, a single enantiomer of ammonium salt is required.  Previously within our group, 
a chiral camphorsultam auxilary has been utilised in attempts to isolate a single diastereomer of 
ammonium salt.  The ammonium salt (47) was isolated in 1:1 ratio of diastereoisomers, showing that in 
this instance, the chiral auxilaries has no influence over the stereochemistry of the quaternary nitrogen.  
However, [2,3]-rearrangement of the mixture gave the two corresponding diastereomeric pyrrolidines 
(48a) and (48b) with cis configuration, which were readily separable by column chromatography (Scheme 
53).
[132]
   
 
Scheme 53. [2,3] Rearrangement of 47 
 
Mills has reported the synthesis of quaternary ammonium salts derived from 1-methyl-4-phenylpiperidine 
(49) and 4-hydroxy-piperidine (50), during their research into the tetrahedral configuration of nitrogen 
(Scheme 54).
[133]
 For the hydroxyl substituted salt, the less soluble α-trans isomer could be isolated by 
crystallisation of the crude product. 
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Scheme 54. Millsʼ reported synthesis of quaternary ammonium salts 
 
If a single enantiomer of ammonium tetrahydropyridine salt could be synthesised, the facial selectivity in 
the [2,3]-rearrangement may be controlled.  A possible synthetic route to a single enantiomer could be 
developed, as shown by the retrosynthesis in Scheme 55, utilising manipulation of nitrogen chirality.  The 
synthesis initiates from the formation of a quaternary ammonium salt.  If racemic starting material were 
used, a racemic mixture of quaternary ammonium salts would be produced.  When the hydroxyl and the 
benzyl ester are cis to each other, cyclisation would be induced to produce a lactone, which may then be 
separated from the trans quaternary ammonium salt.  Ring opening and dehydration would result in a 
single enantiomer of ammonium tetrahydropyridine salt from which further functionalisation or [2,3]-
rearrangement could be carried out towards the synthesis of kainoids (Scheme 55). 
 
Scheme 55. Towards the synthesis of a single enantiomer of quaternary ammonium salts 
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CHAPTER 2: RESULTS AND DISCUSSION: DIRECT FUNCTIONALISATION OF NITROGEN 
CONTAINING HETEROCYCLES 
 
2.1 The Heck-Mizoroki Arylation of Tetrahydropyridines 
Previous work within our group has demonstrated that the Heck-Mizoroki reaction can be utilised to arylate 1-
methyl-1,2,5,6-tetrahydropyridine (NMTP, 29) with only the 3-aryl tetrahydropyridine (46) observed (Scheme 
56).[130]  Screening reactions were carried out which successfully optimised the reaction to produce 1-methyl-
5-phenyl-1,2,5,6-tetrahydropyridine (5-PhNMTP, 46).   Repetition of this previous work resulted in 63% 
isolated yield achieved, under standard Heck reaction conditions (phosphine ligand, silver source, base, 
polar aprotic solvent, Scheme 56). 
 
Scheme 56. Optimised aryl Heck reaction of NMTP (29) 
 
1-Methyl-1,2,5,6-tetrahydropyridine (NMTP, 29) was used, which was isolated via basification of the 
commercially available hydrochloride salt (NMTP.HCl, 50).  To obtain optimum yields, it was found that a 
large excess (4 equivalents) of 29 was required.  This is due to its high volatility, therefore residing in the 
reaction headspace and reducing the amount of 29 available for cross-coupling.   Use of the non-volatile 
hydrochloride salt 50 would enable a reduction in the excess required, and eliminate the need to carry out 
the initial basification.  The hydrochloride salt (50) would also enable the reaction to be investigated in a 
aqueous environment, eliminating the need for flammable, toxic solvent systems.  Aqueous conditions would 
require assessment of the efficiency of water soluble ligands as potential substitutes for the P(o-tolyl)3 ligand 
utilised in the previously optimised organic Heck arylation, and would allow for easier removal of the ligands 
from the reaction products during purification. 
 
Initial Heck arylation reactions were therefore carried out using NMTP.HCl (50) with iodobenzene (1).  It was 
found that the water soluble phosphine triphenylphosphine-3,3′,3′′-trisulfonic acid trisodium salt (TPPTS, 6) 
was a suitable replacement phosphine ligand and that the reaction could be carried out in an 
acetonitrile/water solvent system (Scheme 67).  TPPTS (6) has previously been used by Arai[134] in a nickel-
catalysed Heck alkylation of styrene, methyl acrylate (2) and butyl acrylate with iodobenzene (1), with the 
Ni/TPPTS (6) catalyst phase immobilised on ethylene glycol film on silica support. 
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Scheme 57. Heck-Mizoroki reaction of NMTP.HCl (50) with iodobenzene (1) and TPPTS (6) ligand 
 
In aqueous MeCN (5% H2O) 1-methyl-5-phenyl-1,2,5,6-tetrahydropyridine 46 was obtained in 34% isolated 
yield, allowing for simplification of the reaction procedure, with a  decrease in the excess of olefin (from 4 
equivalents to 1.5 equivalents).  The reaction was also carried out at a slightly lower temperature to that 
previously employed (80 oC cf. 100 oC), although extension of the reaction time (48 hrs vs. 36 hrs) was 
required to ensure completion.    
 
To overcome the volatility of the NMTP, the reactions were also carried out in sealed screw-cap vials.  
However, when 29 was used, as previously found, 4 equivalents were still required to drive the reaction 
towards completion and maintain high yields. 
 
The two original publications by Mizoroki[135] and Heck[1] described phosphine- and ligand-free reactions, and 
therefore in an attempt to further streamline the reaction, the procedure was carried out without inclusion of a 
silver salt or phosphine ligand (TPPTS 6, Table 5).   
 
Table 5. Heck-Mizoroki reaction of NMTP.HCl (50) with iodobenzene (1) 
 
Entry Silver Source Ligand Time (hrs) Yield 46 (%) 
1 AgNO3 6 48 34 
2 - 6 48 36 
3 - - 72 38 
 
Silver salts are classically included in Heck-Mizoroki reactions to act as halide scavengers to drive the 
reaction towards the cationic pathway.  Experimental investigation found that inclusion of a silver salt had a 
nominal effect on the reaction yield, and could therefore be excluded.  Ligand-free conditions (Table 5, entry 
3) were also found to successfully produce the desired product 46, however the reaction time required 
extension to 72 hours, for comparable product yield (38%, cf. 36%).  This phosphine-free method is 
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beneficial as the ligands used in the classical phosphine-assisted reactions are expensive, toxic and 
unrecoverable.  Elimination of phosphine ligands and silver salts reduces the cost of the reaction, which is of 
consequence when reactions are scaled up, simplifying the process. 
 
2.1.1 Development of the Heck-Mizoroki Reaction 
The Heck-Mizoroki reaction of NMTP.HCl (50) was conducted in a 95:5 ratio of acetonitrile to water.  If the 
proportion of acetonitrile in the solvent system can be reduced, the cost of the reaction can be decreased, 
and the reaction may be considered more “green”.  Variation of the solvent ratio was undertaken, using 
phosphine-free reaction conditions utilising 1-(benzyloxy)-3-iodobenzene (51) (Table 6). 
 
Table 6. Effect of solvent ratio on the Heck-Mizoroki reaction of NMTP.HCl (50). 
 
Entry MeCN H2O Yield 52 (%) 
1 95 5 30 
2 75 25 19 
3 50 50 9 
4 25 75 21 
5 5 95 21 
 
When 1-(benzyloxy)-3-iodobenzene (51) was utilised, 1-methyl-5-(3-(benzyloxy)phenyl)-1,2,5,6-
tetrahydropyridine (52) was successfully synthesised and identified for each reaction solvent ratio as the sole 
product using 1H NMR spectroscopy.  The yields obtained varied, with entry 3, (50:50 MeCN:H2O) resulting 
in the lowest yield (9%), and entry 1, (original 95:5) resulting  in the highest yield (30%).   
 
When the above screen was conducted with iodobenene (1), it was noted that when the water content of the 
reaction solvent was increased, multiple products were obtained, as demonstrated by multiple resonances 
corresponding to the N-methyl protons.  Column chromatography isolated two of these products as the 
desired 1-methyl-5-phenyl-1,2,5,6-tetrahydropyridine (46), and also what appeared by 1H NMR spectroscopy 
to be the product of a second Heck reaction, 1-methyl-3,5-diphenyl-1,2,5,6-tetrahydropyridine (53).   
 
LC-MS analysis of the reaction mixture enabled confirmation of the presence of a compound with a 
molecular mass consistent with a doubly-arylated tetrahydropyridine.  In an attempt to isolate increased 
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quantities of this compound in order to confirm its presence and define its structure, 1-methyl-5-phenyl-
1,2,5,6-tetrahydropyridine 46 was reacted under the developed Heck-Mizoroki conditions with iodobenzene 
cross-coupling partner (Scheme 58). 
 
Scheme 58. Heck reaction of 1-methyl-5-phenyl-1,2,5,6-tetrahydropyridine (46) 
 
The di-phenylated product (53) was successfully synthesised by a second Heck reaction of 46, as a yellow 
oil in 9% isolated yield. 1H NMR spectroscopy demonstrated the disappearance of one resonance 
corresponding to an alkene proton in the 5.5-6.5 ppm region, and an increase in the resonance 
corresponding to aromatic protons (Figure 10).  The ability to further functionalise the tetrahydropyridine will 
allow for wider access to a greater library of compounds. 
 
Figure 10. 
1
H NMR spectra showing fragments isolated from the aqueous Heck reaction of NMTP.HCl (50) with  
iodobenzene (1). Products 53 top, 46 lower spectrum 
 
2.1.2 Attempted Optimisation of the Heck-Mizoroki Arylation 
With moderate reaction yields for the ligand and silver-free Heck-Mizoroki arylation of NMTP.HCl (50) 
achieved, the reaction components were further explored for reaction optimisation.   
 
2.1.2.1 Palladium Catalyst 
To assess the suitability of the palladium catalyst, five commercially available palladium sources were 
applied to the Heck-Mizoroki reaction of NMTP.HCl (50) and iodobenzene (1) in aqueous acetonitrile (Table 
7). 
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Table 7. Analysis of palladium catalyst 
 
Entry Pd catalyst Yield 46 (%) 
1 PdCl2(MeCN)2 31 
2 Pd(OAc)2 24 
3 PdCl2(PPh3)2 24 
4 Pd(dba)2 30 
5 Pd(118) 0 
 
It was observed that although PdCl2(MeCN)2 (Table 7, entry 1) and Pd(dba)2 (Table 7, entry 4) gave the 
highest product yields (31% and 30% respectively), Pd(OAc)2 and PdCl2(PPh3)2 (Table 7, entries 3 and 4 
respectively) gave similar yields, suggesting that the reaction is relatively amenable to a variety of palladium 
catalysts.  Only Pd-118 (1,1ʼ-bis(di-tertbutylphosphino)ferrocene palladium dichloride, entry 4) was deemed 
unsuitable, as no product was detected, even at increased reaction time (96 hours).   
 
By reaction monitoring, a reaction yield maximum of approximately 30% was apparent, suggesting the 
possibility that catalyst is no longer active after the three days at 80 oC required for the reaction.  Addition of 
extra catalyst over the reaction period was therefore attempted, however this did not result in increased yield.  
 
De Vries demonstrated that ligand-free Pd(OAc)2 can be used as a catalyst in the Heck reaction of aryl 
bromides as long as catalyst loading is low (between 0.01 and 0.1 mol%).  At higher concentrations 
palladium black formation was reported during the early stages of the reaction progression, which resulted in 
the prevention of full conversion, by removal of the active palladium from the catalytic cycle.[136]  The 
palladium species aggregate to form initially soluble palladium clusters, which turn into insoluble palladium 
black.   
 
In the Heck-Mizoroki arylation of NMTP (29), Pd black formation occurs rapidly.  It is therefore feasible that a 
reduction in the catalyst loading may result in higher yield by reducing Pd black formation and increasing the 
palladium available in the catalytic cycle.  A screen of catalyst loading was therefore conducted, with catalyst 
loading from 3 to 0.01 mol%, however product was only observed when 3 mol% was used.  Lower loading 
failed to result in detection of any 46 by LCMS. 
 
+ Ph-I
Pd cat [3 mol%]
NEt3 (2.5 eq)
aq. MeCN (95%)
80 oC, 72 hrs
N
Ph
461
N
50
.HCl
46 
 
  
 
2.1.2.2 Assessment of the Role of Base 
Although base-free Heck-Mizoroki reactions have been reported, in general the catalytic cycle requires a 
base present to reduce Pd(II) to Pd(0), and to facilitate reductive elimination, by neutralisation of the acid 
(HX) produced when the hydridopalladium(II) species is reduced to regenerate the active Pd(0) catalyst.  A 
stoichiometric amount of base is needed, but in practice 2-5 molar equivalents are often used.  Generally, 
hindered tertiary amines are chosen.[137]  
 
The base in the arylation of NMTP.HCl (50) is not only required for reductive elimination to regenerate the 
active Pd(0) catalyst, but is also required initially for release of the free amine NMTP (29) from the HCl salt 
(50).  As 1.5 equivalents of NMTP.HCl (50) are utilised, an initial 1.5 eq of base was predicted to be required, 
with another 1 eq of base for removal of the HI species.  2.5 equivalents have therefore been utilised 
predominantly.  A screen of base charge from 1 to 4 equivalents was subsequently carried out.  46 was 
detected in each reaction, with a general increase in product observed with charge increase up to 3 
equivalents.  Above this level, no further increase was observed.  The initially applied 2.5 equivalents of base 
was therefore applied to all further reactions, to ensure maximum yield without unnecessary excess wastage 
of reagents. 
 
Typically, triethylamine is the base of choice for Heck reactions, but inorganic bases such as potassium 
carbonate (K2CO3) and calcium carbonate (CaCO3) have also been used under aqueous-phase transfer 
conditions.[138] Other tertiary amines such as N,N-diisopropylethylamine (Hünig's base, DIPEA, i-Pr2NEt), 1,8-
bis(dimethylamino)naphthalene (Proton Sponge), 2,2,6,6-tetramethylpiperidine (TMP) and the extremely 
hindered base 1,2,2,6,6-pentamethylpiperidine (PMP) are also commonly employed.   A range of bases were 
therefore screened for suitability in the Heck arylation (Table 8). 
 
Table 8. Base screen 
 
Entry Base Yield (%) 
1 none 0 
2 NEt3 25 
3 TMP 29 
4 MeCy2N 39 
5 K2CO3 44 
 
It was observed that base was required in order for successful product formation under reaction conditions.  
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After 46 hours, all bases examined gave good yields particularly potassium carbonate (Table 8, entry 5).  
However, use of the insoluble inorganic base resulted in a heterogeneous reaction. 
 
2.1.2.3 Attempted stabilisation of the Palladium catalyst 
It has been widely reported that unless exceptionally mild reaction conditions are applicable, any Pd 
precursor will release underligated free Pd(0), which is the actual active species.[139]  The released Pd 
species are unstable and likely to agglomerate forming Pd black and deactivate; therefore, stabilisation is 
crucial for reasonable catalytic activity (Figure 5).[39]  Formation of large amounts of Pd black were observed 
in the Heck-Mizoroki arylation of NMTP (29). 
 
Expensive and often sensitive ligands such as phosphines are often incorporated into palladium cross-
coupling reactions to stabilise palladium against agglomeration. Less costly tetralkyl ammonium halides such 
as TBAB (tetrabutylammonium bromide) are also often utilized, as they have been reported to stabilize 
palladium catalysts and pre-catalysts.[140]     
 
A range of phosphine ligands were applied to the Heck-Mizoroki arylation of NMTP (29) and were found to 
have negligible effect on reaction yield of 5-PhNMTP (46).  With all of the phosphine ligands studied, (P(o-
tolyl)3, P(m-tolyl)3, dppe, dppp, dppb, dppf, PPh3, AsPh3, (R)-BINAP) there appeared be be no increase in 
the reaction homogeneity, or a reduction in the Pd precipitate formation. 
 
Two ammonium bromides were therefore also screened: tetrabutylammonium bromide (TBAB) and 
tetrahexylammonium bromide (THAB), and compared to the additive free reaction (Table 9).  Under the 
reaction conditions, the yield remained roughly constant (32-38%) in the presence and absence of the 
additives.  As found with the ligands study, there was no observed reduction in precipitated Pd. 
 
Table 9. Addition of quaternary ammonium bromides 
 
Entry Additive Yield (%) 
1 None 32 
2 TBAB 38 
3 THAB 33 
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2.1.2.4 Assessment of Solvent 
It has been demonstrated that Heck arylations are favoured in polar aprotic σ-donor type solvents, with DMF, 
DMAc and MeCN commonly favoured.[141]  A range of solvents including polar aprotic, polar protic and non-
polar were applied to the Heck-Mizoroki reaction of NMTP.HCl (50) and iodobenzene (1) with triethylamine 
base (Table 10).  It was observed that aqueous acetonitrile, the solvent previously utilised, gave the highest 
yield, with the general trend showing aq. MeCN > MeCN > alcohols > Dioxan, DMF, THF, EtOAc, DMAc, 
Toluene.   
 
Table 10. Effect of solvent 
 
Entry Solvent Yield (%) 
1 aq. MeCN (95%) 26 
2 MeCN 18 
3 DMF 8 
4 THF 3 
5 EtOAc 5 
6 DMAc 5 
7 MeOH 11 
8 BuOH 17 
9 Toluene 4 
10 Dioxane 10 
 
The NMTP.HCl salt (50) was shown to be soluble only in acetonitrile and methanol, with butanol only 
resulting in a homogeneous reation mixture upon heating.   All other reaction mixtures were heterogeneous, 
with large amounts of solid present in some solutions, particularly dioxan and toluene, potentially resulting in 
the observed lower yields if reaction components are unable to interact resulting in reduced cross-coupling. 
 
2.1.2.5 Aryl-Halide Coupling Partner 
Charette demonstrated that !-arylation of 1,2,3,4-tetrahydropyridines could be carried out with a variety of 
aryl halides in good yields and with complete selectivity at the !-position.[142]  They reported that aryl iodides 
with electron rich substituents gave good regioselectivity and high yields (Table 10, entries 2-5, 71-85%), and 
that although those containing electron-withdrawing substituents also gave good selectivity, these required 
longer reaction time and gave slightly lower yields (Table 11, entries 6-10, 55-76%).  
+ Ph-I
PdCl2(MeCN)2 [3 mol%]
NEt3 (2.5 eq)
Solvent
80 oC, 72 hrs
N
Ph
461
N
50
.HCl
49 
 
  
 
 Table 11. Charetteʼs !-arylation of 1,2,3,4-tetrahydropyridines 
 
Entry Ar Yield (%)  Entry Ar Yield (%) 
1 Ph 84  8 3-Cl-C6H4 64 
2 2-Me-C6H4 80  9 4-CO2Et-C6H4 68 
3 3-Me-C6H4 75  10 3-CF3-C6H4 55 
4 4-Me-C6H4 85  11 1-naphthyl 75 
5 3,4-OCH2O-C6H4 71  12 2-thiophene 46 
6 4-F-C6H4 76  13 3-pyridine 32 
7 3-Br-C6H4 68  14 2-benzofuran 50 
Charrette also reported that the arylation could be carried out under phosphine-free conditions with 
iodobenzene (1).  In an attempt to confirm the suitability of our phosphine-free reaction, a range of aryl 
halides were employed (Table 12). 
 
Table 12. Effects of aryl halides on the Heck-Mizoroki reaction of NMTP.HCl (50).  All yields reported from single 
reaction attempt with each iodide analogue.  *Purified product obtained from aqueous workup without chromatographic 
purification 
 
 
Entry R Product Yield (%)  Entry R Product Yield (%) 
1 m-OBn 52 76*  10 o-OH 62 <5 
2 p-OBn 54 <5  11 o-NH2 63 15 
3 o-Me 55 14  12 p-NH2 64 0 
4 m-Me 56 11  13 o-NO2 65 <5 
5 p-Me 57 7  14 m-NO2 66 9 
6 o-OMe 58 <5  15 o-CF3 67 5 
7 m-OMe 59 21  16 m-CF3 68 19 
8 p-OMe 60 7  17 o-CO2H 69 0 
9 o-napthyl 61 24  18 p-CO2H 70 0 
 
It was found that for most analogues, although product formation could clearly be detected by 1H NMR 
analysis of the crude reaction mixtures, isolation of the products proved difficult.  The purification techniques 
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applied generally resulted in only milligram quantities of the purified products obtained.  Only the meta-
benzyloxy analogue (Table 12, entry 1) was isolated in sufficiently pure form from reaction work-up, such that 
further purification was not required.  This compound however gave variable reaction yields, initially high 
(Table 12, entry 1, 76%) but varying with repeated reactions (from 22-76% isolated yield), highlighting 
inherent problems with the reaction procedure and reliability. 
 
With the exception of the ortho/meta carboxyl analogues and para amino (Table 12, entries 17, 18 and 12), 
product was obtained from all iodo analogues screened.  Carboxy analogues (69 and 70) may have 
successfully been produced, however as the reaction workup required an acid extraction, isolation of the 
product from the aqueous phase would prove difficult, and therefore it cannot be definitively stated that 
cross-coupling did not occur.   
 
It has been reported by Alami that the oxidative addition process of the catalytic cycle is generally found to 
be slower for ortho-substituted halides than the corresponding meta-substituted aryl halides due to steric 
hindrance.[143] Increased steric hindrance asserted by ortho-substituents may therefore also be a contributing 
factor to the generally lower amounts of product observed from cross-coupling of ortho-substituted 
arylhalides.    
 
It is generally reported that oxidative addition of arylhalides is highly disfavoured when powerful electron 
donors such as -NH2 or -OH reside on the aromatic ring.
[144]  This was observed, with low yields of product 
obtained from the deactivating analogues, (Table 12, p-NH2 
 entry 12, o-/m-NO2 entries 13 and 14 and o-CF3 
entry 15).  The bulkier cross-coupling partners or those not containing heteroatoms or halides generally gave 
the highest yields  (Table 12, m-OBn, o-napthyl, o/m/p-Me).  This may again be due to difficulties in the 
product purification stages, or particularly in the case of the benzyloxy and napthyl, due to the steric bulk of 
the compounds resulting in reduction in the polarity of the compounds and reduction in the amount of by-
product formation.   
 
With several analogues, second arylated compounds  (Figure 11) were isolated by preparative TLC, with 
quantities obtained typically <10mg (<5%) and therefore full analysis was not always possible.  These 
compounds had analogous 1H NMR spectra resonance patterns to the di-phenylated compound 53 isolated 
previously.   
 
Figure 11. Di-aryl analogues isolated in Heck-Mizoroki reaction 
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The ability to conduct cross-coupling of NMTP.HCl in the presence of a variety of functional groups with 
varying electronic and steric properties, demonstrates the versatility of the reaction.  With an improved 
purification method and use of in-line analysis, the scope of the reaction may be more fully explored.  Several 
methods of product purification were examined, including silica column chromatography, silver nitrate column 
chromatography, alumina column chromatography and preparative TLC.  In general products were only 
isolated by preparative TLC, and results obtained by repetition of reactions were often variable.  Although 
analysis by LCMS and GC proved valuble in qualitatively analysing reactions, the low quantities of procuct 
isolated prevented the ability to calibtrate the instrumentation, and therefore quantification remained difficult. 
 
2.1.2.6 Alternative Tetrahydropyridines 
The scope of the reaction was further probed by synthesis of several alternative tetrahydropyridine 
analogues.  These were synthesised by alkylation of pyridine and also via the Zinke reaction which proved to 
be higher yielding and more reproducible (Scheme 59). 
 
Scheme 59. Synthesis of alternate tetrahydropyridines 
 
These tetrahydropyridines were subjected to the Heck-Mizoroki reaction under conditions described 
previously through method development (NEt3 base, PdCl2(MeCN)2 catalyst, aq. MeCN solvent, 80 
oC, 72 
hours).  Again as previously observed, the desired arylated products were believed to have been 
synthesised successfully by 1HMR analysis, however poor isolation protocol resulted in the inability to obtain 
the products in their purified form at this time, emphasising the need for a more robust and reliable 
purification process or in-line analysis method.    
 
2.1.2.7 GC Analysis for Reaction Profiling 
In collaboration with Dr Matthew Stirling from IPOS, the reaction of NMTP.HCl (50) and Iodobenzene (1) was 
carried out in a screw cap tube, with an aliquot removed at set time intervals over 74 hours, which was then 
analysed by GCMS with comparison of reaction componants to standards of known concentration.  For 
quantification, biphenyl was incorporated as an internal standard.  The mass balance was observed to be 
>90% throughout, demonstrating that the majority of the reaction products are volatile and observable by GC 
analysis.  Although the desired reaction product was clearly observed, a large number of impurities were also 
formed at low level.   
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Graph 1. Reaction profile by GCMS over time 
 
 
 
The reaction profiling data obtained indicated the formation of approximately 28% of the desired product over 
74 hours, however, it was found that the rate of consumption of NMTP (29) and formation of product were 
effectively zero after approximately 50 hours.  At this point the concentration of iodobenzene had significantly 
diminished, suggesting near-full consumption and therefore the reaction approaching end-point under the 
examined conditions (Graph 1).   
 
The rate of consumption of iodobenzene (1) exceeded that of NMTP (29).  With the formation of impurities, 
the high 1 consumption may be accounted for if the impurities are di- and tri-aryl NMTP derivatives, formed 
from sequential cross-coupling rections.  The iodobenzene concentration appeared to continue to drop after 
both the NMTP and product concentrations reached a plateau and remained unchanged (at approx. 50 
hours), indicating an alternative decomposition of iodobenzene (1) concurrently with the desired reaction.  
Both the desired product 46 and the unknown impurities were formed at a similar rate, both starting at t=0, 
suggesting that the impurities are not formed via a consecutive process but via an alternative reaction path.   
 
The reaction profiling was repeated several times, with consistant results obtained, suggesting that the 
difficulties which had been observed previously with reproducibility and the subsequent low yields, was most 
likely an isolation and purification challenge and not inherently connected to the reaction success. 
 
The formation of the desired product (5-PhNMTP, 46) and the major impurities gave a good fit to 1st order 
kinetics over the first 32 hours (R2 0.997 and 0.991 respectively).   
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The most interesting observation from reaction profiling by GCMS came from inspection of the impurities.  
Although the exact structures of the impurities could not be determined by GCMS data, the consistency of 
the 249 m/z molecular ion strongly suggested that all the major impurities were isomers of the disubstituted 
product 53.  The reaction mechanism is clearly complex, with several processes occurring simultaneously.  
The simultaneous production of both 46 and 53 from t=0, along with the greater reduction in 1 than 50 
indicated the possibility that the monosubstituted product 46 may remain ligated to the palladium during loss 
of HI from the catalyst and reformation of Pd(0).  A second iodobenzene (1) may oxidatively add to the 
palladium prior to dissociation of the product, resulting in formation of the disubstituted impurities 53, as 
represented in blue in Scheme 60.   
 
It had previously been observed that the di-phenylated product (3,5-PhNMTP, 53) could be successfully 
synthesised by a separate Heck reaction of 5-PhNMTP (46), with iodobenzene (1).  This reaction was 
repeated with inline analysis by GCMS.  The reaction profile demonstrated that 5-PhNMTP is not stable 
under reaction conditions, and can itself act as a reactant, with the major reaction product identified as the di-
PhNMTP (249 m/z).  The reaction profile indicated immediate formation of products from t=0 hours, and a 
profile loosely matching the reaction of 50 with 1, with rapid consumption of 46 and 1 in the first 10 hours, 
and negligible change in starting material concentration after 50 hours (Graph 2).      
 
 
Scheme 60. Possible reaction mechanism for concurrent formation of 46 and 53 
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Graph 2. Reaction profile by GCMS over time 
 
 
 
Under the standard reaction conditions of 50 with 1, GCMS indicated an impurity peak at 15.95 minutes was 
observed with molecular ion 249 m/z, presumed to be the di-PhNMTP product 53.  This peak corresponded 
to only 3-8% of total reaction impurites.  In the reaction of 46 with 1, this peak is still observed, however it 
now corresponds to approximately 60% of total reaction impurites (by peak area).  The total impurity profile 
for the reaction of 46 with 1 is much simpler than the standard reaction of 50 with 1, indicating that although 
5-PhNMTP (46) can act as a reagent, it is not the major source of the observed reaction impurities.    
Interestingly, in the case of 46, a peak corresponding to a possible tri-PhNMTP product (325 m/z) was also 
observed, however the structure was unable to be confirmed.   
 
2.1.3 Microwave Assisted Heck-Mizoroki Reaction 
With a few exceptions, most Heck-Mizoroki reactions require reaction temperatures of 80-120 °C and 
reaction times ranging from hours to days for full conversion.[145]  Attempts to reduce the reaction time by 
raising the temperatures are seldom effective due to decomposition of the catalytic system.  Therefore, 
access to alternative and general synthetic procedures that permit fast coupling reactions is valuable.   
 
Microwave-promoted synthesis is an area of increasing research interest.  As well as being energy efficient, 
use of microwave heating has been shown to enhance the reaction rates and in many cases improve product 
yields.[146]   
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The application of microwaves as an efficient heating source for organic synthesis was recognised in the 
mid-1980s.  Since then, numerous successful reactions with dramatically enhanced reaction rates have been 
reported. Very high yields and clean reactions have been obtained using small amounts of energy due to the 
superheating effect of microwaves.[147]  Superheating occurs when a liquid or solvent is heated to a 
temperature above its normal boiling point.  The possibility of employing milder and less toxic reagents and 
solvents offers a further advantage of use.  The non-inert atmosphere conditions and simple experimental 
procedures of many microwave reactions offer additional convenience in chemical synthesis, especially for 
high-throughput applications.   
 
By using closed microwave-transparent vessels, which can sustain higher pressures, the superheating 
effects are substantially magnified and it is possible to maintain solutions at temperatures much above their 
conventional reflux temperature.[148] 
 
 
 
Figure 12. Diagram representing a) microwave in-situ heating and b) thermal wall heating, with red areas corresponding 
to the hottest areas, and blue the coolest areas.
[149] 
Reprinted with permission from Ref. 145, Copyright 2002, American Chemical Society. 
 
The higher purity of products often observed after microwave irradiation can probably be largely attributed to 
the homogeneous in-situ heating (Figure 12).  Microwave heating of closed reaction vessels is an energy 
efficient technique since only the reaction mixture is directly heated and not the reaction vessel.  The heating 
procedure is also highly controlled since the energy input starts and stops immediately when the power is 
turned on or off, respectively.[150] 
 
Microwave heating has been used for Heck reactions with a range of solvents and catalysts utilised.[151]  
Aqueous reaction conditions are also possible with microwave heating and offers a safe, economic, and 
environmentally friendly alternative in organic synthesis, as water is cheap, readily available, nontoxic and 
non-flammable.[152]  In an investigation by Wang, microwave-mediated Heck couplings were rapidly 
performed in water under phase-transfer conditions (TBAB).[153]  A mixture of water and acetonitrile was 
found by Villemine to be highly efficient for microwave-assisted Heck reactions utilising a water-soluble 
ligand.[154]    
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Initial investigations were carried out in an attempt to transfer the Heck-Mizoroki arylation to microwave 
synthesis.  Triethylamine was predominantly utilised during microwave studies to ensure a homogeneous 
reaction mixture, in comparison to the heterogeneous reaction mixture obtained when K2CO3 is utilized as 
base.   
 
It was found that at least 150 oC heating for a minimum of 10 minutes was required for arylation to occur and 
resultant formation of 5-PhNMTP (46) to be detected by LCMS.  In all reactions where the arylated product 
46 was obsereved, masses corresponding to the di-phenyl Heck product 53, [M+H]+ 250 were also shown.  
However, a mass ion [M+H]+ 176 was also observed, which is consistant with reduced 1-methyl-3-
phenylpiperidine (75).  This product increased in prevalence (by LCMS) as temperature and time increased 
(from 150 oC to 200 oC, 5 minutes to 20 minutes).  At 200 oC no 46 was observed and 75 was the major 
product.   With increasing temperature, mass ion [M+H]+ 252 was observed in increasing proportions, 
consistant with the presence of the reduced 3,5-PhNMTP (76, Figure 13).   
 
Figure 13. nPhNMTP and reduced forms 
 
The presence of these reduced by-products results in difficulties in purification and isolation, as the reduced 
products (75 and 76) co-elute with the corresponding olefins (46 and 53 respectively), preventing accurate 
evaluation of the reaction yields, and product separation.  Therefore, yields were not obtained for the 
microwave reactions, and reaction progression was observed solely by peak area and LCMS analysis. 
Reduction of the olefinic products 46 and 53 to 75 and 76 respectively may be occurring due to LnPd-H 
formed from reductive elimination during the Heck-Mizoroki reaction acting as a reducing agent at high 
temperatures.   
 
When stock solutions of reaction components in aq. MeCN were prepared, all reagents were soluble and 
homogeneous at room temperature, however a palladium species rapidly precipitated out of solution.  This 
solid was observed in both the stock solution over time and in the completed microwave reaction vessels.  
Decreasing catalyst charge from 3 mol% to 1 mol%, failed to reduce the precipitate formation.  It was 
observed that for formation of 5-PhNMTP (46) by microwave reaction, palladium catalyst loading was 
required to be 1 mol% or higher.  Even at this concentration, a Pd precipitate was observed.  Lower 
concentrations of catalyst failed to give product.   
 
Although it has been shown that microwave heating could be applied the cross-coupling of 1 and 50, to 
N
46
Ph
N
53
PhPh
N
75
Ph
N
76
PhPh
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synthesise 46 (as shown by LCMS), the presence of the co-eluting reduced products resulted in inaccurate 
evaluation of product formation and yields which were unable to be calculated.  As a consequence of the 
high amount of di-arylation, microwave synthesis was deemed an unsuitable method for rapid screening for 
reaction optimisation.  
 
2.2 The Oxidative Heck Reaction 
While the Heck-Mizoroki reaction has been highly utilised, providing desirable products, the overall process 
requires prefunctionalisation of the cross-coupling partner by formation of the required halide.  An alternative 
process has been developed as a more efficient process; the Fujiwara–Moritani or Oxidative Heck reaction.  
This process enables direct coupling of an arene or boronic acid with an alkene, avoiding the use of 
halides.[155]  Boronic acids are stable, of low toxicity, and a wide variety are commercially available.  The 
relatively simple synthesis of further complex, non-commercially available boronic acids makes them useful 
and versatile reagents for cross-coupling. 
 
The first example of a direct oxidative coupling of arenes with alkenes was described by Fujiwara and 
Moritani in 1967.[156] The reaction involved direct coupling of unfunctionalised arenes with methyl acrylate 
(Scheme 61, R = H).  Although initially low yielding, this novel reaction opened a new area of palladium(II)-
catalysed reactions. 
 
Scheme 61. Fujiwara–Moritani Oxidative Heck Reaction with methyl acrylate 
 
The oxidative Heck mechanism involves use of a palladium catalyst (A, Scheme 62), which undergoes 
transmetallation with phenylboronic acid (B, Scheme 62).  This species coordinates to the olefin to form an 
associated intermediate (C, Scheme 62), which undergoes an insertion to the olefin (D, Scheme 62). β-
Hydride elminination and reductive elimination results in the cross-coupled product (E, Scheme 62).  and a 
palladium(0) species (F, Scheme 62), from which the palladium(II) species (A, Scheme 62) is then 
regenerated in the presence of an oxidant.[157]   
R1
R2
PdCl2 or Pd(OAc)2 
AcOH
Cu(OAc)2 or AgOAc
10-90% yield
CO2Me
R1
CO2Me
R2 = H or B(OH)2
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Scheme 62. Oxidative Heck catalytic cycle 
 
 
Although arylboronic acids or esters are most commonly employed in the oxidative Heck reaction, other 
arylating agents have also been reported, such as arylmercury compounds,[158] arylstannanes,[159] 
arylsilanes,[160] arylantimony compounds[161] and arylphosphonic acids.[162]  However, these organometallic 
(or organometalloid) reagents are often unstable, and their byproducts highly toxic and difficult to remove.   
 
The oxidative Heck reaction using organoboronic acids was first described in 1975 by Heck, using 
stoichiometric palladium acetate (Scheme 63).[163]  
 
Scheme 63. Oxidative Heck reaction using organoboronic acids as described by Heck 
 
This coupling reaction did not receive much attention however until the mid 1990s, when Uemura reported 
the first sub-stoichiometric protocol using acetic acid as solvent, providing good yields of arylated olefins.[164]  
Since this, many such oxidative Heck methods have been reported, including ligand-modulated oxidative 
Heck reaction to facilitate the palladium reoxidation,[165] base-free oxidative Heck reactions,[166] and enantio- 
and regioselective reactions.[167] The wide availability of aryl boronic acids, their relative stability and the 
resultant non-toxic waste produced in the reactions, leads the oxidative Heck process to be one of great 
interest.  
 
2.2.1 The Oxidative Heck Reaction of Tetrahydropyridines 
In 2003, Jung developed a procedure where molecular oxygen was shown to act as an efficient palladium 
reoxidant (Scheme 64).[168]   It was found that reaction yield doubled when carried out under an O2 
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atmosphere compared to in air (87% cf. 44%), and no product was isolated when performed under nitrogen.  
The use of oxygen gas for palladium recycling is inconvenient, expensive, and associated with dangerous 
handling, and is therefore not often applied to large-scale commercial applications, however for small-scale 
investigatory probing of a reaction, can be easily and safely applied. 
 
Scheme 64. Use of oxygen reoxidant in Oxidative Heck reaction 
 
 NMTP (29) and NMTP.HCl (50) were subjected to the oxidative Heck reaction, initially under conditions 
developed by Jung,[74] utilising molecular oxygen to facilitate the palladium reoxidation (Scheme 65). 
 
Scheme 65. Oxidative Heck reaction with oxygen reoxidant 
 
Under Jungʼs conditions, 46 was not isolated.  However, substantial amounts of a precipitated palladium 
species was observed within the reaction mixture and therefore oxygen facilitated reoxidation may not have 
been effective, resulting in the catalyst not being regenerated. 
 
Prior to Jungʼs work with oxygen, Mori reported the use of a dedicated co-oxidant in the Oxidative Heck 
reaction.[169] Mori used Cu(OAc)2 to regenerate Pd(II) from Pd(0), (Scheme 66).  Copper(II) acetate and 
lithium acetate were found by Mori to realise the catalytic reaction successfully, with lithium acetate believed 
to enhance solubility of the copper(II) acetate.[170]  Although high yielding, this method requires high reaction 
temperatures (100 oC, DMF) and excess Cu(II), which results in the production of stoichometric metal salts. 
 
Scheme 66. Moriʼs oxidative Heck protocol utilising Copper as a reoxidant 
 
Copper acetate is a commonly used re-oxidant.  Gaunt reported the use of copper(II) acetate as re-oxidant in 
the C3-selective cross-coupling of indoles, in a solvent-controlled regioselective palladium-catalysed 
alkenylation by C-H functionalisation.  They found that by changing the re-oxidant and solvent conditions, 
oxidative-Heck reactions may be tuned to occur selectively at the C3 or C2 positions (Scheme 67).[171]   
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Scheme 67. Tunable Oxidative Heck reaction of indoles 
 
 
As conditions developed by Jungʼs utilizing oxygen as the reoxidant were unsuccessful with NMTP, copper 
acetate was applied under conditions developed by Mori, to both NMTP (29) and NMTP.HCl (50), using 
phenyl boronic acid 77 (Scheme 68).  Cross-coupling occurred to produce 46 from 50 after 4 hours, identified 
by 1H NMR spectroscopy, but in poor yield.  Extension of the reaction time to 24 hours did not result in higher 
yield (7%).  Changing to acetonitrile as the solvent system gave comparable results to that of DMF (7% 
DMF, 6% MeCN), however yield decreased (3%) when water was used as the solvent.   
 
Scheme 68. Oxidative Heck reaction with copper reoxidant, where solvent = DMF, MeCN or H2O 
 
1H NMR analysis of the oxidative Heck reaction product is comparable to that obtained under the developed 
Heck-Mizoroki conditions between iodobenzene and 50, however the yield is significantly decreased (7%, cf 
36%, 38% phosphine free).  As previously suggested from reaction profiling, it is feasible that product was 
lost during purification and isolation, leading to the low yield.  
 
Further optimisation of this oxidative Heck reaction is required.  If comparable yields to the standard Heck-
Mizoroki method can be obtained, this would provide a more rapid, cost-effective route to tetrahydropyridine 
functionalisation.  This route is beneficial as it utilises the more widely available Pd(OAc)2 catalyst, cheap 
copper oxidant and the wide variety of boronic acids commercially available, which would open the reaction 
to a wide scope of applications.  Alternative oxidants could also be explored, such as benzoquinones 
reported by Van der Eycken in the catalytic oxidative Heck cyclisation for the construction of the 
azepinoindole framework (Scheme 69).[172]   
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Scheme 69. Oxidative Heck intramolecular cyclisation of nitrogen heterocylces 
 
2.3 Exploiting Nitrogen Chirality of Tetrahydropyridine Salts 
When tetrahydropyridine ammonium salts are formed, a racemic mixture is usually produced which cannot 
be separated chromatographically.  This asymmetry controls the face selectivity in the [2,3]-rearrangement 
reaction. To control the facial-selectivity, a single enantiomer of ammonium salt is required.  Previously, 
attempts to isolate a single diastereoisomer through use of a chiral camphorsultam auxiliary failed, and 
therefore attention has been focused on an alternate route.  
 
Synthesis of diastereomerically pure lactone 80 from racemic N-methyl-3-piperidinol (78) via racemic 3-
hydroxy ammonium salt (1-ethoxycarbonylmethyl-3-hydroxy-1-methyl-piperidinium bromide, 79) was 
investigated.  79 was isolated as a racemic oil (d.r. 1:1). Upon treatment of the salt with ethanolic HCl, the 
cis-isomer (79a) cyclised to give a mixture of the lactone (1-methyl-3-oxo-4-oxa-1-azonia-
bicyclo[3.3.1]nonane bromide, 80) and cis (79a) and trans hydroxy-ammonium salts (79b) as a yellow oil.  
Repeated crystallisation from aqueous ethanol gave the less soluble lactone (80) as colourless rod-like 
crystals in an isolated yield of 42% (Scheme 70), with structure confirmed by x-ray crystallography (Figure 
14).[173]  
 
Scheme 70. Two step synthesis of lactone 80 from N-methyl-3-piperidinol 78 
 
Figure 14. 3 Perspectives of the X-ray crystal structure of cyclised lactone salt 80 
 
Lactone ethanolysis subsequently led to a single diastereoisomer of ammonium salt 81 (Scheme 71).  
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Subsequent dehydration of the alcohol provides access to the tetrahydropyridines 82 and 83.    
 
Scheme 71. Towards the synthesis of a single diastereoisomer of ammonium salts 
 
Initially, dehydration was achieved with phosphorus(V) oxychloride and pyridine, with the two olefinic 
products observed (82 and 83), identifiable by the characteristic resonances of the cyclic olefinic protons 5.7-
6.5 ppm in the 1H NMR specta.  To eliminate the requirement for the use of phosphorus oxychloride, the 
dehydration was conducted in situ via activation of the hydroxyl as a triflate.[174] This resulted, as observed 
with POCl3, in the detection of the two isomeric olefins (82 and 83) in approximately equal amount (1:1 by 
1H 
NMR spectroscopy, Scheme 72).  The reaction is efficient, but did not progress to completion, as the triflate 
(84) was still detectable in the reaction mixture.  Extension of the reaction time did not decrease the ratio of 
triflate to olefins.   
 
Scheme 72.  In situ dehydration via triflate 
 
In an attempt to distinguish between the steric environment of Hα and Hγ, in favour of the production of 82 by 
preferential elimination of the γ−hydride, pyridine was replaced with 2,6-di-tert-butyl-3-methyl pyridine 
(Scheme 73). 
 
Scheme 73.  In situ dehydration via triflate 
 
Conducting the reaction in deuterated chloroform allowed for reaction sampling to be undertaken, resulting in 
visualisation of the olefin formation.  The desired 1,2,5,6-tetrahydropyridine (82) was detected from 20 hours 
(9:1, triflate:olefin), and increased rapidly up to 44 hours (1:1, triflate:olefin) with no further change after this 
time.  Throughout the monitoring process 83 was not detected by 1H NMR analysis, demonstrating 
preferential elimination of the γ−hydride in the presence of 2,6-di-tert-butyl-3-methyl pyridine (Figure 15).    
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Figure 15. In situ dehydration of quaternary ammonium hydroxyl salts via triflate with a bulky base, monitoring over 55 
hours by 
1
H NMR spectroscopy 
 
In an attempt to reduce the amount remaining 84 and increase conversion to the olefin (82), the amount of 
base and trifluoromethanesulfonic anhydride were increased.  Increasing the amount of base without 
increasing the Tf2O had no observable effect on the olefin:triflate ratio as observed by 
1H NMR spectroscopy.  
However, increasing both (base from 1 equivalent to 5 equivalents, trifluoromethanesulfonic anhydride from 
1.2 equivalent to 4 equivalents) resulted in a single olefin detected by 1H NMR analysis, with no starting 
material or triflate detected suggesting full conversion to the desired 1,2,5,6-tetrahydropyridine (82). 
 
The requirement for 5 equivalents of 2,6-di-tert-butyl-3-methyl pyridine in the synthesis results in increased 
cost and reagent consumption.  Therefore, a screen was conducted to find the lowest excess of triflate and 
base required to give full conversion, while maintaining a single olefin product (Table 13). Reaction mixtures 
were analysed by 1H NMR spectroscopy to determine the ratio of compound 82:83.   
 
Results demonstrated that 3 equivalents of base and 2 equivalents of Tf2O may be applied to generate a 
single olefin (82) with no starting material (79) or triflate (84) remaining.  This is a significant reduction from 
the 5 equivalents of base and 4 equivalents of Tf2O applied previously, providing a more cost-effective 
method and resulting in the formation of a single enantiomer of tetrahydropyridine salt 82 in high yield (83%). 
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Table 13. Effect of altering base and triflic anhydride on olefin production  
 
Entry [Base] (X eq) [Tf2O] (Y eq) Ratio 82:83 
1 2.4 1.2 1:0.5 
2 3 2 1:0 
3 4 3 1:0 
4 5 4 1:0 
 
 
Scheme 74. Route to single enantiomer of 1-ethoxycarbonylmethyl-1-methyl-1,2,5,6-tetrahydropyridine bromide (±82) 
from 1-methyl-3-piperidinol (±78) 
 
The route developed commenced with racemic starting material 1-methyl-3-piperidinol (±78), and resulted in 
±82 in 29% yield over four steps.  To enable the synthesis of optically pure products, a single enantiomer of 
78 is required. Methylation of commercially available (R)-3-hydroxypiperidine (85) will give (R)-1-methyl-3-
piperidinol (86) which may be employed into the developed synthesis to give (S)-1-ethoxycarbonylmethyl-1-
methyl-1,2,5,6-tetrahydropyridine bromide (82, Scheme 75).  This may then be applied to the developed 
direct functionalisation method or [2,3]-rearrangement to access kainoid-like structures of pharmaceutical 
interest. 
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Scheme 75. Route to (S)-1-ethoxycarbonylmethyl-1-methyl-1,2,5,6-tetrahydropyridine bromide (82) 
 
[2,3]-Rearrangement of 82 will give a pyrrolidine dicarboxylate with cis configuration at the C-2 and C-3 
positions.  In 2002, Karoyan reported the asymmetric synthesis of both the cis- and trans-3-prolinoglutamic 
acids in a diastereoselective and enantioselective manner via amino–zinc–enolate cyclisation.[81]  The trans 
isomer was produced from the cis isomer by heating with water in a sealed tube, resulting in epimerisation at 
the 2 position (Scheme 76).  
 
Scheme 76. Karoyanʼs inversion of stereochemistry 
 
Epimerisation in this manner may be a valuable tool towards the synthesis of Acromelic acid A (21), if 
transferrable to the NMTPs under investigation (Scheme 77). 
 
Scheme 77. Inversion of stereochemistry to obtain trans C2-C3 configuration 
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2.4 Conclusion and Future Work 
As demonstrated, palladium-catalysed direct arylation of N-methyl-1,2,5,6-tetrahydropyridine 29 and the 
hydrochloride salt 50 is feasible under the reported streamlined phosphine- and silver-free conditions.  A 
reduction in the excess of NMTP starting material required has been achieved, through use of the 
hydrochloride salt 50.  The reaction mechanism has been shown to be complex, and the arylated 
compounds produced difficult to purify utilising standard methods.  The presence of the di-arylated products 
further emphasise the complexity of the catalytic processes involved.   However, the reaction remains of 
great interest due to the difficulty in direct functionalisation of these highly polar nitrogen containing 
compounds.      
 
Further probing of the reaction by in-line GCMS or LCMS may go further to explore the reaction process and 
lead to an improved method of purification and isolation.  Once isolated, these compounds are clearly of 
interest in the telescoped route to 3-aryl-piperidines, or may be applied to the developed [2,3]-rearrangement 
to give coumpounds comprising of the pyrrolidine dicarboxylic acid structures found in kainoids, aided by the 
development of the route to a single diastereomer of quaternary ammonium salt to control the face 
selectivity.   
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CHAPTER 3: EXPERIMENTAL: DIRECT FUNCTIONALISATION OF NITROGEN CONTAINING 
HETEROCYCLES 
 
Reagents were purchased from Sigma-Aldrich, Acros, Alfa Aesar, Fisher Scientific, TCI UK or Lancaster 
Research Chemicals and were not purified except where stated.  Solvents were purchased anhydrous 
and stored over molecular sieves, or distilled under nitrogen from an appropriate drying agent.  THF, 
diethylether, DCM and acetonitrile were distilled from calcium hydride. Thin layer chromatography was 
performed on aluminum sheets coated with Merck silica gel 60 F254 with visualisation using potassium 
permanganate solution and/or scrutinised under 254 nm UV light. Column chromatography was 
performed using Silica 60 (35-70 microns) supplied by Fisher. Crude N-alkyl-5-aryl-1,2,5,6-
tetrahydropyridines were purified by preparative thin layer chromatography utilising Analtech 1000mm 
plates (5% MeOH in EtOAc). 
 
Nuclear magnetic resonance (NMR) spectroscopy was performed on a Bruker Ultrashield 400 Plus NMR 
spectrometer or Bruker Avance 400 NMR spectrometer (1H NMR at 400 MHz, 13C NMR at 100 MHz) with 
the appropriate deuterated solvent.  1H chemical shifts (δH) are expressed in parts per million (ppm) 
relative to tetramethylsilane (TMS), and reported as singlet (s), doublet (d), triplet (t), quartet (q) and 
combinations thereof, or multiplet (m).  Coupling constants (J) are quoted in Hz and are rounded to the 
nearest 0.5 Hz.  13C chemical shifts (δC) are reported rlative to internal solvent peaks from the stated 
deuterated solvent.  Mass spectrometry was performed using a Thermo Fisher Scientific Orbitrap XL or 
Bruker MicroTOF-Q instrument with electrospray ionisation in the positive mode.  FT-IR data was 
acquired using a PerkinElmer Spectrum RX1 FT-IR Spectrometer instrument on germanium ATR or a 
Thermo Electron Corporation Nicolet 380 FTIR with Smart Orbit diamond window instrument; selected 
absorbance maxima are reported in wavenumbers (cm-1). All melting points were obtained using a Stuart 
SMP10 melting point instrument and are uncorrected. 
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3.1 Heck Arylation of N-methyl-1,2,5,6-tetrahydropyridine  
 
General Procedure for Heck-Mizoroki Arylation:  
N-Alkyl-1,2,5,6-tetrahydropyridine (1.5 mmol, 1.5 eq), arylhalide (1.0 mmol, 1.0 eq), Pd(OAc)2 (7 mg, 0.03 
mmol, 0.03 eq), and NEt3 (0.35 mL, 2.5 mmol, 2.5 eq) were combined in screw cap tubes with aq. MeCN 
(3 mL) and heated at 80 oC for 48 to 72 hours.  The reaction mixture was then allowed to cool to room 
temperature before addition of Et2O (15 mL) and filtration through Celite
®.  The filtrate was treated with 
0.5M HCl (3 x 15 mL) and the combined aqueous layers were treated with sufficient NaOH (2M) for 
neutralisation (as shown by pH indicator paper), prior to further extracted with Et2O (3 x 20 mL).  The 
combined organic fractions were dried over Na2SO4 and concentrated in vacuo yielding the corresponding 
crude N-alkyl-5-aryl-1,2,5,6-tetrahydropyridine.  Crude N-alkyl-5-aryl-1,2,5,6-tetrahydropyridines were 
purified by preparative thin layer chromatography utilising Analtech 1000mm plates (5% MeOH in EtOAc), 
or flash column chromatography (95:5 DCM:MeOH). 
 
1-Methyl-5-phenyl-1,2,5,6-tetrahydropyridine (46) 
 
Iodobenzene (0.17 mL, 1.54 mmol, 1 eq), was used in the general method to yield 1-methyl-5-phenyl-
1,2,5,6-tetrahydropyridine as a red oil (98 mg, 38%); 1H NMR (CDCl3, 400 MHz) δH 2.38 (dd, J 10.0 Hz 
11.0 Hz, 1H, 6 -CH2), 2.46 (s, 3H, -NCH3), 2.95-3.06 (m, 1H, 2 -CH2), 3.10 (q, J 6.5 Hz 12.0 Hz, 1H, 6 -
CH2), 3.35 (br.d, J 14.5 Hz, 1H, 2 –CH2), 3.75-3.81 (m, 1H, 5 -CH), 5.86-5.90 (m, 2H, 3, 4 -CH=CH), 7.21-
7.34 (m, 5H, Ar-H); 13C NMR (100 MHz) δC 42.9 (5 -CH), 45.8 (-NCH3), 54.3 (6 -CH2), 60.8 (2 -CH2), 
126.2 (3 -CH), 126.5, 127.9, 128.4 (Ar-C), 128.4 (4 -CH), 143.5 (Ar-C); νmax (thin film, cm
-1) 3028 (C=CH) 
2966, 2936, 2917, 2869 (CH2, C-H stretch), 2839, 2777 (N-CH3), 1658, 1491 (Aromatic C=C), 1602 
(C=C), 757 (mono-substituted phenyl), 699 (CH=CH cis); m/z (ES+) calculated for C12H16N
 [M+H+]; 
174.1283, found 174.1277. 
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1-Methyl-5-(3ʼ-benzyloxyphenyl)-1,2,5,6-tetrahydropyridine (52) 
 
Benzyloxy-3-iodobenzene (0.310 g, 1 mmol) was used in the general method to yield 1-methyl-5-(3ʼ-
benzyloxyphenyl)-1,2,5,6-tetrahydropyridine (212 mg, 76 %); 1H NMR (CDCl3, 400 MHz) δH 2.23 (dd, J 
9.0 Hz 11.0 Hz, 1H, 6 -CH2), 2.33 (s, 3H, -NCH3), 2.79-2.84 (m, 1H, 2 -CH2), 2.93 (q, J 5.5 Hz, 1H, 6 -
CH2), 3.16 (br d, J 16.5 Hz, 1H, 2 -CH2), 3.61-3.65 (m, 1H, 5 -CH), 5.04 (s, 2H, -OCH2), 5.76-5.79 (m, 1H, 
4 -CH), 5.84-5.89 (m, 1H, 3 -CH), 6.82-6.88 (m, 4H, Ar-H), 7.20-7.24 (m, 5H, Ar-H);  13C NMR (100 MHz) 
δC 42.0 (5 -CH), 45.2 (-NCH3), 53.7 (2 -CH2), 60.1 (6 -CH2), 69.9 (-OCH2), 125.1 (3 -CH), 129.1 (4 -CH), 
112.8, 114.6, 120.5, 127.6, 128.3, 128.5, 129.4 (Ar -CH), 137.0, 145.3, 159.0, (Ar-C); νmax (thin film, cm
-1) 
3013 (C=CH) 2935 (CH2, C-H stretch), 2870 (N-CH3), 1656, 1448 (Aromatic C=C), 1597 (C=C), 1448 (C-
N), 1315, 1157 (Ar-O-R), 777 (meta di-substituted benzene), 736 (mono-substituted phenyl) 696 (CH=CH 
cis); m/z (ES+) calculated for C19H22NO
 [M+H]+; 280.1701, found 280.1692. 
 
1-Methyl-5-(4ʼ-benzyloxyphenyl)-1,2,5,6-tetrahydropyridine (54) 
 
Benzyloxy-4-iodobenzene (0.310 g, 1 mmol) was used in the general method to yield 1-methyl-5-(4-
benzyloxyphenyl)-1,2,5,6-tetrahydropyridine (10 mg, <5%); 1H NMR (CDCl3, 400 MHz) δH 2.20 (dd, J 9.0 
Hz 11.0 Hz, 1H, 6 -CH2), 2.33 (s, 3H, -NCH3), 2.79-2.84 (m, 1H, 2 –CH2), 2.91 (q, J 5.5 Hz, 1H, 6 -CH2), 
3.51 (d, J 16.0 Hz, 1H, 2 -CH2), 3.59-3.61 (m, 1H, 5 -CH), 5.04 (s, 2H, -OCH2), 5.74-5.77 (m, 1H, 4 -CH2), 
5.83-5.87 (m, 1H, 3 -CH), 7.03 (dd, J 8.5 Hz 9.0 Hz, 4H, Ar-H), 7.27-7.43 (m, 5H, Ar-H);  13C NMR (100 
MHz) δC 41.9 (5 -CH), 45.7 (-NCH3), 54.2 (2 -CH2), 60.9 (6 -CH2), 60.0 (-OCH2), 125.8 (3 -CH), 128.8 (4 -
CH), 114.7, 127.4, 127.9, 128.5, 128.7 (Ar-CH), 135.9, 137.1, 157.5 (Ar-C); Due to low quantities of 
product isolated, only partial characterization is reported. 
 
1-Methyl-5-(o-tolyl)-1,2,5,6-tetrahydropyridine (55) 
 
2-Iodotoluene (0.218 g, 1 mmol) was used in the general method to yield 1-methyl-5-(o-tolyl)-1,2,5,6-
tetrahydropyridine (26 mg, 14%); 1H NMR (CDCl3, 400 MHz) δH 2.15 (dd, J 9.0 Hz 11.0 Hz, 1H, 6 -CH2), 
2.35 (s, 3H, -NCH3), 2.37 (s, 3H, 2ʼ -CH3), 2.81-2.86 (m, 1H, 2 -CH2), 2.95 (q, J 5.5 Hz, 1H, 6 -CH2), 3.21 
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(br d, J 17.0 Hz, 1H, 2 –CH2), 3.91-3.93 (m, 1H, 5 -CH), 5.76 (br d, J 10.0 Hz, 1H, 4 -CH), 5.88-5.91 (m, 
1H, 3 -CH), 7.10-7.19 (m, 4H, Ar-H);  13C NMR (100 MHz) δC 29.7 (2ʼ -CH3), 38.8 (5 -CH), 45.8 (-NCH3), 
54.4 (2 -CH2), 59.3 (6 -CH2), 125.9 (4 -CH), 128.8 (3 -CH), 126.2, 126.3, 127.6, 130.2 (Ar-CH), 135.7, 
141.3 (Ar-C); Due to low quantities of product isolated, only partial characterization is reported. 
 
1-Methyl-5-(m-tolyl)-1,2,5,6-tetrahydropyridine (56) 
 
3-Iodotoluene (0.218 g, 1 mmol) was used in the general method to yield 1-methyl-5-(m-tolyl)-1,2,5,6-
tetrahydropyridine (20 mg, 11%); 1H NMR (CDCl3, 400 MHz) δH 2.22 (dd, J 9.0 Hz 11.0 Hz, 1H, 6 -CH2), 
2.33 (s, 3H, -NCH3), 2.34 (s, 3H, 3ʼ -CH3), 2.71-2.84 (m, 1H, 2 -CH2), 2.93 (q, J 5.5 Hz, 1H, 6 -CH2), 3.18 
(dd, J 1.0 Hz 16.5 Hz, 1H, 2 -CH2), 3.62-3.66 (m, 1H, 5 -CH), 5.77-5.80 (m, 1H, 4 -CH), 5.85-5.90 (m, 1H, 
3 -CH), 7.04-7.21(m, 4H, Ar-H);  13C NMR (100 MHz) δC 21.4 (3ʼ -CH3), 42.8 (5 -CH), 45.8 (-NCH3), 54.4 
(2 -CH2), 60.8 (6 -CH2), 127.2 (4 -CH), 128.6 (3 -CH), 124.9, 126.0, 128.3, 128.6 (Ar-CH), 137.9, 143.5 
(Ar-C); Due to low quantities of product isolated, only partial characterization is reported. 
 
 1-Methyl-5-(p-tolyl)-1,2,5,6-tetrahydropyridine (57) 
 
 4-Iodotoluene (0.218 g, 1 mmol) was used in the general method to yield 1-methyl-5-(p-tolyl)-1,2,5,6-
tetrahydropyridine (14 mg, 7%); 1H NMR (CDCl3, 400 MHz) δH 2.21 (dd, J 9.0 Hz 11.0 Hz, 1H, 6 -CH2), 
2.32 (s, 3H, -NCH3), 2.34 (s, 3H, 4ʼ -CH3), 2.79-2.85 (m, 1H, 2 -CH2), 2.93 (q, J 5.5 Hz, 1H, 6 -CH2), 3.17 
(br d, J 16.5 Hz, 1H, 2 -CH2), 3.61-3.64 (m, 1H, 5 -CH), 5.76-5.79 (m, 1H, 4 -CH-), 5.83-5.89 (m, 1H, 3 -
CH), 7.11 (s, 4H, Ar-H);  13C NMR (100 MHz) δC 21.0 (4ʼ -CH3), 42.4 (5  -CH), 45.7 (-NCH3), 54.4 (2 –
CH2), 60.9 (6 -CH2), 125.9 (4 -CH), 127.8, 28.6 (Ar-CH), 129.1 (3 -CH), 136.0, 140.5 (Ar-C); Due to low 
quantities of product isolated, only partial characterization is reported.  
 
1-Methyl-5-(2ʼ-methoxyphenyl)-1,2,5,6-tetrahydropyridine (58) 
 
2-Iodoanisole (0.234 g, 1 mmol) was used in the general method to yield 1-methyl-5-(2ʼ-methoxyphenyl)-
1,2,5,6-tetrahydropyridine (6 mg, 3%); 1H NMR (CDCl3, 400 MHz) δH 2.20 (dd, J 7.9 Hz 11.0 Hz, 1H, 6 -
CH2), 2.32 (s, 3H, -NCH3), 2.83-2.89 (m, 1H, 2 -CH2), 2.95 (q, J 5.5 Hz, 1H, 6 -CH2), 3.11 (br d, J 16.5 Hz, 
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1H, 2 -CH2), 3.82 (s, 3H, -OCH3), 4.09-4.13 (m, 1H, 5 -CH), 5.76 (dd, J 2.0 Hz 10.0 Hz, 1H, 4 -CH), 5.86-
5.90 (m, 1H, 3 -CH), 6.85 (d J 8.5 Hz, 1H, Ar-H), 6.91 (t J 7.0 Hz, 1H, Ar-H), 7.17-7.21 (m, 2H, Ar-H); 13C 
NMR (100 MHz) δC 35.3 (5 -CH), 4.45 (-NCH3), 54.4 (2 -CH2), 55.3 (-OCH3), 58.8 (6 -CH2), 126.0 (3 -CH), 
128.4 (4 -CH), 110.2, 120.5, 127.3, 128.5 (Ar-CH), 131.1 (Ar-C), 157.0 (Ar-C); Due to low quantities of 
product isolated, only partial characterization is reported. 
 
1-Methyl-5-(3ʻ-methoxyphenyl)-1,2,5,6-tetrahydropyridine (59) 
 
3-Iodoanisole (0.234 g, 1 mmol) was used in the general method to yield 1-methyl-5-(3ʼ-methoxyphenyl)-
1,2,5,6-tetrahydropyridine (43 mg, 21%); 1H NMR (CDCl3, 400 MHz) δH 2.24 (dd, J 9.0 Hz 11.0 Hz, 1H, 6 -
CH2), 2.34 (s, 3H, -NCH3), 2.80-2.86 (m, 1H, 2 -CH2), 2.94 (q, J 5.5 Hz, 1H, 6 -CH2), 3.71 (br d, J 16.5 Hz, 
1H, 2 -CH2), 3.61-3.65 (m, 1H, 5 -CH), 3.80 (s, 3H, -OCH3), 5.77-5.80 (m, 1H, 4 -CH), 5.85-5.90 (m, 1H, 3 
-CH), 6.73-6.84 (m, 2H, Ar-H), 7.20-7.26 (m, 2H, Ar-H); 13C NMR (100 MHz) δC 42.1 (5 -CH), 45.2 (-
NCH3), 53.9 (2 -CH2), 55.1 (-OCH3), 60.2 (6 -CH2), 111.9, 112.7, 113.0, 120.3 (Ar -CH), 125.4 (3 -CH), 
128.5 (Ar-C), 128.5 (4 -CH), 129.5 (Ar-C); νmax (thin film, cm
-1) 3029 (C=CH) 2954 (CH2, C-H stretch), 
2836 (O-CH3), 2779 (N-CH3), 1671, 1453 (Aromatic C=C), 1599 (C=C), 1453 (C-N), 1315, 1156 (Ar-O-R), 
768 (meta di-substituted phenyl), 680 (CH=CH cis); m/z (ES+) calculated for C13H18NO
 [M+H]+; 204.1383, 
found 204.1381. 
 
1-Methyl-5-(4ʼ-methoxyphenyl)-1,2,5,6-tetrahydropyridine (60) 
 
4-Iodoanisole (0.234 g, 1 mmol) was used in the general method to yield 1-methyl-5-(4ʼ-methoxyphenyl)-
1,2,5,6-tetrahydropyridine (16 mg, 7%); 1H NMR (CDCl3, 400 MHz) δH 2.21 (dd, J 9.0 Hz 11.0 Hz, 1H, 6 -
CH2), 2.34 (s, 3H, -NCH3), 2.80-2.86 (m, 1H, 2 -CH2), 2.92 (q, J 5.5 Hz, 1H, 6 -CH2), 3.17 (br d, J 16.5 Hz, 
1H, 2 -CH2), 3.60-3.63 (m, 1H, 5 -CH), 3.79 (s, 3H, -OCH3), 5.75-5.78 (m, 1H, 4 -CH), 5.83-5.88 (m, 1H, 3 
-CH), 6.84 (d, J 8.5 Hz, 2H, Ar-H), 7.14 (d, J 8.5 Hz, 2H, Ar-H);  13C NMR (100 MHz) δC 41.9 (5 -CH), 45.7 
(-NCH3), 54.4 (2 -CH2), 55.2 (-OCH3), 60.9 (6 -CH2), 125.8 (3 -CH), 128.7 (4 -CH), 113.8, 128.8 (Ar-CH), 
125.8, 135.6 (Ar-C); νmax (thin film, cm
-1) 2935 (CH2, C-H stretch), 2834, 2775 (N-CH3), 1653, 1509 
(Aromatic C=C), 1607 (C=C), 1245 (C-O), 668 (CH=CH cis); m/z (ES+) calculated for C13H18NO
 [M+H]+; 
204.1383, found 204.1382. 
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1-Methyl-5-napthyl-1,2,5,6-tetrahydropyridine (61) 
 
Iodonapthalene (0.254 g, 1 mmol) was used in the general method to yield 1-methyl-5-napthyl-1,2,5,6-
tetrahydropyridine  (54 mg, 24%); 1H NMR (CDCl3, 400 MHz) δH 2.33 (s, 3H, -NCH3), 2.36 (dd, J 8.5 Hz 
11.0 Hz, 1H, 6 -CH2), 2.88-2.94 (m, 1H, 2 -CH2), 3.11 (q, J 5.5 Hz, 1H, 6 -CH2), 3.21 (br d, J 17.4 Hz, 1H, 
2 -CH2), 3.48-3.52 (m, 1H, 5 -CH), 5.90-5.94 (m, 1H, 4 -CH), 5.96-6.00 (m, 1H, 3 -CH), 7.37-7.56 (m, 4H, 
napth-CH), 7.69-7.80 (m, 1H, napth-H), 7.84-7.87 (m, 1H, napth-H), 8.14-8.16 (m, 1H, napth-H); 13C NMR 
(100 MHz) δC 38.2 (5 -CH), 45.8 (-NCH3), 54.5 (2 -CH2), 59.8 (6 -CH2), 123.0, 125.1, 125.4, 125.6, 126.0, 
126.4 (napth-C), 127.0 (4 -CH), 128.7 (napth-C), 129.0 (3 -CH), 131.5, 133.9, 139.3 (napth-C); νmax (thin 
film, cm-1) 1653, 1507 (Aromatic C=C), 669 (CH=CH cis);  m/z (ES+) calculated for C16H18N
 [M+H]+; 
224.1439, found 224.1438. 
 
1-Methyl-5-(2ʼ-hydroxyphenyl)-1,2,5,6-tetrahydropyridine (62) 
 
2-Iodophenol (0.220 g, 1 mmol) was used in the general method in aq. MeCN (3 mL, 95%) yielding 1-
methyl-5-(2ʼ-hydroxyphenyl)-1,2,5,6-tetrahydropyridine (<10 mg, <5%); 1H NMR (CDCl3, 400 MHz) δH 
2.32 (td, J 12.7 Hz 3.7 Hz, 1H, 6 -CH2), 2.52 (s, 3H, -NCH3), 2.26-2.60 (m, 1H, 2 -CH2), 2.76 (dd, J 5.0 Hz 
11.8 Hz, 1H, 5 -CH2), 3.02-3.04 (m, 1H, 2 -CH2), 3.36-3.41 (m, 1H, 5 -CH), 4.95 (br. s, 1H, 2ʼ -OH), 5.72-
5.79 (m, 2H, 3, 4 -CH), 6.72-7.14 (m, 4H, Ar-H); 13C NMR (100 MHz) δC 42.8 (-NCH3), 44.3 (5 -CH), 45.3 
(6 -CH2), 56.0 (2 -CH2), 123.1 (3 -CH), 127.0 (4 -CH), 114.9, 118.3, 119.3, 127.8 (Ar-CH), 128.4, 130.3, 
(Ar-C); νmax (thin film, cm
-1) 3068, 3039 (C=CH), 2994 (-OH), 2821 (N-CH3), 1581 (Aromatic C=C), 1484 
(C=C), 1457 (C-N), 1279 (O-H bending), 753 (ortho di-substituted phenyl); m/z (ES+) calculated for 
C12H16NO
 [M+H]+; 190.1232, found 190.1225. 
 
1-Methyl-5-(2ʼ-aminophenyl)-1,2,5,6-tetrahydropyridine (63) 
 
2-Iodoaniline (0.219 g, 1 mmol) was used in the general method in aq. MeCN (3 mL, 95%) yielding 1-
methyl-5-(2-aminophenyl)-1,2,5,6-tetrahydropyridine (28 mg, 15%); 1H NMR (CDCl3, 400 MHz) δH 2.50 
(dd, J 7.0 Hz 11.5 Hz, 1H, 6 -CH2), 2.55 (s, 3H, -NCH3), 2.87 (dd, J 5.0 Hz 10.6 Hz, 1H, 6 -CH2), 2.96-
3.02 (m, 1H, 2 -CH2), 3.04-3.11 (m, 1H, 2 -CH2), 3.60-3.64 (m, 1H, 5 -CH), 5.77-5.81 (m, 1H, 4 -CH), 
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5.88-5.93 (m, 1H, 3 -CH), 6.45-7.64 (m, 4H, Ar-H); νmax (thin film, cm
-1) 3058 (C=CH), 2924 (CH2, C-H 
stretch), 2786 (N-CH3), 1609 (NH2), 1495, 1440 (Aromatic C=C), 1476 (C-N), 740 (ortho di-substituted 
phenyl), 695 (CH=CH cis);  Due to low quantities of product isolated, only partial characterization is 
reported. 
 
1-Methyl-5-(2ʼ-nitrophenyl)-1,2,5,6-tetrahydropyridine (65) 
 
1-Iodo-2-nitrobenzene (0.249 g, 1 mmol, 1.0 eq) was used in the general method in aq. MeCN (3 mL, 
95%) yielding 1-methyl-5-(2-nitrophenyl)-1,2,5,6-tetrahydropyridine (<10 mg, <5%); 1H NMR (CDCl3, 400 
MHz) δH 2.34 (s, 3H, -NCH3), 2.46 (dd, J 6.2 Hz 11.4 Hz, 1H, 6 –CH2), 3.00 (d, J 5.4 Hz, 1H, 6 -CH2), 
3.02-3.04 (m, 2H, 2 -CH2), 4.08-4.12 (m, 1H, 5 -CH), 5.67-5.71 (m, 1H, 4 -CH), 5.95-5.99 (m, 1H, 3 -CH), 
7.28-7.87 (m, 4H, Ar-H); 13C NMR (100 MHz) δC 38.3 (5 -CH), 45.5 (-NCH3), 54.0 (2 -CH2), 60.3 (6 -CH2), 
126.4 (3 -CH), 127.9 (4 -CH), 125.0, 125.7, 126.7, 126.6, (Ar-CH), 131.6, 130.8, (Ar-C); νmax (thin film, cm
-
1) 2955, 2922 (CH2, C-H stretch), 2853 (N-CH3), 1660, 1459 (Aromatic C=C), 1580 (C=C), 1527, 1346 
(NO2), 1346 (C-N), 729 (ortho di-substituted phenyl), 695 (CH=CH cis); m/z (ES
+) calculated for 
C12H15N2O2
 [M+H]+; 129.1128, found 219.1126. 
 
1-Methyl-5-(3ʼ-nitrophenyl)-1,2,5,6-tetrahydropyridine (66) 
 
1-Iodo-3-nitrobenzene (0.249 g, 1.0 mmol, 1.0 eq) was used in the general method in aq. MeCN (3 mL, 
95%), yielding 1-methyl-5-(3-nitrophenyl)-1,2,5,6-tetrahydropyridine (20 mg, 9%); 1H NMR (CDCl3, 400 
MHz) δH 2.31-2.36 (m, 1H, 6 -CH2), 2.34 (s, 3H, -NCH3) 2.89-3.01 (m, 2H, 2, 6 -CH2), 3.12 (br.d, J 17.4 
Hz, 1H, 2 -CH2), 3.71-3.75 (m, 1H, 5 -CH), 5.75-5.79 (m, 1H, 4 -CH), 5.95-6.00 (m, 1H, 3 -CH), 7.45-4.49 
(m, 1H, Ar-CH), 7.60-7.62 (m, 1H, Ar-CH), 8.07-8.13 (m, 2H, Ar-CH); 13C NMR (100 MHz) δC 42.6 (5 -
CH), 45.7 (-NCH3), 54.2 (2 -CH2), 60.0 (6 -CH2), 126.6 (4 -CH), 126.6 (3 -CH), 121.6, 122.8, 126.9, 129.2, 
(Ar-CH), 134.5, 134.9 (Ar-C); νmax (thin film, cm
-1) 3033 (C=CH) 2976, 2917 (CH2, C-H stretch), 2853 (N-
CH3), 1656, 1527 (Aromatic C=C), 1606 (C=C), 1527, 1349 (NO2), 1349 (C-N), 737 (meta di-substituted 
phenyl), 687 (CH=CH cis); m/z (ES+) calculated for C12H15N2O2
 [M+H]+; 219.1134, found 219.1127. 
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1-Methyl-5-(2ʼ-(trifluoromethyl)phenyl)-1,2,5,6-tetrahydropyridine (67) 
 
1-Iodo-2-(trifluoromethyl)benzene (0.272 g, 1 mmol) was used in the general method in aq. MeCN (3 mL, 
95%) yielding 1-methyl-5-(2-(trifluoromethyl)phenyl)-1,2,5,6-tetrahydropyridine (11 mg, 5%); 1H NMR 
(CDCl3, 400 MHz) δH 2.27 (dd, J 7.8 Hz 11.3 Hz, 1H, 6 -CH2), 2.34 (s, 3H, -NCH3), 2.91-2.98 (m, 2H, 2, 6 
-CH2), 3.15 (br.d, J 17.5 Hz, 1H, 2 -CH2), 4.06-4.10 (m, 1H 5 -CH), 567-5.70 (m, 1H, 4 -CH), 5.90-5.95 
(m, 1H, 3 -CH), 7.49-7.63 (m, 4H, Ar-CH); 13C NMR (100 MHz) δC 30.2 (5 –CH2), 45.5 (-NCH3), 54.1 (6 -
CH2), 59.8 (2 -CH2), 126.4 (3 –CH), 128.0 (4 -CH), 123.6, 124.4, 125.6, 126.3 (Ar-CH), 126.7, 131.2, (Ar-
C); νmax (thin film, cm
-1) 2978, 2918 (CH2, C-H stretch), 2853 (N-CH3), 1663, 1492 (Aromatic C=C), 1607 
(C=C), 1311, 1159, 1161, 1036 (C-F), 1454 (C-N), 769 (ortho di-substituted phenyl), 709 (CH=CH cis); 
m/z (ES+) calculated for C13H15NF3
 [M+H]+; 242.1157, found 242.1150. 
 
1-Methyl-5-(3-(trifluoromethyl)phenyl)-1,2,5,6-tetrahydropyridine (68) 
 
1-Iodo-3-(trifluoromethyl)benzene (0.272 g, 1.0 mmol, 1.0 eq) was used in the general method in aq. 
MeCN (3 mL, 95%), yielding 1-methyl-5-(3-(trifluoromethyl)phenyl)-1,2,5,6-tetrahydropyridine (46 mg, 
19%); 1H NMR (CDCl3, 400 MHz) δH 2.26 (dd, J 8.4 Hz 11.2 Hz, 1H, 6 -CH2), 2.35 (s, 3H, -NCH3), 2.87-
2.96 (m, 1H, 2, 6 -CH2), 3.17 (br.d, J 15.8 Hz, 1H, 2 -CH2), 3.68-3.73 (m, 1H 5 -CH), 5.75-5.79 (m, 1H, 4 -
CH), 5.92-5.95 (m, 1H, 3 -CH), 7.41-7.49 (m, 4H, Ar-CH); 13C NMR (100 MHz) δC 42.5 (5 –CH2), 45.7 (-
NCH3), 54.4 (2 -CH2), 60.2 (6 -CH2), 127.0 (3 -CH), 127.2 (4 -CH), 123.0, 123.6, 124.4, 128.8 (Ar-CH), 
131.0, 131.6, (Ar-C); νmax (thin film, cm
-1) 2943 (CH2, C-H stretch), 2787 (N-CH3), 1662, 1490 (Aromatic 
C=C), 1613 (C=C), 1377, 1119, 1072 (C-F), 1447 (C-N), 767 (meta di-substituted phenyl), 701 (CH=CH 
cis); m/z (ES+) calculated for C13H15NF3
 [M+H]+; 242.1157, found 242.1148. 
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3.2 Diaryl N-Methyl Tetrahydropyridines  
Diaryl N-methyl-1,2,5,6-tetrahydropyridines were isolated as by-products from the Heck arylation, isolated 
for identification purposes by 1H NMR from preparative TLC (5% MeOH in EtOAc).  Quantities obtained 
were typically <10mg (<5%) and therefore full analysis was not always possible. 
 
1-Methyl-3,5-diphenyl-1,2,5,6-tetrahydropyridine (53)  
 
Iodobenzene (0.17 mL, 1.54 mmol, 1 eq), was used in the general method to yield 1-methyl-3,5-diphenyl-
1,2,5,6-tetrahydropyridine as a yellow oil (14 mg, 9%) Rf 0.14.  
1H NMR (CDCl3, 400 MHz) δH
 2.31 (dd J 
8.9 Hz 11.2 Hz, 1H, 2 -CH2), 2.46 (s, 3H, -NCH3), 3.02 (dd J 6.0 Hz, 11.0 Hz, 1H, 2- CH2), 3.23 (dq J 16.0 
Hz 2.0 Hz 3.5 Hz 6.0 Hz, 6 -CH2), 3.57 (dt J 16.0 Hz 1.0 Hz 2.5 Hz, 6 -CH2), 3.80-.84 (m, 1H, 5 -CH), 6.17 
(d J 1.5 Hz, 1H, 4 -CH), 7.18-7.47 (m, 10H, Ar-CH); 13C NMR (100 MHz) δC
 29.7 (3 -C), 43.2 (5 -CH), 45.7 
(-NCH3), 56.3 (6 -CH2), 60.4 (2 -CH2C), 125.2, 125.7, 126.7, 127.4, 128.1, 128.4, 128.5, 136.7, 143.6 (Ar-
C); νmax (thin film, cm
-1) 3026 (C=CH) 2936, 2918 (CH2, C-H stretch), 2783 (N-CH3), 1675, 1493 (Aromatic 
C=C), 1600 (C=C), 753 (mono-substituted phenyl); m/z (ES+) calculated for C18H20N
 [M+H+]; 250.1596, 
found 250.1586. 
 
1-Methyl-3,5-(o-tolyl)-1,2,5,6-tetrahydropyridine (55b) 
 
2-Iodotoluene (0.218 g, 1 mmol) was used in the general method to yield 1-methyl-3,5-(o-tolyl)-1,2,5,6-
tetrahydropyridine (<5 mg, <5%). 1H NMR (CDCl3, 400 MHz) δH 2.26 (dd J 9.5 Hz 11.5 Hz, 1H, 2 -CH2), 
2.41 (s, 9H, -NCH3, 2ʼ, 2ʼʼ -CH3), 2.86 (d, J 9.0 Hz, 1H, 6 -CH2), 3.02-3.06 (m, 1H, 2 -CH2), 3.32 (br d, J 
16.0 Hz, 1H, 6 -CH2), 4.05-4.10 (m, 1H, 5 -CH), 5.64 (s, 1H, 4 -CH), 7.12-7.24, 7.44-7.49, 7.53-7.57, 
7.64-7.69 (m, 8H, 2x C6H4); Due to low quantities of product isolated, only partial characterization is 
reported. 
 
1-Methyl-3,5-(m-tolyl)-1,2,5,6-tetrahydropyridine (56b) 
 
3-Iodotoluene (0.218 g, 1 mmol 1.0 eq) was used in the general method to yield 1-methyl-3,5-(m-tolyl)-
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1,2,5,6-tetrahydropyridine (<10 mg, <5%). 1H NMR (CDCl3, 400 MHz) δH 2.28 (dd J 9.0 Hz 10.9 Hz, 1H, -
2 -CH2), 2.34 (s, 3H, -CH3), 2.36 (s, 3H, -CH3), 2.46 (s, 3H, -NCH3), 3.02 (q, J 5.5 Hz, 1H, 6 -CH2), 3.18-
3.23 (m, 1H, 2 -CH2), 3.56 (br d, J 15.5 Hz, 1H, 6 -CH2),  3.76-3.80 (m, 1H, 5 -CH-), 6.15 (s, 1H, 4 -CH), 
7.04-7.08, 7.17-7.23 (m, 8H, Ar-CH); Due to low quantities of product isolated, only partial 
characterization is reported. 
 
1-Methyl-3,5-(3ʼ,3ʼʼ-dimethoxyphenyl)-1,2,5,6-tetrahydropyridine (59b) 
 
3-Iodoanisole (0.234 g, 1 mmol) was used in the general method to yield 1-methyl-3,5-(3ʼ,3ʼʼ-
dimethoxyphenyl)-1,2,5,6-tetrahydropyridine  (<10 mg, <5%). 1H NMR (CDCl3, 400 MHz) δH 2.31 (dd J 9.0 
Hz 11.0 Hz, 1H, 2 -CH2), 2.46 (s, 3H, -NCH3), 3.02 (q, J 5.5 Hz, 1H, 6 –CH2), 3.18-3.24 (m, 1H, 2 -CH2), 
3.55 (br d, J 16.0 Hz, 1H, 6 -CH2),  3.80 (s, 3H, -OCH3), 3.81 (s, 3H, -OCH3), 6.17 (s, 1H, 4 -CH), 6.77-
7.01, 7.22-7.26 (m, 8H, Ar-CH); Due to low quantities of product isolated, only partial characterization is 
reported. 
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3.3 Synthesis of Pyridinium salts and corresponding Tetrahydropyridines  
 
1-Methyl-pyridinium iodide
[175]
 
 
To a solution of pyridine (6.4 mL, 80 mmol, 1 eq) in THF (30 mL) was added dropwise Iodomethane (5.9 
mL, 95 mmol, 1.5 eq) under N2.  The reaction mixture was stirred at room temperature for 13 hours after 
which time the resulting solid was triturated with light petroleum ether, filtered and washed with further 
light petroleum ether to give 1-methylpyridinium iodide as a pale yellow solid (11.87 g, 85%); mpt 117-118 
oC (Lit. 116-117 oC); 1H NMR (D2O, 400 MHz) δH 4.30 (s, 3H, -NCH3), 7.96 (t J 7.0 Hz, 2H, 3, 5 -CH), 8.44 
(t J 8.0 Hz, 1H, 4 -CH), 8.67 (d J 6.0 Hz, 2H, 2, 6 -CH); 13C NMR (100 MHz) δC 48.2 (-NCH3), 128.0 (3, 5 -
CH), 145.0 (2, 6 -CH), 145.3 (4 -CH); νmax (thin film, cm
-1) 3117, 3073, 3028, 2988 (C=CH), 2792 (N-CH3), 
1628  (C=N), 1482 (C-N); m/z (ES+) calculated for C6H8N [M
+]; 94.0651, found 94.0648.   
 
1-Methyl-1,2,5,6-tetrahydropyridine (29)
[176]
 
 
To a solution of 1-methylpyridinium iodide (2 g, 9.0 mmol, 1.0 eq) in NaOH (1M, 25 mL) was added 
sodium borohydride (0.51 g, 13.5 mmol, 1.5 eq) in two portions under N2 at room temperature and stirred 
for 3 hours.  The solution was washed with saturated sodium chloride solution and extracted with Et2O.  
The organic layers were combined, dried over Na2SO4, filtered and concentrated in vacuo to yield 1-
methyl-1,2,5,6-tetrahydropyridine  as a pale yellow oil (0.75 g, 85%).  1H NMR (CDCl3, 400 MHz) δH
 2.16-
2.22 (m, 2H, 5 –CH2), 2.34 (s, 3H, -NCH3), 2.51 (t J 6.0 Hz, 2H, 6 -CH2), 2.90-2.92 (m, 2H, 2 -CH2), 5.63-
5.69 (m, 1H, 3 -CH), 5.71-5.76 (m, 1H, 4 –CH); 13C NMR (100 MHz) δC 25.9 (5 -CH2), 46.0 (-NCH3), 51.9 
(6 -CH2), 56.5 (2 -CH2), 124.8 (4 –CH), 125.2 (3 -CH); νmax (thin film, cm
-1) 2990, 2972, 2941, 2918 (CH2, 
C-H stretch), 2783 (N-CH3), 1658 (C=C), 1450 (C-N), 652 (CH=CH cis); m/z (ES
+) calculated for C6H12N
 
[M+H+]; 98.0970, found 98.0964. 
 
1-Benzyl pyridinium chloride (71)
[177]
 
 
Benzylamine  (0.32 mL, 3.0 mmol, 3 eq) was added to a stirred solution of N-(2,4-dinitrophenyl)pyridinium 
chloride (0.281 g, 1.0 mmol, 1 eq) in methanol (20 mL) under nitrogen at room temperature. After 2 hours 
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the resulting red mixture was heated to reflux for 18 hours, cooled, concentrated in vacuo and partitioned 
between H2O (20 mL) and DCM (20 mL).  The aqueous layer was washed repeatedly with DCM (20 mL) 
until no further colour was removed from the aqueous layer. The aqueous portion was concentrated in 
vacuo to give 1-benzylpyridinium chloride as a low melting point colourless solid (0.69 g, 93%); mpt 
<30oC; 1H NMR (MeOD, 400 MHz) δH 5.89 (s, 2H, -CH2), 7.51 (dd J 6.0 Hz 19.5 Hz, 5H, Ar-CH), 8.16 (t J 
6.5 Hz, 2H, 3, 5 -CH), 8.64 (t J 8.0 Hz, 1H, 4 -CH), 9.11 (d J 6.0 Hz, 2H, 2, 6 -CH); 13C NMR (100 MHz) δC 
64.3 (-CH2), 128.3 (3, 5 -CH), 128.5, 128.7, 128.8, 129.3, 129.6 (Ar-CH), 133.2 (Ar-C), 144.6 (2, 6 -CH), 
145.9 (4 -CH); νmax (solid, cm
-1) 3065 (C-H), 1630  (C=N), 1486 (C-N), 745 (C-H alkene); m/z (ES+) 
calculated for C12H12N
 [M]+; 170.0970, found 170.0964. 
 
1-Benzyl-1,2,5,6-tetrahydropyridine (73)
[178]
 
 
To a solution of 1-benzylpyridinium chloride (0.25 g, 1.21 mmol, 1 eq) in MeOH (20 mL) was added 
sodium borohydride (55 mg, 1.45 mmol, 1.2 eq) under N2 at room temperature and stirred for 3 hours and 
partitioned between H2O and DCM.  The organic layers were combined, dried over Na2SO4, filtered and 
concentrated in vacuo to yield 1-benzyl-1,2,5,6-tetrahydropyridine  as an orange oil (0.151 g, 72%); 1H 
NMR (CDCl3, 400 MHz) δH
 2.15 (br s, 2H, 5 -CH2), 2.55 (t J 5.5 Hz, 2H, 6 -CH2), 2.96 (br s, 2H, 2 -CH2), 
3.57 (s, 2H, -CH2), 5.65 (d J 10.0 Hz, 1H, 3 -CH), 5.74 (d J 10.5 Hz, 1H, 4 -CH), 7.22-7.41 (m, 5H, Ar-
CH); 13C NMR (100 MHz) δC 24.3 (5 -CH2), 49.6 (6 -CH2), 52.8 (2 -CH2), 62.9 (-CH2), 125.2 (3 -CH), 125.3 
(4 –CH), 128.0, 128.2, 128.9 (Ar-CH), 138.3 (Ar-C); νmax (thin film, cm
-1) 3028 (C-H aromatic), 2912 (C-H), 
1659 (C=C), 1601, 1493 (C=C aromatic), 1453 (C-N), 653 (CH=CH cis);  MS m/z [M+H]+ C12H16N
+ 
requires 174.1283 found 174.1283 (100%);  
 
1-Propyl pyridinium chloride (72)
[168]
 
 
Propylamine  (0.25 mL, 3.0 mmol, 3 eq) was added to a stirred solution of N-(2,4-dinitrophenyl)pyridinium 
chloride (0.281 g, 1.0 mmol, 1 eq) in methanol (20 mL) under nitrogen at room temperature. After 2 hours 
the resulting red mixture was heated to reflux for 18 hours, cooled, concentrated in vacuo and partitioned 
between H2O (20 mL) and DCM (20 mL).  The aqueous layer was washed repeatedly with DCM (20 mL) 
until no further colour was removed from the aqueous layer. The aqueous portion was concentrated in 
vacuo to give 1-propylpyridinium chloride as an orange oil (0.45 g, 96%); 1H NMR (MeOD, 400 MHz) δH 
1.03 (t J 7.o Hz, 3H, 9 -CH3), 2.08 (sext J 7.0 Hz, 2H, 8 -CH2), 4.64 (t J 7.5 Hz, 2H, 7 -CH2), 8.15 (t J 6.5 
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Hz, 2H, 3, 5 -CH), 8.63 (t J 8.0 Hz, 1H, 4 -CH), 9.04 (d J 6.0 Hz, 2H, 2, 6 -CH); 13C NMR (100 MHz) δC 9.2 
(9 -CH3), 24.4 (7 -CH2), 63.0 (6 -CH2), 128.0 (3, 5 -CH), 144.5 (2, 6 -CH), 145.5 (4 -CH); νmax (thin film, 
cm-1) 3041, 2966, 2936 (C-H), 2878 (N-CH3), 1633  (C=N), 1487 (C-N), 775 (C-H alkene); m/z (ES
+) 
calculated for C18H12N
 [M]+; 122.0970, found 122.0964. 
 
1-Propyl-1,2,5,6-tetrahydropyridine (74)
[179]
 
 
To a solution of 1-propylpyridinium chloride (0.20 g, 1.26 mmol, 1 eq) in MeOH (10 mL) was added 
sodium borohydride (57 mg, 1.52 mmol, 1.2 eq) under N2 at room temperature and stirred for 3 hours and 
partitioned between H2O and DCM.  The organic layers were combined, dried over Na2SO4, filtered and 
concentrated in vacuo to yield 1-propyl-1,2,5,6-tetrahydropyridine as an orange oil (99 mg, 63%); 1H NMR 
(CDCl3, 400 MHz) δH
 0.91 (t J 7.0 Hz, 3H, 9 -NCH3), 1.55 (sext J 7.5 Hz, 2H, 8 -CH2), 2.18 (br s, 2H, 5 -
CH2), 2.35 (t J 8.0 Hz, 2H, 7 -CH2), 2.54 (t J 5.5 Hz, 2H, 6 -CH2), 2.95 (s, 2H, 2 -CH2), 5.66 (d J 10.5 Hz, 
1H, 3 -CH), 5.73 (d J 11.0 Hz, 1H, 4 –CH); 13C NMR (100 MHz) δC 11.9 (9 -CH3), 17.0 (8 -CH2), 26.1 (5 -
CH2), 50.0 (7 -CH2), 51.9 (2 -CH2), 60.2 (C6 -CH2), 125.1 (3 –CH), 125.4 (4 –CH); νmax (thin film, cm
-1) 
2958, 2928 (C-H stretch), 1663 (C=C), 1461 (C-N), 654 (CH=CH cis); MS m/z [M+H]+ C8H16N
+ requires 
126.1283 found 126.1276 (100%);  
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3.4 Manipulation of Nitrogen Chirality  
 
1-Ethoxycarbonylmethyl-3-hydroxy-1-methyl-piperidinium bromide (79)
[180]
 
 
To a solution of 1-methyl-3-piperidinol (6.1 mL, 53.0 mmol, 1.0 eq) in toluene (80 mL) was added ethyl 
bromoacetate (7.90 mL, 71.0 mmol, 1.3 eq) and the reaction mixture left to stir at room temperature for 16 
hours. The crude product was collected by filtration as a colourless solid (14.53 g, dr 1:1, 97%), 
diastereomeric ratio calculated from 1H NMR spectrum by integration of the NCH3 resonances 3.21 trans 
and 3.32 cis ppm. Repeated crystallization from EtOH(aq) gave white solid 1-ethoxycarbonylmethyl-3-
hydroxy-1-methyl-piperidinium bromide in a 2:1 trans:cis ratio, which was taken on for further 
lactonisation, and 1:3 trans:cis ratio in the liquor; mpt 150-152 oC; 1H NMR (MeOD, 400 MHz) δH
 1.22 
(sext, J 3.5 Hz, 3H, –CH2CH3), 1.60-1.67 (m, 1H, 4 -CH2), 1.76-1.86 (m, 2H, 5 -CH2), 2.05-2.15 (m, 1H, 4 
-CH2), 3.24 (s, 3H, -NCH3), 3.51-3.66 (m, 2H, 2, 6 -CH2), 3.74-3.78 (m, 2H, 2, 6 -CH2), 4.07 (br t J 3.0 Hz, 
1H, 3 -CH), 4.16-4.23 (m, 2H, -CH2CH3), 4.64 (dd J 16.5 Hz 119.0 Hz, 2H, -NCH2CO2Et); 
13C NMR 
(MeOD, 100 MHz) δC
 12.8 (-CH2CH3), 16.3 (5 -CH2), 28.7 (4 -CH2), 50.2 (-NCH3), 60.4 (-NCH2CO2Et), 
61.9 (-CO2CH2CH3), 62.2 (3 -CH), 63.7 (6 -CH2), 64.5 (2 -CH2), 164.4 (-CO2Et); νmax (solid, cm
-1) 3257 (O-
H), 2980 (C-H), 1736 (C=O), 1240, 1210 (C-N), 1077, 1042, 1025 (C-O); MS m/z [M-Br]+• C10H20NO3
+ 
requires 202.1438, found 202.1437. 
 
(±)1-Methyl-3-oxo-4-oxa-1-azonia-bicyclo[3.3.1]nonane bromide (80) 
 
A solution of 1-ethoxycarbonylmethyl-3-hydroxy-1-methyl-piperidinium bromide (8.0 g, 28.35 mmol, dr 1:1 
trans:cis) in 5% HCl in EtOH (125 mL) was heated to reflux for 16 hours.  Evaporation of the solvent left 
the crude product as a yellow oil which was a mixture of product, cis-1-ethoxycarbonylmethyl-3-hydroxy-
1-methyl-piperidinium bromide and trans-1-ethoxycarbonylmethyl-3-hydroxy-1-methyl-piperidinium 
bromide. Nonane crystallized out of the crude reaction product on standing and was isolated by washing 
with cold EtOH to give as colourless needles (2.81 g, 42%); mpt 182 oC (decomposes); 1H NMR (D2O, 
400 MHz) δH 1.84-2.16 (m, 4H, 3ʼ, 4ʼ -CH2), 3.23 (s, 3H, -NCH3), 3.48-3.56 (m, 1H, 2ʼ –CH2), 3.66 (dd J 
2.0 Hz, 12.0 Hz, 1H, 2ʼ –CH2), 3.78 (dd J 2.5 Hz, 13.5 Hz, 1H, 6 –CH2), 3.88 (br d J 13.5 Hz, 1H, 6 –CH2), 
4.39 (d J 18.0 Hz, 1H, 2 -NCH2CO), 4.49 (d J 18.0 Hz, 1H, 2 -NCH2CO), 5.16 (br s, 1H, 5 -CH); 
13C NMR 
(100 MHz) δC 15.7, 25.4 (3ʼ, 4ʼ –CH2), 55.8 (-NCH3), 57.3 (2ʼ -CH2), 58.7 (6 -CH2), 64.4 (2 -NCH2CO), 
73.2 (5 -CH), 164.6 (CO); νmax (solid, cm
-1) 2929 (C-H), 1736 (C=O), 1236, 1216 (C-N), 1035 (C-O); MS 
m/z [M-Br]+• C8H14NO2 requires 156.1019, found 156.1017. 
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(1S, 3R)-1-Ethoxycarbonylmethyl-3-hydroxy-1-methyl-piperidinium bromide (81)
[181]
 
 
To a solution of 1-methyl-3-oxo-4-oxa-1-azonia-bicyclo[3.3.1]nonane bromide (0.5 g, 2.0 mmol) in EtOH 
(30 mL) was added Ti(OiPr)4 (0.25 mL, 0.84 mmol, 0.4 eq) and the reaction heated to reflux for 5 hours. 
The reaction mixture was cooled and HCl (0.1 M, 50 mL, 5 mmol, 2.5 eq) added, filtered to remove any 
solid and concentrated in vacuo to yield (1S,3R)-1-methoxycarbonylethyl-3-hydroxy-1-methyl-piperidinium 
bromide as a yellow solid (0.492 g, 87%); mpt 152-154 oC; 1H NMR (MeOD, 400 MHz) δH
 1.33 (t J 7.0 HZ, 
3H, –CH2CH3), 1.73-1.80 (m, 1H, 4 -CH2), 1.88-1.94 (m, 2H, 5 -CH3), 2.19-2.24 (m, 1H, 4 -CH2), 3.35 (s, 
3H, -NCH3), 3.49-3.56 (m, 2H, 2, 6 -CH2), 3.17-3.75 (m, 1H, 2 -CH2), 3.88 (br dd J 4.5 Hz 13.0 Hz, 1H, 6 -
CH2),  4.18 (br t J 3.0 Hz, 1H, 3 -CH), 4.27-4.35 (m, 2H, -CH2CH3), 4.61 (dd J 17.0 Hz 119.0 Hz, 2H, -
NCH2CO2Et); 
13C NMR (MeOD, 100 MHz) δC
 12.8 (-CH2CH3), 16.2 (5 -CH2), 28.5 (4 -CH2), 51.4 (-NCH3), 
60.4 (-NCH2CO2Et), 62.0 (-CO2CH2CH3), 62.5 (3 -CH), 62.6 (6 -CH2), 63.5 (2 -CH2), 164.9 (-CO2Et); νmax 
(solid, cm-1) 3256 (O-H), 2976 (C-H), 1721 (C=O), 1242, 1215 (C-N), 1074, 1040, 1025 (C-O); MS m/z 
[M-Br]+• C10H20NO3
+ requires 202.1438, found 202.1439. 
 
1-Ethoxycarbonylmethyl-1-methyl-1,2,5,6-tetrahydropyridine bromide (82)
[182]
 
 
Trifluoromethanesulfonic anhydride (0.34 mL, 2.0 mmol, 2.0 eq) was added dropwise to a mixture of 
racemic 1-ethoxycarbonylmethyl-3-hydroxy-1-methyl-piperidinium bromide (0.282 g, 1.0 mmol, 1 eq) and 
2,6-di-tertbutyl pyridine (0.616 g, 3.0 mmol, 3.0 eq) in DCM (5 mL) at 0 oC and stirred for 1 hour.  The 
reaction mixture was warmed to room temperature and stirred for a further 16 hours.  The reaction 
mixture was partitioned between DCM (10 mL) and H2O (10 mL), and the aqueous layer concentrated in 
vacuo to give 1-ethoxycarbonylmethyl-1-methyl-1,2,5,6-tetrahydropyridine bromide as a yellow oil (0.220 
g, 83%); 1H NMR (MeOD, 400 MHz) δH 1.34 (t J 7.0 Hz, 3H, –CH2CH3), 2.54-2.60 (m, 2H, 5 –CH2), 3.34 
(s, 3H, -NCH3), 3.61-3.85 (m, 2H, 6 –CH2), 4.08-4.21 (m, 2H, 2 –CH2), 4.33 (q J 7.5 Hz, 2H, -CH2CH3), 
4.58 (dd J 2.0 Hz 14.0 Hz, 2H, -NCH2CO2Et), 5.75 (br dt J 2.0 Hz 10.5 Hz, 1H, 3 –CH) 6.04-6.09 (m, 1H, 
4 –CH); 13C NMR (100 MHz) δC 12.8 (–CH2CH3), 20.7 (5 –CH2), 47.7 (-NCH3), 57.8 (6 –CH2), 58.2 (–
CH2CO2Et), 59.9 (2 –CH2), 62.4 (–CH2CH3), 118.8 (3 -CH), 124.6 (4 -CH), 164.5 (CO); νmax (thin film, cm
-
1) 1748 (C=O), 1222 (C-N), 1023 (C-O); MS m/z [M-Br]+• C10H18NO2
+ requires 184.1332, found 184.1334. 
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CHAPTER 4: RESULTS AND DISCUSSION: IRON CATALYSED ARYLATIVE SPIROCYCLISATION  
 
4.1 Iron Catalysed Radical Cyclisations 
Radical cyclisations are useful tools for the preparation of five-membered cyclic compounds,[183] often 
employing tributyltin hydride as a reagent.  As a result of the toxicity of tin reagents and the difficulty in 
removing the residues from the products, alternative reagents have been extensively investigated 
recently, including the use of manganate and iron.[184] 
 
Oshima demonstrated that trialkylmanganate salts and alkyl magnesium salts can initiate a radical 
cyclisation of halo acetals, allyl o-halophenyl ethers and diallyl iodoanilines in the presence of catalytic 
amounts of MnCl2 or FeCl2, via a single electron transfer process (Scheme 78).
[185]  Oshima proposed a 
radical intermediate formed by single-electron transfer from the electron-rich manganese to the substrate.  
 
Scheme 78. Mechanistic Grignard cross-coupling pathway, where X = O or NR 
 
In the case of the manganese-catalysed cyclisation, iodo-compounds are required, with the 
corresponding bromides not delivering in the desired cyclised products efficiently.  The iron-catalysed 
reactions however, can be used to cyclise bromo ethers in fair to good yields (Scheme 79).[186]   
 
Scheme 79. Cyclisation of bromo ethers in the presence of PhMgBr and iron(II) catalyst 
 
When using aromatic Grignard reagents, arylative capture results in the aromatic group being 
incorporated into the cyclised product.  Thus, radical cyclisation and subsequent coupling with aromatic 
Grignard reagents can be achieved in a single operation.  Alkyl Grignard species however, cannot be 
introduced in the products, leading to the reduced products as shown in Scheme 80, by Oshima.  
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Scheme 80. Cyclisation in the presence of aryl or alkyl Grignards 
 
4.2 Initial Investigations 
Though there have been many well-designed studies into iron-mediated cross-coupling of Grignard 
reagents, to date there have been no reports describing a cyclisation-arylation cascade via spirocyclising 
capture of intermediate iron species.  We postulated that a new catalytic method for arylative 
spirocyclisation would occur in the presence of stoichiometric Grignard reagents and iron(III) catalysts, to 
induce cyclisation of (2-iodo)benzyl ethers of furan in a highly stereoselective manner.  The reaction 
would occur through oxidative addition of an iron species to the C-Hal bond, followed by an iron-mediated 
exo-cyclisation.  The resultant organoiron intermediate captures an aryl group from the Grignard reagent, 
to give novel compounds containing spirocyclic centres (Scheme 81).   
 
Scheme 81. Proposed cyclisation-arylation cascade 
 
Following reported methods by Toste,[187] 2-[(2-Iodophenoxy)methyl]furan (89) was synthesised via 
activation of furfuryl alcohol (90) as the mesylate, and subsequent nucleophilic substitution with 
iodophenol (91).  Initial cross-coupling of 89 with phenylmagnesium bromide in the presence of an iron 
catalyst (Fe(acac)3) at room temperature, lead to the formation of the corresponding phenylated cyclised 
product 5ʼ-phenyl-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (88) in moderate yield (41%, Scheme 82).  
 
Scheme 82. Synthesis of 5-phenyl-2H,5H-spiro[benzofuran-3,2'-furan] (88) 
 
The reaction mechanism is unknown, but likely involves radical process in a similar mannor to that 
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postulated by Oshima (Scheme 78), resulting in a cyclised intermediate, which may then undergo cross-
coupling with the Grignard reagent (Scheme 83).  
 
Scheme 83. Postulated reaction mechanistic pathway for the formation of 88 
 
In an attempt to increase the isolated yield of 88, reaction time was extended.  This did not result in an 
increased yield, and therefore other reaction conditions were investigated for optimisation. 
 
4.3 Solvent Effects 
Grignard cross-coupling reactions are typically carried out in ethereal solvents such as diethyl ether, 
diisopropyl ether, dibutyl ether, tetrahydrofuran, and butyldiglyme.  This is due to the nature of the RMgX 
reagent, which is polar and consequently requires a coordinating solvent to keep it in solution. Ethers are 
most suitable owing to the availability of lone-pair electrons for coordination to the magnesium ion and 
resulting solubilisation in organic media.  Solvents with electrophilic sites such as acetonitrile, DMF, 
acetone, and ethyl acetate are unsuitable owing to their reactivity with RMgX.[188]  Following the work of 
Cahiez into the advantages associated with the use of NMP (14) as a co-solvent, a variety of solvent 
systems were applied to the reaction in the presence of NMP (8:1, solvent:14, Table 14). 
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Table 14. Solvent effect on synthesis of 88 
 
Entry Solvent A Solvent B Yield 88 (%) 
1 THF NMP 41 
2 Et2O NMP 63 
3 DMF NMP 0 
4 DMPU NMP 0 
5 DMA NMP 12 
6 Dioxane NMP 0 
 
As expected, the ethereal solvents (Table 14, THF entry 1 and Et2O entry 2) resulted in the highest yield 
of isolated product, with ether leading to the highest reaction yield and 100% conversion, with no starting 
material recovered.  As expected, electrophilic solvents (Table 14, DMF entry 3 and DMPU entry 4) were 
unsuitable, with only starting material recovered. 
 
The effect of the NMP co-solvent addition was examined to observe if an increase in NMP addition would 
affect the stability of the Grignard cross-coupling reagent in the ethereal solvent, and therefore affect the 
reaction yield (Table 15). 
 
In both solvents examined, a normal distribution trend was observed with highest yields at 50:50 
NMP:solvent (Table 15, entries 3 and 8 respectively).  The highest yield achieved was in 50:50 NMP:Et2O 
(Table 15, entry 8, 55%).   Although a higher reaction yield had previously been achieved at 1:1 
NMP:Et2O ratio (Table 14, entry 2), consistently high yields were obtained with 1:1 NMP:Et2O, where as 
with 1:8 yields appeared less reliable, with higher variation in reaction repeats.  Therefore, the 1:1 
NMP:Et2O ratio was taken on for further reaction investigation and optimisation.   
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Table 15. Effect of NMP co-solvent on synthesis of 88 
 
Entry Solvent A Solvent B Ratio A:B Yield 88 (%) 
1 THF NMP 0:100 9 
2 THF NMP 25:75 36 
3 THF NMP 50:50 44 
4 THF NMP 75:25 27 
5 THF NMP 100:0 30 
6 Et2O NMP 0:100 27 
7 Et2O NMP 25:75 37 
8 Et2O NMP 50:50 55 
9 Et2O NMP 75:25 27 
10 Et2O NMP 100:0 19 
 
4.4 Effect of Grignard 
In the 1:1 NMP:Et2O solvent system, 100% consumption of starting material was observed, however 
reaction yield remained modest.  In an attempt to optimise the yield, the amount of Grignard was 
increased in an attempt to increase the yields of the desired product and avoid side-product formation 
(Table 16).  
 
An increase in the excess of Grignard (1.2 eq to 2.4 eq) resulted in a higher isolated yield of 88, (Table 16 
entries 1 and 3, 73% cf. 63%).  Under all conditions examined, full conversion was observed, with no 
starting material (89) recovered after 6 hours.  With increased Grignard addition, ʻclumpedʼ solid was 
observed at the bottom of the reaction flask suggesting reaction end point.  Although the amount of 
Grignard is in significant excess, the increase allows for higher reaction yield and is therefore beneficial. 
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Table 16. Effect of increased excess of Grignard addition on synthesis of 88 
  
 
Entry 
PhMgBr 
(X eq) 
Yield 88 (%) Conversion (%) 
1 1.2 63 100 
2 1.8 64 100 
3 2.4 73 100 
 
4.5 Iron Catalyst 
In order to examine the influence of the iron catalyst, and to test the Cahiez hypothesis that the nature of 
the iron salt used as catalyst leads to no significant difference in the reaction yield in the presence of 
NMP, a range of iron(III) salts were applied to the reaction conditions.  Although Iron(III) chloride (Table 
17, entry 2) gave comparable results to that of Fe(acac)3, salts bearing bulkier ligands were less 
productive in the reaction. 
 
Table 17. Effect of Iron Catalyst on synthesis of 88; 
a
 dbm = dibenzoylmethido, 
b
 dpm = dipivaloylmethido 
 
Entry Catalyst Yield 88 (%) Conversion (%) 
1 Fe(acac)3 73 100 
2 FeCl3 70 100 
3 aFe(dbm)3 7 43 
4 bFe(dpm)3 39 100 
5 Fe2(SO4)3 0 0 
 
Iron(III) sulfate was the only catalyst examined which failed to result in conversion, however this may be 
due to the nature of the compound which commonly exists as the hydrate.  Grignard reagents are highly 
water sensitive and therefore the presence of any hydrated catalyst may have resulted in deactivation of 
the Grignard and subsequent failure in the reaction. With the highest yield of 88 obtained with Fe(acac)3, 
O
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this catalyst appears to be the most suitable from those examined, with FeCl3 an appropriate substitute.  
Access to chiral Fe(acac)3-like catalysts would in future allow for asymmetric varients of the reaction to be 
investigated, and therefore Fe(acac)3 was applied to further reactions.   
 
4.6 Reaction Scope 
Once a robust method had been developed with phenylmagnesium bromide, a range of aryl Grignards 
were applied to the reaction conditions under optimised conditions; iron(III) catalyst [5 mol%], NMP:Et2O 
(1:1) and excess Grignard (2.4 eq).   As FeCl3 had previously been found to be comparable to Fe(acac)3 
catalyst with phenylmagnesium bromide, both were also examined with each of the aryl Grignard 
reagents examined. 
 
4.6.1 Screening of Commercially Available Grignards  
When using Fe(acac)3 with sterically hindered mesitylmagnesium bromide (Table 18, entry 15), no 
coupling was observed.  Molander reported the Grignard cross-coupling of aryl magnesium bromides with 
bromostyrene and found that arylated derivatives were not obtained from the reaction with 
mesitylmangesium bromide.  This was attributed to steric hinderance from the 3 methyl groups on 
benzene.[189]   
 
With the o-methoxy reagent (Table 18, entry 8), coupling was also not observed, possibly due to steric 
interference, however the o-tolyl resulted in cross-coupling in moderate yield (76%, Table 18, entry 6).   
Meta-substituted reagents resulted in mixed results, with m-chlorophenyl and m-fluorophenyl (Table 18, 
entries 2 and 4 respectively) showing no or very little product formation, whereas m-methoxyphenyl 
(Table 18, entry 9, 88%) giving good yield.  In general, all the para-substituted Grignards gave good to 
high yields (39-96%), supporting the theory of steric influence as found by Fürstner. 
 
Isolated yields with FeCl3 catalyst were generally slightly lower, but camparable to when Fe(acac)3 was 
employed.  The only significant differences were found with the p-chlorophenyl and m-fluorophenyl 
analogues (Table 18, entries 3 and 4).  With Fe(acac)3, p-chlorophenyl gave a moderate yield (49%), 
however with FeCl3 no product was able to be isolated or detected by 
1H NMR spectroscopy.  In a similar 
manner, m-fluorophenyl previously showed very low yields with Fe(acac)3 (6%, Table 18, entry 4), 
however gave the highest yield of all the analogues examined with FeCl3 (88%).   
 
All reactions were conducted with commercially available Grignard cross-coupling reagents, and therefore 
relied on the suppliers for accuracy in the reagent strength and quality.  Grignard reagents are notoriously 
difficult to store due to their rapid decomposition when exposed to air and therefore have a reduced shelf-
life.  There was no discernable steric or electronic reason as to why the halo Grignards gave such 
89 
 
  
 
contrasting and unexpected results, based on the other results obtained, and it can therefore not be ruled 
out that the quality of the starting material may be a possible factor. 
 
All products were isolated as predominantly a single diastereoisomer (>20:1 diastereoselectivity), as 
determined by NMR spectroscopy, demonstrating that the reaction is a steroeselevtive processs. 
 
Table 18. Reaction scope: Compatability of aryl Grignards 
     
 
Entry R Product 
Yield  (%) 
Fe(acac)3 
Yield  (%) 
FeCl3 
1 C6H5 88 74 72 
2 m-ClC6H4 92 0 0 
3 p-ClC6H4 93 49 0 
4 m-FC6H4 94 6 88 
5 p-FC6H4 95 74 42 
6 o-MeC6H4 96 76 34 
7 p-MeC6H4 97 89 63 
8 o-OMeC6H4 98 0 0 
9 m-OMeC6H4 99 88 21 
10 p-OMeC6H4 100 74 74 
11 p-tBuC6H4 101 52 41 
12 p-OCF3C6H4 102 39 55 
13 p-PhC6H4 103 96 85 
14 1-Napthyl 104 91 41 
15 2,4,6-MeC6H2 105 0 0 
 
 
4.6.2 Synthesis of Additional Aryl Grignards 
The aryl Grignard screen demonstrated the robustness of the reaction, tolerating a variety of functional 
groups of differing electronic properties.  In an attempt to further probe the reaction, a variety of additional 
non-commercially available Grignard reagents were attempted to be synthesised.  Of particular interest to 
gain wider information as to the electronic tolerance of the reaction are the electron withdrawing p-
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nitrophenyl and p-aryl methyl ester Grignards. 
 
Nitro groups are electrophilic and therefore not suitable for preparation by activated magnesium, as the 
presence of the nitro group inhibits insertion of magnesium into the carbon-halogen bond.[190]  Knochelʼs 
chemoselective magnesium-iodine exchange reaction has however been used to synthesise nitro 
Grignards and Grignards containing ester functional groups.[191]   
 
Due to the instability of Grignards and difficulties associated with storage, the desired Grignards were 
generated in situ directly followed by arylative spirocyclisation with 89 and Fe(acac)3 catalyst.  As the 
Grignard is not isolated, it cannot be concluded as to whether both or one of the two steps in the process 
are unsuccessful.  For this reason, p-methoxy was also included, as the arylative spirocyclisation reaction 
has been shown to be successful with this Grignard reagent in consistently high yields (Scheme 84).   
 
Scheme 84. Synthesis of Aryl Griganrds via magnesium-iodine exchange 
 
Only the p-(methoxycarbonyl)phenyl Grignard gave the desired product, though in lower yield than 
previously observed with the commercially produced Grignard (15% yield, cf. 74% Table 17, entry 10), 
showing that the magnesium-iodide exchange can be achieved for this analogue, though not as 
successfully as with the use of the commercially available Grignard.. 
 
Knochel has reported that whereas bromine-lithium exchange is a rapid process, occuring at low 
temperatures, bromine-magnesium exchange is considerably slower.  This results in the exchange 
process requiring higher temperatures, which limits the application to sensitive functional groups.  
Knochel found that by incorporating lithium salts (LiCl), the exchange occurred at an increased rate with 
higher yields obtained (Scheme 85).[192]  Further optimisation lead to the development of a range of 
commercially available Turbo Grignards, such as iPrMgBr.LiCl.  Turbo Grignards have lead to the ability 
to convert a variety of sensitive, functionalised halides to their corresponding organometallic Grignard 
reagents.   
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Scheme 85. Knochelʼs investigations into the developement of the Turbo Grignard iPrMgCl.LiCl 
 
The sysnthesis of p-(Methoxycarbonyl)phenyl Grignard and indolyl Grignard were attempted from Turbo 
Grignard iPrMgCl.LiCl and the corresponding iodide and bromide respectively (Scheme 86 and 87). 
 
Scheme 86. Synthesis of Indolyl Grignard via Turbo Grignard 
 
 
Scheme 87. Synthesis of p-(methoxycarbonyl) phenyl via Turbo Grignard 
 
In both examples examined, the desired products were not observed by 1H NMR spectroscopic analysis.  
Again, as the Grignard generation occurs in situ, the unsuccessful step in the process could not be 
identified.  However, if successfully formed, magnesium chlorides would be produced.  Commercially 
available magnesium chloride Grignard reagents were found to be incompatible with the spirocyclisation 
reaction, and therefore synthsis of Grignards in the manner is not ideal (Scheme 88). 
 
Scheme 88. Arylative spirocyclisation with aryl Grignard chlorides 
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4.7 Determining Product Structure 
When products are examined by NMR spectroscopy in d6-DMSO, the peak dispersion increased, which 
allows for nOe to be conducted on each environment.  All products isolated were produced as 
predominantly a single diastereoisomer (>20:1 diastereoselectivity).  nOe experiments were conducted to 
provide evidence for the structure of the major product.  If the rings were in a cis-conformation, nOe would 
be observed between the proton at C-11 and the methylene protons at C-7, as demonstrated in Figure 
16A.  The lack of an nOe interaction between the C-11 proton and the C-7 protons can be visualised by 
nOe, as shown for the p-Me analogue 97 in Figure 17, which provides some evidence for the major 
product to be that of the isomer in which the aryl rings are in the trans-arrangement.  Further work would 
be required to confirm the structure, by methods such as functionalisation of the olefin.  
 
Figure 16. Conformations of arylative cyclisation products, 
with aryl rings in A) cis- and B) trans-arrangement 
 
 
Figure 17. nOe spectra of 97, with irradiation at C-11. 
 
We suggest that the reaction proceeds through an intermediate σ-bonded aryl-iron species, which 
cyclises to give an allyl iron species 106 which can isomerise via 107 to the less hindered intermediate 
108.  Reductive elimination results in 5ʼ-phenyl-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] 88 (Scheme 89).     
O
O
1
2
3
4
5
6
7
8
9
1011
12
13
14
15
16
17
O
O
H
Ar
vs
A B
O
O
1
2
3
4
5
6
7
8
9
1011
12
13
14
15
16
17
H
H
nOe
nOe
O
O
Ar
H
H
H
93 
 
  
 
 
Scheme 89. Postulated arylative spirocyclisation process 
 
4.8 Application of Alternative Grignard Reagents 
The arylative spirocyclisation reaction has been shown to occur in moderate to high yields with a variety 
of aryl Grignards.  The reaction may potentially also occur with alkyl- or heteroaryl-Grignards.  Although 
Indole Grignard was unable to be synthesised, a variety of other alkyl- and heteroaryl-Grignards are 
commercially available, a few of which were applied to the reaction under the previously described 
reaction conditions developed (Table 19).   
 
Table 19. Reaction scope: Compatability of Grignards 
 
Entry R Product Yield  (%) 
1 Me 109 0 
2 Et 110 36 
3 iPr 111 0 
4 2-Thienyl 112 0 
 
Fürstner conducted extensive investigations into the series of organoiron complexes, showing that 
MeMgBr and EtMgBr (and higher chains) exhibit strikingly different behavior.  They report that in 
attempted cross coupling reactions of aryl chlorides with EtMgBr the desired product is obtained in 
virtually quantitative yield within minutes, whereas MeMgBr fails to react (Scheme 90).[193]   
 
Scheme 90. Behavious of different Grignards towards cross-coupling 
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Application of MeMgBr and EtMgBr to the spirocyclisation reaction gave results in accordance with the 
work of Fürstner, with only EtMgBr resulting in cross-coupling (110), isolated in moderate yield (Table 19, 
entry 2).  The thienyl compound failed to give the desired product 112 (entry 4, Table 18).   
 
The reaction of isopropylmagnesium bromide with 89 did not result in spirocyclisation, instead giving 
quantitative formation of the de-iodinated product 113 (Scheme 91).   
 
Scheme 91. Reaction of 
i
PrMgBr with 89 
 
4.7 Conclusions and Future Work 
Arylative spirocyclisation in the presence of stoichiometric Grignard reagents and iron(III) catalysts has 
been developed, to induce cyclisation of 2-[(2-Iodophenoxy)methyl]furan 89 in a highly stereoselective 
manner, to give novel compounds containing spirocyclic centres.    The reaction has proved highly 
versatile with application of a range of arylmagnesium bromide Grignard reagents of varying electronic 
and steric properties in good to excellent yields.  Although initial examination of alkyl Grignards has not to 
date provided many compatible cross-coupling partners, further exploration is necessary, in particular 
examination of the applicability of heterocylic and heteroaryl Grignards such as furans and indoles.  
Alteration of the starting material would also enable access to a wider range of spirocyclic compound, for 
example variation of the chain length or heteroatoms. 
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CHAPTER 5: EXPERIMENTAL: IRON CATALYSED ARYLATIVE SPIROCYCLISATION  
 
2-[(2-Iodophenoxy)methyl]furan (89)
[187]
 
 
To a stirred solution of furfuryl alcohol in DCM (0.5 M, 57.4 mL, 30 mmol, 1 eq) and triethylamine (4.6 mL, 
33 mmol, 1.1 eq) at 0 oC was added methanesulfonyl chloride (2.4 mL, 31.5 mmol, 1.05 eq) dropwise. 
The reaction mixture was maintained at 0 oC for 30 minutes and then poured into saturated aqueous 
NaHCO3 (20 mL). The aqueous and organic layers were separated, and the aqueous layer was extracted 
with DCM (2 x 20 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo to afford the crude product which was used without further purification. 
 
To a solution of the crude product in acetone (30 mL) was added in succession iodophenol (3.05 g, 27 
mmol, 0.90 eq), K2CO3 (8.29 g, 60 mmol, 2.0 eq) and NaI (0.44 g, 3 mmol, 0.1 eq). The reaction mixture 
was stirred for 24 hours and then concentrated in vacuo.  To the crude residue was added water (20 mL) 
and DCM (20 mL).  The aqueous and organic layers were separated and the aqueous layer extracted 
with DCM (2 x 20 mL). The combined organic layers were washed with NaOH (1M, 20 mL), dried over 
Na2SO4, filtered and concentrated in vacuo to afford the crude product which was purified by column 
chromatography (Pet. Ether: EtOAc, 9:1, Rf 0.40) to yield 2-[(2-iodophenoxy)methyl]furan as a yellow oil 
(3.13 g, 39%); 1H NMR (CDCl3, 400 MHz) δ
H 5.06 (s, 2H, CH2), 6.37 (br t J 1.5 Hz, 1H, 4 -CH), 6.45 (d J 
3.0 Hz, 1H, 3 -CH), 6.73 (t J 7.5 Hz, 1H, 4ʼ Ar -CH), 6.94 (d J 8.0 Hz, 1H, 6ʼ Ar -CH), 7.28 (t J 7.5 Hz, 1H, 
5ʼ Ar -CH), 7.44 (s, 1H, 5 -CH), 7.77 (d J 8.0 Hz, 1H, 3ʼ Ar -CH); 13C NMR (100 MHz) δC 63.8 (-CH2), 
87.23 (2 quat. C), 110.5 (4 -CH), 111.0 (3 -CH), 113.4, 123.2, 129.3, 139.5 (Ar -CH), 142.9 (5 -CH), 
149.8, 157.0 (1ʼ, 2ʼ Ar -C); νmax (thin film, cm
-1) 1579 (C=C), 1502 (C=C aromatic) 1236 (C-O); m/z 
[C11H9O2INa]
+ expected 322.9545, found 322.9538. 
 
General Method for arylative spirocyclisation:   
An oven dried flask was charged with 2-[(2-iodophenoxy)methyl]furan (0.300 g, 1.0 mmol, 1 eq) and 
Fe(III) catalyst (0.05 mmol, 5 mol%) and purged with nitrogen.  Et2O (2.5 mL) and NMP (2.5 mL) were 
then added and the flask evacuated and refilled with nitrogen (x 3). To the resulting solution was added 
arylmagnesium bromide (1M in THF or Et2O, 2.4 mmol, 2.4 eq) dropwise over 30 min, and the resulting 
solution stirred for 6 hours at room temperature.  The reaction mixture was diluted with ethyl acetate (25 
mL) and the organic washed sequentially with aq. HCl (2M, 20 mL), water (20 mL) and brine (20 mL). The 
organic was then dried over MgSO4, filtered and concentrated in vacuo to give the crude product which 
was purified by flash column chromatography (2% EtOAc in Hexane) to give the corresponding spirocyclic 
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compound.  
 
5ʼ-Phenyl-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (88) 
 
5ʼ-Phenyl-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid (0.182 g, 73%) from 
phenyl magnesium bromide (1M in THF, 2.4 mL) following the general method; Rf 0.17 (2% EtOAc in 
Hex); 1H NMR (DMSO-d6, 400 MHz) δH 4.50 (d J 10.5 Hz, 1H, 2 -CH2), 4.61 (d J 10.5 Hz, 1H,  2 -CH2), 
5.95 (br s, 1H,  5ʼ -CH), 6.12 (dd J 1.0 Hz 6.0 Hz, 1H, 3ʼ -CH), 6.30 (d J 6.0 Hz, 1H, 4ʼ -CH), 6.91 (d J 8.0 
Hz, 1H, Ar -H), 6.97 (t J 7.5 Hz, 1H, Ar -H), 7.24 (d J 7.0 Hz, 1H, Ar -H), 7.28-7.34 (m, 4H, Ar -H),  7.39-
7.52 (m, 2H, Ar -H); 13C NMR (100 MHz) δC
 80.1 (2 -CH2), 87.1 (5ʼ -CH), 95.9 (3  quat. -C), 110.7, 124.9, 
125.5, 126.8, 128.2, 128.8 (Ar -C), 128.9 (3ʼ -CH), 129.2 (Ar -C), 131.1 (4ʼ -CH), 133.7, 141.6, 160.0 (Ar  
quat. -C); νmax (thin film, cm
-1) 1599 (C=C), 1492 (C=C aromatic) 1178 (C-O); m/z [C17H14O2Na]
+ expected 
273.0891, found 273.0888. 
 
5ʼ-(4-Chlorophenyl-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (93) 
 
5ʼ-(4-Chlorophenyl-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid (0.188g, 
49%) from 4-chloromagnesium bromide (1M in Et2O, 2.4 mL) following the general method; Rf 0.04 (2% 
EtOAc in Hex);  1H NMR (CDCl3, 400 MHz) δH 4.41 (d J 10.5 Hz, 1H, 2 -CH2), 4.48 (d J 10.5 Hz, 1H, 2 -
CH2), 5.84 (t J 2.0 Hz, 1H, 5ʼ -CH), 5.88 (dd J 2.5 Hz 6.0 Hz, 1H, 3ʼ -CH), 6.85 (dd J 2.0 Hz 8.0 Hz, 1H, 4ʼ 
-CH), 6.79 (d J 8.0 Hz, 1H, Ar -H), 6.87 (dt J 1.0 Hz 7.5 Hz, 1H, Ar -H), 7.12-7.27 (m, 6H, Ar -H); 13C NMR 
(100 MHz) δC
 79.2 (2 -CH2), 85.5 (5ʼ -CH), 95.1 (3 -quat. C), 109.7, 120.0, 123.2, 126.8, 127.7 (Ar -C), 
128.2 (3ʼ -CH), 129.7 (Ar -C), 130.7 (4ʼ -CH), 132.8, 138.3, 141.8, 159.0 (Ar quat. -C); νmax (thin film, cm
-1) 
1597 (C=C), 1475 (C=C aromatic) 1177 (C-O); m/z [C17H13O2
35ClNa]+ expected 307.0502, found 
307.0496. 
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5ʼ-(3-Fluorophenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (94) 
 
5ʼ-(3-Fluorophenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained synthesised as a pale yellow liquid 
(17 mg, 6%) from 3-fluoromagnesium bromide (1M in THF, 2.4 mL) following the general method; Rf 0.04 
(2% EtOAc in Hex); 1H NMR (CDCl3, 400 MHz) δH 4.52 (d J 10.5 Hz, 1H, 2 -CH2), 4.68 (d J 10.5 Hz, 1H, 2 
-CH2), 5.83-5.90 (m, 2H, 3ʼ, 5ʼ -CH), 6.06 (d J 5.5 Hz, 1H, 4ʼ -CH), 6.79 (d J 8.0 Hz, 1H, Ar -CH), 6.87 (t J 
7.5 Hz, 1H, Ar -CH), 7.10-7.24 (m, 6H, Ar -CH); 13C NMR (100 MHz) δC
 80.2 (2 -CH2), 86.6 (C11- CH), 
96.3 (3 quat. -C), 110.7, 113.2, 115.0, 121.1, 124.3 (Ar -C), 127.7 (quat. Ar -C), 129.2 (3ʼ -CH), 130.1, 
130.2 (Ar -CH), 130.8 (4ʼ -CH), 131.7 (Ar -C), 143.6, 160.1, 164.2 (quat. Ar -C); 19F NMR (CDCl3, 400 
MHz) δF
 -112.5 (CF); νmax (thin film, cm
-1) 1592 (C=C), 1476 (C=C aromatic) 1179 (C-O); m/z 
[C17H13O2FNa]
+ expected 291.0797, found 291.0792. 
 
5ʼ-(4-Fluorophenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (95) 
 
5ʼ-(4-Fluorophenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid (0.198 g, 
74%) from 4-fluoromagnesium bromide (1M in THF, 2.4 mL) following the general method; Rf 0.04 (2% 
EtOAc in Hex); 1H NMR (CDCl3, 400 MHz) δH 4.49 (d J 10.5 Hz, 1H, 2 -CH2), 4.55 (d J 10.5 Hz, 1H, 2 -
CH2), 5.92 (t J 2.0 Hz, 1H, 5ʼ -CH), 5.95 (dd J 2.0 Hz 6.0 Hz, 1H, 3ʼ -CH), 6.11 (dd J 1.5 Hz 6.0 Hz, 1H, 4ʼ 
-CH), 6.86 (d J 8.0 Hz, 1H, Ar -CH), 6.94 (dd J 1.0 Hz 7.5 Hz, 1H, Ar -CH), 6.98-7.04 (m, 2H, Ar -CH), 
7.20-7.26 (m, 4H, Ar -CH); 13C NMR (100 MHz) δC
 80.3 (2 -CH2), 86.6 (5ʼ -CH), 96.0 (3 quat. -C), 110.7, 
115.5, 121.0, 124.3 (Ar -C), 128.3 (quat. Ar -C), 128.4 (3ʼ -CH), 129.2 (Ar -C), 130.7 (4ʼ -CH), 131.9 (Ar -
C), 136.7, 160.1, 163.8 (quat. Ar -C); 19F NMR (CDCl3, 400 MHz) δF
 -114.0 (CF); νmax (thin film, cm
-1) 1600 
(C=C), 1476 (C=C aromatic) 1177 (C-O);m/z [C17H13O2FNa]
+ expected 291.0797, found 291.0787. 
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5ʼ-(o-Tolyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (96) 
 
5ʼ-(o-Tolyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid (0.200 g, 76%) from 
2-methylmagnesium bromide (2M in THF, 1.2 mL) following the general method; Rf 0.14 (2% EtOAc in 
Hex); 1H NMR (CDCl3, 400 MHz) δH 2.37 (s, 3H, -CH3), 4.58 (d J 10.5 Hz, 1H, 2 -CH2), 4.78 (d J 10.5 Hz, 
1H, 2 -CH2), 5.92 (dd J 2.5 Hz 8.0 Hz, 1H, 3ʼ -CH), 6.15 (dd J 1.5 Hz 6.5 Hz, 1H, 5ʼ -CH), 6.19 (t J 2.0 Hz, 
1H, 4ʼ -CH), 6.86 (d J 8.0 Hz, 1H, Ar -CH), 6.93 (t J 7.5 Hz, 1H, Ar -CH), 7.10-7.29 (m, 6H, Ar -CH); 13C 
NMR (100 MHz) δC
 19.3 (-CH3), 80.4 (2 -CH2), 84.3 (5ʼ -CH), 95.8 (3 quat. -C), 110.4, 121.1, 124.6, 126.0 
(Ar -C), 127.9 (3ʼ -CH), 128.5 (quat. Ar -C), 129.2, 130.6 (Ar -C), 130.7 (4ʼ -CH), 131.6 (Ar -C), 135.5, 
138.8, 160.2 (quat. Ar -C); νmax (thin film, cm
-1) 1598 (C=C), 1476 (C=C aromatic) 1178 (C-O); m/z 
[C18H16O2Na]
+ expected 287.1048, found 287.1044. 
 
5ʼ-(p-Tolyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (97) 
 
5ʼ-(p-Tolyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid (0.235 g, 89%) from 
4-methylmagnesium bromide (1M in THF, 2.4 mL) following the general method; Rf 0.06 (2% EtOAc in 
Hex); 1H NMR (CDCl3, 400 MHz) δH 2.38 (s, 3H, -CH3), 4.46 (d J 10.5 Hz, 1H, 2 -CH2), 4.55 (d J 10.5 Hz, 
1H, 2 -CH2), 5.91-5.94 (m, 2H, 3ʼ, 5ʼ -CH), 6.12 (t J 3.5 Hz, 1H, 4ʼ -CH), 6.56 (dd J 1.0 Hz 8.0 Hz, 1H, Ar -
CH), 6.93 (dt J 1.0 Hz 7.5 Hz, 1H, Ar -CH), 7.14-7.19 (m, 4H, Ar -CH), 7.22-7.27 (m, 2H, Ar -CH); 13C 
NMR (100 MHz) δC
 21.2 (-CH3), 80.5 (2 -CH2), 87.3 (5ʼ -CH), 95.9 (3 quat. -C), 110.7, 121.1, 124.4 (Ar -
C), 128.1 (quat. Ar -C), 128.3 (3ʼ -CH), 128.9 (Ar -C), 130.7 (4ʼ -CH), 132.2 (Ar -C), 137.9, 160.2 (quat. Ar 
-C); νmax (thin film, cm
-1) 1598 (C=C), 1475 (C=C aromatic) 1177 (C-O); m/z [C18H16O2Na]
+ expected 
287.1048, found 287.1042. 
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5ʼ-(3-Methoxyphenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (99) 
 
5ʼ-(3-Methoxyphenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid (0.246 g, 
88%) from 4-methoxyphenylmagnesium bromide (1M in THF, 2.4 mL) following the general method, 
purified by flash column chromatography (activated basic alumina, 2% EtOAc in Hex); Rf 0.53 (20% 
EtOAc in Hex); 1H NMR (CDCl3, 400 MHz) δH 3.78 (s, 3H, -OCH3), 4.47 (d J 10.5 Hz, 1H, 2 -CH2), 4.58 (d 
J 10.5 Hz, 1H, 2 -CH2), 5.94 (br d J 3.5 Hz, 2H, 3ʼ, 5ʼ -CH), 6.15 (t J 3.5 Hz, 1H, 4ʼ -CH), 6.80-6.87 (m, 3H, 
Ar -CH), 6.94 (t 7.5 Hz, 1H, Ar -CH), 7.21-7.35 (m, 4H, Ar -CH); 13C NMR (100 MHz) δC
 55.2 (-OCH3), 
80.4 (2 -CH2), 87.2 (5ʼ -CH), 96.1 (3 quat. -C), 110.7, 112.2, 112.4, 118.8, 121.1, 124.4 (Ar -C), 128.2 
(quat. Ar -C), 128.9 (3ʼ -CH), 129.6 (Ar -C), 130.7 (4ʼ -CH), 132.1 (Ar -C), 142.5, 159.9, 160.0 (quat. Ar -
C); νmax (thin film, cm
-1) 1608 (C=C), 1475 (C=C aromatic) 1172 (C-O); m/z [C18H16O3Na]
+ expected 
303.0997, found 303.0991. 
 
5ʼ-(4-Methoxyphenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (100) 
 
5ʼ-(4-Methoxyphenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid (0.207 g, 
74%) from 3-methoxyphenylmagnesium bromide (0.5M in Et2O, 4.8 mL) following the general method, 
purified by flash column chromatography (activated basic alumina, 2% EtOAc in Hex); Rf 0.49 (20% 
EtOAc in Hex); 1H NMR (CDCl3, 400 MHz) δH 3.79 (s, 3H, -OCH3), 4.39 (d J 10.5 Hz, 1H, 2 -CH2), 4.46 (d 
J 10.5 Hz, 1H, 2 -CH2), 5.93 (br s, 1H, 5ʼ -CH), 5.97 (d J 6.0 Hz, 1H, 3ʼ -CH), 6.14 (d J 6.0 Hz, 1H, 4ʼ -
CH), 6.85-6.89 (m, 3H, Ar -CH), 6.95 (t J 7.0 Hz, 1H, Ar -CH), 7.20-7.30 (m, 4H, Ar -CH); 13C NMR (100 
MHz) δC
 55.3 (-OCH3), 80.5 (2 -CH2), 87.0 (5ʼ -CH), 95.7 (3 quat. -C), 110.6, 114.1, 121.1, 124.4 (Ar -C), 
128.0 (3ʼ -CH), 128.2 (quat. Ar -C), 129.0 (Ar -C), 130.7 (4ʼ -CH), 132.2 (Ar -C), 133.0, 159.6, 160.2 (quat. 
Ar -C); νmax (thin film, cm
-1) 1608 (C=C), 1475 (C=C aromatic) 1172 (C-O); m/z [C18H16O3Na]
+ expected 
303.0997, found 303.0992.  
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5ʼ-(4-(tert-Butyl)-phenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (101) 
 
5ʼ-(4-(tert-Butyl)-phenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid (0.1601 
g, 52%) from 4-(tert-Butyl)phenylmagnesium bromide (0.5M in THF, 4.8 mL) following the general 
method; Rf 0.05 (2% EtOAc in Hex); 
1H NMR (CDCl3, 400 MHz) δH 1.30 (s, 9H, -C(CH3)3), 4.47 (d J 10.5 
Hz, 1H, 2 -CH2), 4.57 (d J 10.5 Hz, 1H, 2 -CH2), 5.91 (dd J 2.0 Hz 6.0 Hz, 1H, 3ʼ -CH), 5.93 (t J 2.0 Hz, 
1H, 5ʼ -CH), 6.12 (dd J 1.5 Hz 6.0 Hz, 1H, 4ʼ -CH), 6.85 (d J 8.0 Hz, 1H, Ar -CH), 6.92 (dt J 1.0 Hz 7.5 Hz, 
1H, Ar -CH), 7.20-7.24 (m, 6H, Ar -CH); 13C NMR (100 MHz) δC
 31.5 (-C(CH3)3), 34.6 (3 quat. -C), 80.5 (2 
-CH2), 87.3 (5ʼ -CH), 96.0 (quat. Ar -C), 110.7, 121.1, 124.5, 125.6, 126.5 (Ar -C), 128.4 (quat. Ar -C) 
128.9 (3ʼ -CH), 130.7 (4ʼ -CH), 132.2 (Ar -C), 137.9, 151.2, 160.2 (quat. Ar -C); νmax (thin film, cm
-1) 2960 
(C-H), 1599 (C=C), 1475 (C=C aromatic) 1177 (C-O); m/z [C21H22O2Na]
+ expected 329.1517, found 
329.1507. 
 
5ʼ-(4-Trifluoromethoxyphenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (102) 
 
5ʼ-(4-Trifluoromethoxyphenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a pale yellow liquid 
(0.130 g, 39%) from 4-(trifluoromethoxy)phenylmagnesium bromide (0.5M in THF, 4.8 mL) following 
general the method; Rf 0.06 (2% EtOAc in Hex); 
1H NMR (CDCl3, 400 MHz) δH 4.42 (d J 10.5 Hz, 1H, 2 -
CH2), 4.49 (d J 10.5 Hz, 1H, 2 -CH2), 5.83-5.90 (m, 2H, 3ʼ, 5ʼ -CH), 6.06 (d J 5.5 Hz, 1H, 4ʼ -CH), 6.79 (d J 
8.0 Hz, 1H, Ar -CH), 6.87 (t J 7.5 Hz, 1H, Ar -CH), 7.10-7.24 (m, 6H, Ar -CH); 13C NMR (100 MHz) δC
 52.5 
(-OCF3), 79.2 (2 -CH2), 85.4 (5ʼ -CH), 95.2 (3 quat. -C), 109.7, 120.1, 123.2,  (Ar -C), 126.4 (quat. Ar -C), 
126.8 (Ar -C), 128.2 (3ʼ -CH), 129.8 (Ar -C), 130.7 (4ʼ -CH), 138.5, 147.9, 159.1 (quat. Ar -C); 19F NMR 
(CDCl3, 400 MHz) δF
 -62.5 (-OCF3); νmax (thin film, cm
-1) 1598 (C=C), 1477 (C=C aromatic) 1259, 1165 (C-
O); m/z [C18H13O3F3Na]
+ expected 357.0714, found 357.0707. 
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5ʼ-(Biphenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (103) 
 
5ʼ-(Biphenyl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a white solid (0.313 g, 96%) from 4-
biphenylmagnesium bromide (0.5M in THF, 4.8 mL) following the general method; Rf 0.04 (2% EtOAc in 
Hex); mpt 82-83 oC; 1H NMR (CDCl3, 400 MHz) δH 4.47 (d J 10.5 Hz, 1H, 2 -CH2), 4.59 (d J 10.5 Hz, 1H, 
2 -CH2), 5.89 (br d J 6.0 Hz, 1H, 3ʼ -CH), 5.96 (br s, 1H, 5ʼ -CH), 6.11 (br d J 6.0 Hz, 1H, 4ʼ -CH), 6.80 (d J 
8.0 Hz, 1H, Ar -CH), 6.93 (t J 7.0 Hz, 1H, Ar -CH), 7.21-7.42 (m, 7H, Ar -CH; ), 7.54 (d J 8.0 Hz, 4H, Ar -
CH); 13C NMR (100 MHz) δC
 80.5 (2 -CH2), 87.2 (5ʼ -CH), 96.2 (3 quat. -C), 110.8, 121.2, 124.5, 126.9, 
127.3, 127.4, 127.5 (Ar -C), 128.2 (quat. Ar -C), 128.9 (3ʼ -CH), 129.1 (Ar -C), 130.8 (4ʼ -CH), 132.2 (Ar -
C), 140.0, 140.8, 141.2, 160.3 (quat. Ar -C); νmax (thin film, cm
-1) 1598 (C=C), 1475 (C=C aromatic) 1176 
(C-O); m/z [C23H18O2Na]
+ expected 349.1204, found 349.1190. 
 
5ʼ-(Napthalen-1-yl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (104) 
 
5ʼ-(Napthalen-1-yl)-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained as a white solid (0.273 g, 91%) from 
2-napthylmagnesium bromide (0.25M slurry in THF, 9.6 mL) following the general method; Rf 0.04 (2% 
EtOAc in Hex); mpt 98-99 oC; 1H NMR (CDCl3, 400 MHz) δH 4.68 (d J 10.5 Hz, 1H, 2 -CH2), 4.55 (d J 10.5 
Hz, 1H, 2 -CH2), 6.03 (dd J 2.0 Hz 6.0 Hz, 1H, 4ʼ -CH), 6.15 (t J 2.0 Hz, 1H, 5ʼ -CH), 6.26 (dd J 1.5 Hz 6.0 
Hz, 1H, 3ʼ -CH), 6.90 (d J 8.0 Hz, 1H, Ar -CH), 6.98 (dt J 1.0 Hz 7.5 Hz, 1H, Ar -CH), 7.26-7.38 (m, 2H, Ar 
-CH), 7.40 (dd J 1.5 Hz, 8.0 Hz, 1H, Ar -CH), 7.46-7.51 (m, 3H, Ar -CH), 7.77 (d J 1.0 Hz, 1H, Ar -CH), 
7.82-7.86 (m, 2H, Ar -CH); 13C NMR (100 MHz) δC
 80.4 (2 -CH2), 87.5 (5ʼ -CH), 96.2 (3 quat. -C), 110.7, 
121.1, 124.3, 124.4, 125.8, 126.1, 126.3, 127.7, 127.8, 128.0 (Ar -C), 128.1 (quat. Ar -C), 128.5 (4ʼ -CH), 
129.1 (Ar -C), 132.1 (3ʼ -CH), 133.2, 133.3, 138.2, 160.1 (quat. Ar -C); νmax (thin film, cm
-1) 1599 (C=C), 
1476 (C=C aromatic) 1178 (C-O); m/z [C21H16O2Na]
+ expected 323.1048, found 323.1039. 
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5ʼ-Ethyl-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] (110) 
 
5ʼ-Ethyl-2H,5ʼH-spiro[benzofuran-3.2ʼ-furan] was obtained in its crude form as an orange oil (0.061 g) 
from ethylmagnesium bromide (1M in THF, 2.4 mL) following the general method; Rf 0; 
1H NMR (CDCl3, 
400 MHz) δH 0.93 (t J 7.5 Hz, 3H, -CH3), 1.55-1.67 (m, 2H, -CH2), 4.39 (d J 10.5 Hz, 1H, 2 -CH2), 4.48 (d 
J 10.5 Hz, 1H, 2 -CH2), 4.96 (dt J 2.0 Hz 5.5 Hz, 1H, 5ʼ -CH), 5.79 (dd J 2.0 Hz 6.0 Hz, 1H, 3ʼ -CH), 6.86 
(dd J 1.0 Hz 6.0 Hz, 1H, 4ʼ -CH), 6.84-6.99 (m, 2H, Ar -CH), 7.15-7.30 (m, 2H, Ar -CH); 13C NMR (100 
MHz) δC
 9.36 (-CH3), 29.3 (-CH2), 80.8 (2 -CH2), 86.9 (5ʼ -CH), 95.2 (3 quat. -C), 110.5, 121.0, 124.4 (Ar -
C), 128.6 (3ʼ -CH), 129.5 (quat. Ar -C), 130.5 (4ʼ -CH), 132.3 (Ar -C), 160.0 (quat. Ar -C); νmax (thin film, 
cm-1) 2964, 2933 (C-H), 1599 (C=C), 1476 (C=C aromatic) 1178 (C-O); m/z [C13H14O2Na]
+ expected 
225.0891, found 225.0886. 
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